Investigations into the Dynamic Molecular Mechanisms that Govern the Final Stages of Neurotransmitter Release. by Lam, Alice D.
Investigations into the Dynamic Molecular Mechanisms                                        












A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
(Neuroscience) 














 Professor Edward L. Stuenkel, Chair 
 Professor Stephen K. Fisher 
 Professor Benjamin L. Margolis 
 Professor Michael D. Uhler 
 Assistant Professor Jose A. Esteban 









for mom and dad, 




















Super thanks to my husband, Ziba Rifulus Scott, for all of his love, patience, 
support, diplomacy, and stealthy ninja moves.   I couldn’t have done this without you! 
Thank you for being ridiculously understanding all those times I said I had an hour’s 
worth of experiments to do in the lab, and it ended up taking 5 hours instead.   Thanks 
for bringing dinner and for keeping me company on those very-late-nights-turned-early-
mornings in the lab, and for never complaining, even when you had to get up early to go 
to work the next day.  Thanks for whole-heartedly supporting my scientific endeavours 
and escapades, even if it meant being apart for the summer, or for several days or 
weeks at a time.  Thanks for your sound advice for all of those sticky situations I 
somehow always managed to get myself into.  Thanks for being my technical guru and 
in-house 3-D graphics artist.  Thanks for driving me to work in the winter because you 
know how much I hate the cold.  Thanks for allowing me to vent all of the frustrations of 
science upon you, and for never once giving me the impression that you were sick of 
hearing about it.  Thank you for being my flashlight when I was in a dark place.   
Many many many many many many many many many many many many many 
many many many many many many many many thanks to my mentor and friend Ed 
Stuenkel, for always pushing me to go one step beyond what I thought was possible, 
and for giving me the growing space to develop into an independently thinking scientist.  
Thank you for treating me as your colleague rather than as your student, and for giving 
me the confidence to pursue my own scientific ideas and interests.  Thanks for putting 
up with my scientific growing pains, and for your words of encouragement during 
rough times.  Thanks for helping me write my NRSA, and for suffering through the 
atrocities of someone who had never even heard of a specific aim before.  Thanks for 
sending me to Woods Hole for a whole summer, even when money was tight and the 
situation was grim.  Thanks for sending me to the Middle East, so that I could be caught 
under sniper fire as I disembarked my private jet.  Thanks for reminding me to always 
keep a sense of humor about life in general. Thanks for the fun, the frustration, the good 
times and the bad, the fish tank, the skateboard rack, First Fridays, setting off illegal 
fireworks at my wedding, useless bickering that just boiled down to semantics in the end, 
ten shekels, teaching me how to drive stick shift, exciting travels all over the world, prank 
calls from the NIH, not getting mad all of those times I schooled you really really badly 
on the basketball court, and for your general irreverence. 
 Thanks to the many former and current members of the Stuenkel Lab for putting 
up with me, and for their help, camaraderie, encouragement, discouragement, DNA 
constructs, stale cookies, middle eastern pastries, thoughtfulness, amusements, dollar 
burger Tuesdays, and in general, for providing a highly memorable experience:  Bill Ho, 
Quanwen Li, Svetlana Gladycheva, Dequan Tian, Jiang Liu, Flora Lee, Matt Merrins, 
Rishi Chaudhuri, Ray Wu, Ashhar Ali, Helen Lee, Randy Hlubek, Sahar Ismail, Woody 
Hoerauf, Ashley Fletcher, and Chris Jaeger.  Special thanks to Matt Merrins, for teaching 
me most of the molecular biology techniques I now know.  Thanks to Steve Ernst, for 
being willing to help out with wacky new ideas for imaging experiments, and for his 
refreshing presence.   
Thanks to our neighboring labs, the Lopatin Lab and the Rui Lab, for coming to 
my rescue when I needed to borrow reagents or supplies, and for allowing me to use 
their lab equipment.   Thanks to the Holz lab for helpful advice and reagents for 
secretion assays and chromaffin cells, and for advice on TIRF imaging.  Thanks to the 
Ashery Laboratory in Tel Aviv for a fun and fruitful scientific collaboration.  Thanks to 
iv 
 
Adam Hoppe, for useful discussions on FRET imaging, and to Dan Axelrod, for useful 
discussions on TIRF imaging.   
Thank you to the members of my Dissertation Committee (Mary Bittner, Jose 
Esteban, Steve Fisher, Ben Margolis, Ed Stuenkel, and Mike Uhler) for all of their time, 
encouragement, intellectual input and ideas, and for perhaps being the only people in 
the world who will ever read this dissertation in its entirety. 
Thanks to the University of Michigan Medical Scientist Training Program (Ron 
Koenig, Penny Morris, Ellen Elkin, Hillka Ketola, Laurie Koivupalo) for all of their help, 
support, and funding through the years.  Thanks also to the Neuroscience Program and 
to the Department of Molecular and Integrative Physiology for funding and administrative 
support.  Thanks to the National Institutes of Health, for funding most of my graduate 
work (NRSA NS053263). 
Thanks to my family for their unconditional love (even in times where I probably 
didn’t warrant it).  Thanks Mom and Dad, for doing everything in your power to make 
sure I would have all of the opportunities I needed to come as far as I have (and to 
maybe even go a bit further!).  Thanks Mom for constantly worrying about everything 
(like a mother should), and for baking me cookies even though they aren’t good for my 
health.  Thanks Dad, for always going through your checklist over the phone to make 
sure everything was going fine, and for teaching me how to load the dishwasher 
correctly.  Thanks to my sister Tina, for always understanding where I’m coming from 
(twin thing), and for encouraging me to “Be like Mike, but shorter, and don’t play 
basketball.”  Thanks to my brother Albert, for not generally understanding from where it 
is I come, but for being a pretty decent piano player despite of it.   
Chapter 2 of this dissertation was previously published in Molecular Biology of 
the Cell (http://www.molbiolcell.org/cgi/content/full/19/2/485) and copyrighted by the 





Petra Tryoen-Toth, Nicolas Vitale, and Bill Tsai.  Thanks also to: Ron Holz and Mary 
Bittner for secretion assay advice, PC-12 cells, bovine adrenal glands, and other 
reagents; Matt Merrins for molecular biology advice; Rishi Chaudhuri and Ray Wu for 
technical assistance; and Joshua Zimmerberg and Stuart McLaughlin for helpful 
comments.  This work was supported by grants from the National Institutes of Health 
(R01 NS039914 and NS053978, ELS; F31 NS053263-01, ADL), as well as from the 
Agence Nationale de la Recherche (ANR-05-BLAN-0326-01, NV) and by the Association 
pour la Recherche sur le Cancer (Grant 4051, NV).  ADL was also supported in part by a 
Medical Scientist Training Grant from the National Institutes of Health (GM007863).   
 Chapter 3 of this dissertation was previously published in the Journal of 
Biological Chemistry (http://www.jbc.org/cgi/content/full/282/31/22887) and copyrighted 
by the American Society for Biochemistry and Molecular Biology.  Many thanks to the 
co-authors of this publication:  Svetlana Gladycheva, Jiang Liu, Matt Merrins, Ofer 
Yizhar, Stephen Lentz, Uri Ashery, and Stephen Ernst.  This work was supported by 
National Institutes of Health (NIH) Grants NS39914 and NS053978 (to ELS), NIDDK, 
NIH, Grants P30DK 34933 and P60DK20572 (to SAE), and National Research Service 
Award RSA NS053263 (to ADL). ADL was also supported in part by National Institutes 
of Health Medical Scientist Training Grant GM007863. This work utilized the Morphology 
and Image Analysis Core of the Michigan Diabetes Research and Training Center 
funded by NIDDK, National Institutes of Health Grant NIH5P60 DK20572.  
Table of Contents 
Dedication          ii 
Acknowledgements         iii 
List of Figures          ix 
Chapter 
1. Introduction          1 
Docking          5 
Priming        10 
  Membrane Fusion       15 
  Regulators of the Neuronal SNARE Complex   20  
  Calcium Sensing for Neurotransmitter Release   23 
  Lipids in Membrane Fusion      25 
  Emerging Tools for the Study of Regulated Exocytosis:  FRET 29 
  Preview to the Investigations of this Dissertation   41 
  Figures        44 
  References        51 
 
2. SNARE-Catalyzed Fusion Events are Regulated by  
Syntaxin1A-Lipid Interactions      61 
 
Abstract        61 
Introduction        62 
Materials and Methods      65 
Results        72 
Discussion        85 
Figures        89 




3. Receptor-Mediated Regulation of Tomosyn-Syntaxin1A  
Interactions in Bovine Adrenal Chromaffin Cells   101 
 
Abstract        101 
Introduction        102 
Materials and Methods      106 
Results        113 
Discussion        125 
Figures        131 
References        139 
 
4. Theory and Application of Sensitized Emission TIRF-FRET  
in Living Cells        143 
 
Abstract        143 
Introduction        144 
Materials and Methods      147 
Results        160 
Discussion        174 
Figures        181 
References        193 
 
5. Conclusion        195 
Lipid Regulators of SNARE Function:  PA and PI(4,5)P2  195 
Protein Regulators of SNARE Function:  Tomosyn   203 
Development of an Optical Method to Visualize the  
Spatiotemporal Dynamics of Molecular Interactions  
that Regulate SNARE Complex Activity    208 
 
Final Remarks        213 
 










1.1 The synaptic vesicle cycle       44 
 
1.2 Lipid intermediates in membrane fusion     45 
 
1.3 Jablonski diagram illustrating the transitioning of a fluorophore            
between  the electronic ground (so) and excited (s1) states   46 
 
1.4 Jablonski diagram illustrating the process of fluorescence resonance   
energy transfer (FRET).         47 
 
1.5 Schematic of the excitation and emission of donor and acceptor             
fluorophores in the absence or presence of FRET    48 
 
1.6 Schematic of FRET as measured using donor dequenching or                
sensitized emission        49 
 
1.7 Schematic of the three images required for determination of apparent            
FRET efficiency, using the method of FRET stoichiometry   50 
2.1  Syn1A directly binds a subset of acidic phospholipids that includes           89       
the  fusogenic lipid phosphatidic acid 
 
2.2 A polybasic juxtamembrane sequence in Syn1A comprises the lipid         90         
binding domain 
 
2.3 Syn1A 5RK/A targets to plasma membrane regions in PC-12 cells  91 
 
2.4 Syn1A 5RK/A interacts normally with Munc18-1 and SNAP25  92 
 
2.5 BoNT-C knockdown allows isolation of functional effects of exogenous    
Syn1A  constructs in live secretory cells     93 
 
2.6 Neutralization of Syn1A’s polybasic juxtamembrane region results in a    
decrease in evoked secretion      95 
 
2.7 Neutralization of Syn1A’s polybasic juxtamembrane region results                       
in a decrease in fusion pore diameter and a lengthening of fusion                   




2.8 Functional phenotypes of Syn1AK253I control and 5RK/A mutant are             
differentially regulated by manipulation of phosphatidic acid levels            
in live PC-12 cells          97 
 
3.1 Expression of fluoroprotein-tagged syntaxin1A, Munc18-1 and                           
m-tomosyn in HEK293 cells and selective action of Munc18-1 to                
facilitate syntaxin1A targeting the plasma membrane   131 
 
3.2 Interaction and surface distribution of cYFP-syntaxin1A and         
CFP-tomosyn as defined by acceptor photobleach FRET in fixed               
HEK293 cells         133 
 
3.3 Interaction of CFP-tomosyn to cYFP-syntaxin1A in bovine chromaffin        
cells is sensitive to mutations in syntaxin1A SNARE motif and subject                   
to competitive inhibition by Munc18-1     134 
 
3.4 Agonist activation of nAChR and application of LPA induce translocation             
of endogenous tomosyn to a membrane fraction in chromaffin cells and         
activate endogenous RhoA       135 
 
3.5 Monitoring targeting of EGFP-tomosyn to cell periphery in live                
chromaffin cells by photobleach of diffusible EGFP fluorescence  136 
 
3.6 Time-lapse imaging of receptor-mediated changes in tomosyn-              
syntaxin1A interactions using dynamic FRET measurements in living           
chromaffin cells        137 
 
3.7 Effect of tomosyn translocation induced by LPA treatment on evoked              
hGH secretion from PC-12 cells      138 
 
4.1 Measurement of evanescent field profiles for 442nm and 514nm       
laser lines         182 
 
4.2 Relationship of FRET values measured under TIRF, to differently               
matched characteristic TIRF depths of excitation wavelengths  184 
 
4.3 Effect of characteristic TIRF depth on FRET calibration constants  185 
 
4.4 Effect of a soluble population of fluorophores on TIRF-FRET                  
measurements        187 
 
4.5 Sensitized-emission TIRF FRET measurements of a plasma                 
membrane targeted linked FRET probe in live MIN6 cells   188 
 
4.6 Sensitized emission TIRF FRET measurements of a linked FRET                 
probe,  targeted to intracellular compartments in live MIN6 cells  190  
 
4.S1 Modeling the effects of three alternative/nonspecific localizations of                 







 Membrane fusion is an important phenomenon that occurs ubiquitously 
throughout cell biology.   Indeed, this process underlies the compartmentalized nature of 
eukaryotic cells, by allowing for communication between most intracellular 
compartments via vesicles that bud from one compartment and subsequently fuse and 
merge their contents with another.   Membrane fusion plays many diverse and critical 
roles in the physiological integration of higher level, multi-cellular organisms.  This 
process is an essential step in the regulation of homeostatic mechanisms involving 
hormone secretion, mast cell degranulation during an immune response, the acrosomal 
reaction that occurs during fertilization of an oocyte by a sperm cell, and release of 
pancreatic enzymes that allow for digestion of a meal.  Membrane fusion is also 
paramount to the process of chemical neurotransmission, which ultimately underlies the 
ability of higher-level organisms to move, sense their environment, feel emotions, 
remember, forget, and ponder important issues such as, “What shall I have for dinner 
tonight?”.     
Biological membrane fusion reactions involved in the secretion of proteins and 
other chemicals from the cell can be broadly classified into two types:  constitutive and 
regulated (for review, see [1]).  For secretion of proteins, both constitutive and regulated 
pathways involve translocation of the proteins first through the rough endoplasmic 
reticulum, and then through the Golgi stacks, where the proteins are ultimately sorted for 
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secretion through either the constitutive or regulated pathways.  Constitutive secretion is 
usually considered the default pathway for secretion, which (for proteins) occurs in the 
absence of the correct sorting signals on the protein to be secreted, and in general, 
occurs without the need for a specific physiological trigger.  Granules destined for 
constitutive release do not contain proteins in high concentrations, and moreover, as 
these granules are constantly being secreted, large intracellular storage pools of these 
granules are not retained.  In contrast, regulated secretion requires the sorting of specific 
proteins or chemicals into specialized secretory granules, in which these substances 
become highly concentrated.  For secretory granules containing proteins, the 
concentrations of the proteins within the secretory granules can be as high as 10-200 
times the concentration of these proteins in early Golgi compartments; as such, these 
granules appear electron-dense in EM micrographs, leading to their being termed 
dense-core granules.  Notably, secretion of these granules requires a specific 
physiological stimulus, which generates a transient rise in intracellular calcium 
concentration that directly triggers the fusion of these granules with the plasma 
membrane.  As these granules are only secreted in response to a stimulus, large 
intracellular storage pools of these granules are often present within the cell.    
Of all the different types of regulated secretion, perhaps the most elegantly 
controlled process is that occurring when a synaptic vesicle filled with neurotransmitter 
fuses with the plasma membrane of a neuron to release its contents into the synaptic 
cleft.  Neurotransmitter release is triggered by the influx of calcium that occurs in 
response to the arrival of an action potential at the nerve terminal, which depolarizes the 
plasma membrane and activates voltage-gated calcium channels.  Unlike most other 
secretory processes, neurotransmission occurs on an extremely rapid timescale (on the 
order of microseconds to milliseconds) and requires precise spatial localization.  
Moreover, unlike the protein-filled dense-core granules described above, synaptic 
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vesicles are filled with chemical neurotransmitters.  As such, these vesicles can be 
synthesized and recycled directly from the plasma membrane or early endosome 
compartments, and can be filled by uptake of neurotransmitter directly from the 
cytoplasm, across transporters in the vesicle membrane.  However, synaptic vesicles 
also require some protein constituents.  These synaptic vesicle proteins are transported 
down the axon in membrane compartments, so that full assembly of synaptic vesicles 
can occur at the synapse (for review, see [2]).  Notably, in contrast to dense-core 
vesicles, which can often be up to several hundred nanometers in diameter, synaptic 
vesicles are one of the smallest intracellular compartments known, with a diameter of 
roughly 50nm.   
Neurotransmitter release and neurosecretion can both be described as multi-
step, sequential processes (for review, see [3]).  In neurosecretion, newly synthesized 
secretory granules are actively translocated from the Golgi network along microtubule 
tracks to the plasma membrane, where they then become tethered, or “docked.”  
Translocation of synaptic vesicles to the plasma membrane is a bit different, as synaptic 
vesicles are synthesized and recycled directly at the nerve terminal.  Most vesicles in the 
nerve terminal are found in a diffusionally restricted vesicle cluster located adjacent to 
the presynaptic active zone, and are held together by actin filaments and other proteins.  
Mobilization of vesicles from this cluster, to allow vesicles to approach the active zone 
and become docked there, is thought to be under the control of the synapsin proteins 
(for review, see [4, 5]).  Following docking, a series of biochemical reactions, termed 
“priming”, then takes place on or near the vesicle, to render the vesicle fusion-
competent.  At some point, influx of calcium into the nerve terminal triggers the fusion of 
docked and primed vesicles with the pre-synaptic plasma membrane, allowing for the 
release of neurotransmitter into the synaptic cleft.   Following fusion, vesicles are 
recycled for reuse by the process of endocytosis, which has been shown to occur in 
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units that exactly match the size of the exocytosed  vesicles [6].  Notably, endocytosis is 
the rate-limiting step for nervous system throughput, as it occurs on a much slower time 
scale (on the order of tens of seconds) compared to exocytosis (for review, see [5, 7]).     
A contemporary model on how the process of membrane fusion might be 
molecularly mediated is termed the “SNARE hypothesis” [8].  In the original model of the 
SNARE hypothesis (which has since been largely revised), specificity of the docking 
reaction was determined by proteins on the vesicle membrane and target membrane, 
termed v-SNAREs and t-SNAREs, respectively (SNARE = soluble NSF attachment 
protein (SNAP) receptor).  As v-SNAREs and t-SNAREs were thought to be localized to 
specific and distinct intracellular compartments, and as each v-SNARE was believed to 
interact specifically with only one cognate t-SNARE, the idea of SNARE-pairing ensured 
that vesicles would only dock at membranes where they were destined to fuse.   
Moreover, the v-SNARE / t-SNARE complex was proposed to provide a binding site for 
the ATPase NSF (N-ethylmaleimide sensitive factor) and its SNAP (soluble NSF 
attachment protein) co-factors.   Hydrolysis of ATP by NSF would then provide the 
energy required to drive membrane fusion, through the disassembly of the SNARE 
complex.     
Since the original SNARE hypothesis was put forth in 1993, much progress has 
been made, and new experimental paradigms and methods developed, ultimately 
leading to modifications of this hypothesis, and generation of many new questions to 
address.  A recent review of the molecular mechanisms of membrane fusion is 
presented below, with a primary focus on membrane fusion as it occurs during 
neurotransmission and neurosecretion (for an overview, see Figure 1.1).  While these 
processes occur on very different time scales, and while experimental findings on 
regulated exocytosis from neurosecretory cells cannot always be assumed to 
extrapolate to synaptic vesicle release in neurons, these processes do in fact share 
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remarkable similarities in their underlying molecular machinery.  Moreover, as 
neurosecretory cells are much larger in size, they are, therefore, more amenable to 
study than central synapses.  As a result, in many cases, experiments in neurosecretory 
cells have provided the first insights into regulatory mechanisms of membrane fusion.   
 
Docking 
 The concept that vesicles must first become docked and tethered at the target 
membrane prior to membrane fusion arose primarily as a result of electron micrographs 
of neurons and neuroendocrine cells that demonstrated a distinct and non-random 
accumulation of vesicles in close proximity (<30nm) to the target membrane under 
resting conditions [9, 10].   As the number of docked vesicles far exceeded the number 
of vesicles released upon stimulation (ie, the readily releasable pool), it was assumed 
that further biochemical reactions were required following docking, to render each 
vesicle fully competent for fusion (see section on Priming).    
More recently, docking of fluorescently-labeled vesicles in live cells has been 
studied using TIRF (total internal reflection fluorescence) microscopy, allowing for a 
more dynamic view of the vesicle motions that occur near the membrane prior to fusion.  
TIRF microscopy utilizes the exponentially decaying evanescent wave that is created 
when light is totally internally reflected at a glass-water interface, to selectively illuminate 
a thin (~100-300nm thick) “footprint” of a cell that includes only those regions of the cell 
closely apposed to the coverslip.  As such, TIRF microscopy allows for extremely high 
axial resolution of events occurring at or near the plasma membrane; in the case of 
secretory vesicles, the Z-motions of individual vesicles can be closely tracked over time 
with millisecond and nanometer resolution (for review, see [11, 12]).  TIRF studies have 
demonstrated that a population of secretory vesicles closely apposed to the plasma 
membrane in neuroendocrine cells undergoes highly restricted, non-Brownian motions, 
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supporting the notion that these vesicles are somehow tethered at the membrane, or are 
trapped in some sort of a molecular cage [13-15].  However, these studies also bring into 
question whether docking is required for fusion, as during sustained stimulation, vesicles 
are sometimes (~20%) observed to approach the plasma membrane from deep within 
the cell and to fuse within 300msec, seemingly without the need to undergo a stable pre-
docking stage [16].    
One of the inherent problems with the concept of vesicle docking is that this 
process has almost always been defined morphologically, and as such, its exact 
functional significance is still not entirely clear.  For instance, it is possible that some 
docked vesicles are actually in a dead-end, non-releasable state;  moreover, the 
necessity of vesicles to be docked prior to fusion has not been clearly demonstrated (for 
review, see [17]).   Surprisingly, at the frog neuromuscular junction, vesicles of the 
readily releasable pool were not preferentially localized adjacent to the plasma 
membrane, but rather, were dispersed throughout the nerve terminal [18].  On the other 
hand, in individual hippocampal synapses, the average number of docked vesicles at the 
active zone correlates to the size of the readily releasable pool, suggesting that the 
docked pool represents the readily releasable pool.  Furthermore, studies in bovine 
adrenal chromaffin cells demonstrated that newly synthesized vesicles are preferentially 
localized to the plasma membrane, whereas older vesicles (~16 hours old) were found 
deeper with the cell; moreover, nicotine-stimulated exocytosis occurred primarily from 
the pool of newly synthesized vesicles [19].  Data regarding vesicle docking may also be 
difficult to interpret in a functionally meaningful way, due to the combination of the strict 
(yet somewhat arbitrary) morphological criteria set to define what constitutes a docked 
vesicle (eg, less than 30nm from the plasma membrane), in addition to fixation artifacts 
that may often arise during preparation of samples for electron microscopy [20].  
However, future TIRF studies in which the mobility of vesicles can be tracked over time, 
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concomitantly with genetic manipulations and functional readouts of fusion competence, 
will likely pave the way to establishment of a more meaningful, biochemical definition of 
docking.  In other words, if docking does have a functional significance, this should be 
borne out by determination of molecular pathways that specifically mediate it.                          
The original SNARE hypothesis suggested that specificity of docking would be 
mediated through the specificity of SNARE pairing.  However, SNARE proteins often 
demonstrate promiscuity in their interactions in vitro [21, 22], and moreover, can be 
found not only on the compartments on which they mediate fusion, but also on 
compartments involved in their biosynthesis and recycling.  A primary role for SNARE 
proteins in docking was further ruled out by experiments demonstrating that vesicle 
docking remained intact even after genetic deletion or cleavage of the SNARE proteins 
using proteolytic toxins [23-25].  It is now widely believed that the initial specificity of 
docking and tethering is under control of the Rab family of proteins and their effectors.  
This is largely the result of extensive work carried out on Rab protein homologs in yeast 
secretory pathways (for review, see [26]).    
Rab proteins are ubiquitously expressed members of the Ras family of small 
GTPases that play key roles in vesicular transport processes.  Rabs act as molecular 
switches, cycling between GTP-bound (“active”) and GDP-bound (“inactive”) states.  In 
their GTP-bound state, Rabs often associate with membrane compartments via an 
exposed C-terminal geranylgeranyl moiety.  GTP-bound Rab proteins can also bind to 
and recruit specific effector molecules to these compartments.  Upon GTP hydrolysis, 
GDP-bound Rabs associate with GDI (guanine dissociation inhibitor) proteins, which 
mask the geranylgeranyl moiety on the Rabs, thereby dissociating the Rab proteins from 
the membrane compartment.  While Rab proteins thus exhibit clear active  and inactive 
states, what is quickly becoming apparent is that it is not so much the particular state, 
but rather the cycling between states, that is critical for Rab protein function [27].    
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In neurons and neuroendocrine cells, Rab3 is highly abundant on synaptic 
vesicles and secretory granules [28].   Rab27 also localizes to secretory granules, but 
may or may not be present on synaptic vesicles, as Rab27 was not detected in mouse 
brain lysates, yet was detected in neurons in C. elegans [29, 30].    Overexpression and 
knockdown studies indicate that both Rab3 and Rab27 have effects on docking in 
neurosecretory cells [31-33]; however, the docking phenotype at neuronal synapses was 
unaffected in a complete Rab3 knockout mouse (ie, quadruple deletion of all four Rab3 
isoforms) [34].  Among the known Rab3/27 effectors are Slps (synaptotagmin-like 
proteins, which contain two C2 domains) of which rabphilin and granuphilin-a are 
members; Slacs (synaptotagmin-like proteins lacking C2 domains), of which 
melanophilin, MyRIP, and Noc2 are members; RIMs (rab3 interacting molecules), and 
Munc13-4 proteins.   Granuphilin-a (Slp4a) interacts with Rab27a (and may also interact 
with Rab3); moreover, it has been shown to bind to the Q-SNARE Syntaxin1 as well as 
Munc18-1, two key members of the secretory machinery [35, 36].   Importantly, the 
granuphilin-a knockout mouse exhibited reduced numbers of docked vesicles in 
pancreatic β cells (although surprisingly, secretion was found to be enhanced) [37].   
Rabphilin is a soluble protein recruited to vesicles on interaction with Rab3 or Rab27, 
and has been shown to interact with the plasma membrane SNARE, SNAP-25 [38].  In 
PC12 cells, overexpression of rabphilin resulted in an increase in docked vesicles as 
visualized under TIRF; overexpression of a mutant rabphilin that was unable to bind to 
SNAP-25 resulted in a decrease in the number of docked vesicles [38].  However, as the 
rabphilin knockout mouse exhibited no synaptic phenotype, it is unclear what the exact 
function of these molecules are in neurons [39].  RIM proteins are large, plasma-
membrane proteins that comprise part of the active zone complex in neurons.  While the 
RIM1α knockout mouse demonstrated defects in hippocampal and cerebellar LTP (long 
term potentiation), there were no apparent defects in vesicle docking [40].   
8 
 
More recently, a compelling role for Munc18-1 in vesicle docking has also been 
described.   Munc18-1 is a member of the highly conserved SM (Sec/Munc18) family of 
proteins (see section below on SNARE regulators) that exhibits a high affinity interaction 
with the plasma membrane SNARE, Syntaxin1.   Vesicle docking in neurons was 
strongly reduced in mice heterozygous for Munc18-1, and expression levels of Munc18-
1 were found to correlate to the number of docked vesicles detected at active zones [41].    
In Munc18-1 null embryonic adrenal chromaffin cells, vesicle docking was reduced 10-
fold, with no change in the total vesicle number [42].  The ability of the exogenously 
expressed Munc18-1 to rescue this phenotype required its ability to bind syntaxin1, as 
overexpression of Munc18-1 mutants that lacked the ability to bind syntaxin1 still 
resulted in reduced numbers of docked vesicles [15, 43].   A potential caveat to the 
studies using the Munc18-1 null mice is that knockout of Munc18-1 results in a 50% 
reduction in the expression levels of the plasma membrane SNARE syntaxin1; thus, the 
decrease in syntaxin1 levels may partially account for the Munc18-1 null phenotype [42].  
However, in Munc18-1 null adrenal chromaffin cells, overexpression of a Munc18-1 
mutant that was sufficient to rescue the expression level of syntaxin1 to that of control 
cells, was still not sufficient to rescue vesicle docking to control levels [43].  Furthermore, 
in C. elegans, mutant unc-18 worms also demonstrate severe defects in evoked 
neurotransmission, and the number of docked vesicles at the neuromuscular junctions of 
these worms is reduced to 36% of wild-type.  While the expression level of syntaxin in 
these worms was also reduced by 50%, this effect cannot account for the unc-18 
phenotype, as worms that are heterozygous for syntaxin do not phenocopy the unc-18 
worm, and moreover, overexpression of syntaxin in unc-18 worms is not sufficient to 
rescue the unc-18 phenotype [44].   These experiments suggest that the effect of 
Munc18-1 knockout on docking is independent of the effects on syntaxin1 expression 
levels.  Another compelling piece of evidence to suggest that Munc18-1 is important in 
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vesicle docking is that the effect of Rab3A on docking has been shown to be dependent 
on Munc18-1.  Overexpression of Rab3A in control chromaffin cells, but not in Munc18-1 
null chromaffin cells, resulted in a substantial increase in docking [27].  Interestingly, 
Rab3A was also recently shown to directly bind to Munc18-1 [45].  Other additional 
mechanisms by which Munc18-1 mediates docking have also been proposed, and may 
involve interactions of Munc18-1 with proteins such as Mint (Munc18-interacting protein), 
DOC2, or granuphilin-a [46].  
In sum, the molecular mediators and pathways involved in docking are continuing 
to be elucidated, but have also generated some puzzles.  While small molecular weight 
GTPases (eg, Rabs/Ypt (yeast protein transport family)) and Munc18/Sec proteins 
especially appear to play key roles in docking, in many cases, these pathways converge 
onto SNARE proteins, for which a clear role for docking has not been demonstrated.  
Moreover, in the case of Rab3 and its effectors, the lack of a docking phenotype in 
neurons for these genetic knockouts is somewhat striking.  An important consideration is 
that these results could potentially reflect the functional redundancy of proteins that 
operate in the docking pathway, particularly in the case of the Rab protein family, of 
which there are over 60 members in mammals [26].   Along these lines, despite the 
many genetic manipulations carried out to date, and despite the vast number of synaptic 
phenotypes that have been observed, surprisingly few of these genetic manipulations 
have resulted in notable docking phenotypes in neurons [17].     
 
Priming 
 Unlike docking, which rests primarily on a morphological analysis, priming 
reactions required for regulated exocytosis have largely been defined functionally.   The 
idea that vesicles must undergo a series of priming reactions following docking and prior 
to fusion was originally proposed as an explanation for why the number of vesicles 
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docked at the plasma membrane or at active zones far exceeded the number of vesicles 
that was released upon stimulation (the readily releasable pool).  However, many 
subsequent studies have supported the concept that specific biochemical priming 
reactions downstream of docking are required to attain fusion competence of vesicles.  
Indeed, the most convincing of these studies are the various genetic manipulations 
which alter the size of the primed (readily releasable) pool of vesicles, without altering 
the total number of docked vesicles [47-49].   
Among the first studies of priming were secretion assays carried out on 
permeabilized neuroendocrine cells [50, 51].  Upon permeabilization, the secretory 
response of these cells to calcium was found to decrease with increasing time between 
permeabilization and the calcium stimulus, largely as a result of the diffusion of essential 
secretory factors out of the cell.  As such, the term “priming” referred the biochemical 
reactions that were required to maintain sustained secretory competence following 
permeabilization.  Notably, addition of concentrated fractions of cytosolic proteins to the 
semi-intact cells was sufficient to reconstitute secretion following permeabilization, and 
moreover, demonstrated that these reactions were readily reversible [52].  While 
secretion assays were critical for the initial discoveries of the key biochemical (ATP, pH, 
temperature) and protein requirements (phosphatidylinositol transfer protein, PITP; 
phosphatidylinositol phosphate kinase type I, PIP5KI; NSF; calcium-dependent activator 
protein for secretion, CAPS; etc) for vesicle priming (see below), they are inherently 
limited in terms of their low temporal resolution (on the order of seconds to minutes).   
More recently, high temporal resolution membrane capacitance measurements 
made under patch-clamp recording in neuroendocrine cells or neurons have become a 
powerful tool to study the priming process with much higher temporal resolution 
(milliseconds).  Capacitance measurements monitor changes in the total capacitance of 
the cell membrane, which based on the specific capacitance of cell membranes 
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(~1µF/cm2), can be used to define the surface area of a cell’s plasma membrane.  These 
measurements thus report on the fusion of vesicles, where vesicle membrane is added 
to the cell membrane, resulting in an increase in total cell surface area.  In conjunction 
with UV flash photolysis of caged calcium (which provides a globally uniform and 
instantaneous trigger to maximally drive secretion in a manner that is independent of 
localized calcium gradients), membrane capacitance measurements have clearly 
demonstrated that there exist multiple distinct kinetic steps by which vesicle fusion 
occurs [53, 54].  These studies have been carried out for a wide variety of cell types and 
preparations, including (and not limited to): adrenal chromaffin cells, the calyx of Held, 
retinal bipolar neurons, pancreatic β-cells, melanotrophs, and cardiac myocytes.  
Notably, the exocytotic responses of adrenal chromaffin cells in response to calcium 
uncaging have been the most thoroughly studied.  Indeed, the response of adrenal 
chromaffin cells to calcium uncaging is characterized by an initial exocytic burst 
(occurring on the order of tens of milliseconds), followed by a slow and sustained phase 
of release (occurring on the order of seconds) (for review, see [55]).  The exocytic burst 
is believed to represent fusion of two distinct readily releasable pools of vesicles that are 
docked and primed, whereas the sustained phase of release represents fusion of 
docked vesicles that must first undergo priming prior to release.   Notably, these 
measurements allow for determination of both the size and release kinetics of each of 
these pools.  In these experiments, the term “priming” refers to the processes that (re)fill/ 
recruit vesicles to the readily releasable vesicle pools, and can be assessed by 
monitoring the refilling kinetics of these pools following their depletion.  Importantly, the 
kinetic scheme established by these high time-resolution capacitance measurements 
has provided a quantitative and functional framework by which the effects of various  
genetic and biochemical manipulations on priming can be organized.   
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 Data from both secretion assays and electrophysiological measurements have 
unequivocally established that priming reactions are dependent on Mg-ATP [52, 54, 56, 
57] as well as calcium [56, 58-60].  The downstream effectors for these priming 
requirements have also begun to be defined, among which include the lipid messenger 
PI(4,5)P2 and NSF/SNAP.   
Generation of PI(4,5)P2 is one of the major events occurring during the ATP-
dependent priming process;  indeed, PI(4,5)P2 production was estimated to account for 
70% of the ATP-dependent component of secretion in permeabilized chromaffin cells 
[61].  Subsequently, two cytosolic enzymes involved in PI(4,5)P2 synthesis, PI(4)P 5-
kinase [62] and PITP [63], were shown to be essential factors for the ATP-dependent 
priming of vesicles.  More recently, genetic deletion of PI(4)P 5-kinase in mice resulted 
in multiple severe synaptic defects, including a reduction in the size of the readily 
releasable pool [64].  In adrenal chromaffin cells of these mice, both the size and refilling 
rates of the readily releasable pool were reduced, with a concomitant increase in the 
number of docked vesicles [65].   
Despite clear evidence that PI(4,5)P2 is important in priming, the exact 
mechanisms by which it operates are still unclear.  Notably, the requirement of PI(4,5)P2 
in priming does not appear to be in its use as a substrate for PLC to produce 
diacylglycerol (DAG) and inosityol 1,4,5-triphosphate (IP3) [61].  One possibility is that 
PI(4,5)P2 may act to recruit key regulatory proteins to sites of fusion.  A number of 
proteins critical for regulated exocytosis have been shown to bind to PI(4,5)P2, including 
synaptotagmin [66], rabphilin [67], CAPS [68], Munc18-interacting protein (MINT) [69], 
and syntaxin1 [70].   On a related note, PI(4,5)P2 may also be involved in clustering one 
or more of these proteins into membrane microdomains, which might then serve as 
hotspots for vesicle fusion.  Clusters of PI(4,5)P2 have been observed in the plasma 
membrane of chromaffin cells and PC-12 cells, and in the latter case, a subset of 
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PI(4,5)P2 clusters was found to co-localize with syntaxin1 clusters [71, 72].  Another 
possibility is that effects of PI(4,5)P2 on priming may occur through interactions of 
PI(4,5)P2 with the cytoskeleton [73, 74]. 
 A second use for Mg-ATP in priming occurs via its hydrolysis by NSF (N-
ethylmaleimide sensitive fusion protein), an AAA-ATPase (AAA=ATPases associated 
with various cellular activities) that has been shown in yeast to be required for almost all 
intracellular trafficking steps [75].  NSF requires SNAP (soluble NSF attachment 
proteins) cofactors to allow it to bind to ternary SNARE complexes [76].  Upon binding, 
hydrolysis of ATP by NSF then provides the energy to disassemble these SNARE 
complexes [77].  As stated earlier, the original SNARE hypothesis posited that NSF was 
the fusion promoting protein, and that its disassembly of SNARE complexes would 
provide the energy required for membrane fusion.  However, in vitro studies 
demonstrated that NSF activity is only required for a predocking stage that precedes 
fusion [78, 79], and moreover, that ATP, while required for priming, is not essential for 
the final triggering of exocytosis [80], necessitated a revision of this hypothesis [81].   
It is now widely accepted that NSF and SNAP are involved in ATP-dependent 
priming, where they function to disassemble dead-end cis-ternary SNARE complexes 
(complexes that occur on the same membrane) to allow for the formation of functionally 
relevant, trans-ternary SNARE complexes (complexes that bridge the vesicle and target 
membranes).  The evidence for this comes from studies in the yeast secretory pathway 
[82], secretion assays in neuroendocrine cells [83], synaptic physiology in the squid giant 
synapse [84], as well as membrane capacitance measurements in chromaffin cells [85].  
In the latter study, dialysis of chromaffin cells with purified α-SNAP protein via patch 
pipette resulted in an increase in the size of the exocytic burst (with no effects on the 
release kinetics of the burst), in addition to an increase in the sustained phase of 
release, compared to control cells.  Treatment with N-ethylmaleimide (NEM) had no 
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effect on the initial size or release kinetics of the exocytic burst, but resulted in a 
decrease in the sustained phase of release.  On repeated stimulation, however, NEM 
treatment resulted in a reduction in the sizes of both the exocytic burst as well as the 
sustained phase of release (with still no effect on the kinetics of the exocytic burst) [85].   
This study clearly demonstrates effects of NSF/SNAP on vesicle priming, rather than on 
the final fusion step, and exemplifies the benefits of organizing the function of various 
proteins in terms of the kinetic framework established by high time-resolution 
capacitance measurements.    
In addition to a dependence on Mg-ATP, priming has also been demonstrated to 
have a calcium dependence as well [58, 60].  The downstream effectors of calcium for 
vesicle priming are quite numerous and include a variety of proteins that have been 
shown to exert important roles in the priming process.  These include (and are not 
limited to):  Munc13 [47, 49], CAPS [86], PKC [87, 88] and PKA [89].  Of note, the 
calcium dependence for regulation of some of these proteins occurs indirectly, i.e., 
through molecules such as calmodulin.  For the sake of brevity, an extensive discussion 
on these various proteins has been omitted here; the reader is instead referred to a 
number of recent reviews on the subject [46, 90].   
 
Membrane Fusion 
 Upon entry of calcium into nerve terminals, synaptic vesicles that are fully primed 
are triggered to fuse with the presynaptic plasma membrane.  While this is a seemingly 
simple task, fusing two lipid bilayers requires the surmounting of an extremely high 
energy barrier, in which membranes must be brought within very close proximity despite 
high electrostatic repulsions, and in which strong hydrophobic forces must be overcome 
to allow for the deformation and rupture of these membranes.  Notably, several types of 
fusion have been demonstrated, ranging to full fusion, in which the vesicle membrane 
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completely collapses into the target membrane upon fusion and is subsequently recycled 
via clathrin-dependent pathways, to kiss-and-run fusion, where the vesicle fuses only 
transiently with the target membrane and subsequently pinches off, having never fully 
collapsed into the plasma membrane [91]. 
Regardless of the mode of fusion, it is now widely agreed upon that SNARE 
(soluble N-ethylmaleimide-sensitive fusion factor attachment protein (SNAP) receptor) 
proteins constitute the minimal protein machinery required to catalyze membrane fusion 
events [92].  Evidence for this role comes from in vitro experiments demonstrating that 
SNARE proteins are sufficient to drive fusion (albeit, rather slowly) in reconstituted 
liposome assays [93], as well as in vivo experiments demonstrating that the loss of 
SNARE protein function as a result of proteolytic cleavage by clostridial and tetanus 
toxins [94-96], or by genetic deletion [25, 97, 98] or mutation [99-101], results in a strong 
inhibition, and in many cases, complete abolishment of evoked neurotransmitter release.  
Another compelling piece of evidence (or lack thereof) supporting the concept that 
SNAREs catalyze the final step in membrane fusion is that despite the many years in 
which genetic screens have been carried out in yeast, no gene products have been 
found to date that act downstream of the SNAREs in fusion [102].   
SNARE proteins were originally discovered as the membrane-associated 
receptors for the NSF/SNAP complex, hence their name (SNAP receptors) [8].  The 
fundamental characteristic shared by all SNARE proteins is the presence of a SNARE 
domain:  a 60-70 residue, cytoplasmic, amphipathic helix containing conserved heptad 
repeats.  Many SNARE proteins are anchored to the membrane via a C-terminal 
transmembrane domain located adjacent to the SNARE domain, while other SNAREs 
associate with the plasma membrane via palmitoylated cysteine residues.  Some 
SNARE proteins contain additional regulatory domains located N-terminally to the  
SNARE motif.   
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Central to the function of SNAREs is their ability to form into a core complex, 
consisting of 4 SNARE domains, contributed by either 3 or 4 SNARE proteins [103].  The 
SNARE core complex is remarkably stable, and has been demonstrated to be resistant 
to denaturing by SDS, resistant to cleavage by a number of proteases, and thermally 
stable in temperatures of up to 90oC [21, 104].  The crystal structure of the neuronal 
SNARE core complex demonstrated a coiled coil of 4 alpha helices aligned in parallel, 
with all N-termini on one end of the coil, and all C-termini on the other end [105].  Fifteen 
layers of hydrophobic contacts are formed along the entire length of the coiled coil, with 
all helices contributing an interacting hydrophobic residue at each layer.  A central, ionic 
layer of contacts is also present, and consists of three glutamine (Q) residues and an 
arginine (R) residue.  As this central layer is highly conserved, it has been used to 
classify the SNARE proteins into the Q- and R-SNAREs, depending on whether the 
residue they contribute to the central layer of the SNARE core complex is a glutamine or 
an arginine, respectively [106].   
SNARE proteins are believed to play a predominantly mechanical role in 
catalyzing membrane fusion.  This requires the formation of a trans-SNARE core 
complex that spans two membranes, with each membrane contributing at least one 
transmembrane-anchored SNARE protein to the core complex.  Nucleation and 
zippering of this stable trans-SNARE core complex from the N-terminal end to the C-
terminal end of the coiled coil (where the transmembrane domains of the SNAREs are 
located) is believed to generate the free energy required to bring the two membranes 
within close enough proximity to initiate the fusion event [107].  While the exact number 
of SNARE core complexes required to catalyze the fusion of a single vesicle with the 
plasma membrane is unknown (and likely depends on the type of vesicle undergoing 
fusion), current estimates in neuroendocrine cells range from anywhere between three 
and fifteen [108]. 
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The SNARE proteins that mediate regulated exocytosis in neurosecretory cells 
and neurons are syntaxin1 [109], SNAP-25 (synaptosomal-associated protein of 25 kDa) 
[110], and synaptobrevin / VAMP2 (vesicle-associated membrane protein 2) [111, 112].  
Syntaxin1 is a 37kDa plasma membrane Q-SNARE that is found only in 
neuronal/neuroendocrine cells, and constitutes 1% of total brain protein [113].  
Interestingly, syntaxin1 is evenly distributed throughout the neuronal plasma membrane 
(ie, it does not localize uniquely to active zones), suggesting that other proteins are 
required to spatially restrict syntaxin1’s fusogenic activity to the active zone.  The 
structure of syntaxin1 consists of an N-terminal regulatory domain termed Habc 
(comprised of 3 alpha helices arranged in anti-parallel), connected to a SNARE domain 
via a flexible linker, and followed closely by a C-terminal transmembrane domain.  
Syntaxin1 can assume two different conformations:  a closed conformation, in which the 
Habc domain folds over to interact with the SNARE domain, thus precluding it from 
participating in SNARE core complex formation; and an open conformation, in which the 
SNARE domain is free to participate in SNARE complex formation, with the Habc 
domain extended away from this complex [114].  Deletion of syntaxin1A in Drosophila 
abolished both evoked and spontaneous neurotransmitter release [25, 115].  Cleavage 
of syntaxin1 by the botulinum neurotoxin type C occurs between the SNARE domain and 
the transmembrane domain, and can completely abolish neurotransmitter release [54, 
95].  In addition to its interaction with other SNARE proteins, syntaxin1 has been 
demonstrated to interact with a number of other proteins critical for regulated exocytosis, 
including Munc18-1, Munc13, synaptotagmin, and even calcium channels (for review, 
see [102]).   Interestingly, the transmembrane domain of syntaxin1 was recently 
proposed to form part of the fusion pore [116, 117].   
SNAP-25 is also a plasma-membrane Q-SNARE, and contains two SNARE 
domains, separated by a linker region, which contains palmitoylated cysteine residues 
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allowing for its association with the plasma membrane.    SNAP-25 contains multiple 
phosphorylation sites, including Thr138 (PKA) and Ser187 (PKC), which may be 
involved in regulation of the size of the readily releasable pool [118-120].  In SNAP-25 
knockout mice, evoked neurotransmission was abolished, although spontaneous 
neurotransmitter release was still observed [121].  SNAP-25 is also the target for the 
botulinum neurotoxins A, C, and E, which cleave SNAP-25 at its C-terminal end  [94, 
122, 123].   Proteolysis by botulinum C and E completely abolishes evoked secretion, 
whereas proteolysis by botulinum A results in only partial inhibition of secretion [54], 
which can be overcome in vivo by elevation of calcium levels [124].  This suggests that 
cleavage of SNAP-25 by botulinum A somehow shifts the calcium sensitivity of 
exocytosis.   
Synaptobrevin is a small vesicle-anchored R-SNARE, consisting of a cytosolic, 
N-terminal proline-rich stretch and SNARE domain, and a C-terminal transmembrane 
domain.  Genetic deletion of synaptobrevin in Drosophila resulted in the complete 
abolishment of evoked neurotransmitter release; however, spontaneous release events 
were still observed [25].  In synaptobrevin knockout mice, evoked neurotransmitter 
release was decreased 100-fold, whereas spontaneous release was decreased only 10-
fold [125].  Synaptobrevin is the target for tetanus toxin and the botulinum toxins B, D, F, 
and G.  These toxins cleave synaptobrevin largely within its SNARE domain, and result 
in a profound inhibition of secretion [54, 126].   
While it is clear from the genetic deletion studies that the neuronal SNARE 
proteins are essential for evoked neurotransmitter release, what is interesting is that only 
in the case of syntaxin1 deletion was spontaneous neurotransmitter release completely 
abolished.  While this could suggest functional redundancy in the roles for SNAP-25 and 
synaptobrevin for spontaneous fusion events, another possibility is that there may be a 
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fundamental molecular difference between spontaneous fusion events and evoked 
fusion events.   
 
Regulators of the Neuronal SNARE Complex 
 As SNARE complexes play a pivotal role in the process of membrane fusion, 
there exist many proteins whose function is to regulate SNARE complex formation.  One 
of the most critical proteins involved in this task is Munc18-1 (for review, see [127]).  
Munc18-1 is a member of the Sec/Munc18 (SM) family, and is the mammalian homolog 
of unc (uncoordinated)-18, a gene that was first discovered in C. elegans during genetic 
screens for mutants displaying defects in membrane trafficking and secretion [128]. 
Homologs in yeast (termed Sec proteins) were identified in parallel, in genetic screens 
for secretory defects [129, 130].   Munc18-1 is a soluble, 65kDa protein consisting of 3 
domains that fold into an arch-shaped structure with a central cleft [114].  A role for 
Munc18-1 in neurotransmitter release was first identified when Munc18-1 was shown to 
bind syntaxin1 with nanomolar affinity [131, 132].  Genetic deletion of Munc18-1 in mice 
completely abolished both evoked and spontaneous neurotransmitter release, 
demonstrating that Munc18-1 is essential for synaptic vesicle exocytosis [133].  
(Remarkably, despite the complete silencing of synapses in these mice, the nervous 
systems of these mice still developed normally up until embryonic day 12!).   
Interestingly, and somewhat unexpectedly, however, the crystal structure of the Munc18-
1 / syntaxin1 complex demonstrated that Munc18-1 bound to the N-terminus of 
syntaxin1, stabilizing syntaxin1 in its closed, non-SNARE pairing conformation [114].  
These apparently contradictory results left the field in a state of confusion for several 
years: how could Munc18-1 be so clearly essential for neurotransmitter release, and yet 
negatively regulate SNARE core complex formation?   Recent evidence has now begun 
to shed light on a new role for Munc18-1 in promoting SNARE core complex activity.  
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First, a novel and high affinity binding mode of Munc18-1 to the neuronal SNARE 
complex was observed [134, 135].  Next, in vitro liposome fusion assays demonstrated 
that addition of Munc18-1 to liposomes containing pre-formed SNARE complexes 
resulted in a 20-fold increase in the initial rate of fusion, compared to liposomes in which 
Munc18-1 was not added.  Notably, this effect of Munc18-1 occurred selectively for 
SNARE complexes involved in exocytosis; moreover, mutations in VAMP that decreased 
the ability of Munc18-1 to facilitate liposome fusion in vitro were found to correlate to 
previously published effects of these mutations in inhibiting exocytosis in vivo [135].    
Thus, it now appears that Munc18-1 exhibits different binding modes to SNARE proteins, 
and that Munc18-1 may both negatively and positively regulate the activity of SNARE 
complexes.  Future challenges in understanding Munc18-1 action will involve 
sequencing its transitions between these states (if such a transition occurs) and 
determining how the positive and negative roles of Munc18-1 are regulated.  Moreover, 
while it is now clear that Munc18-1 can positively regulate SNARE-catalyzed fusion 
events, it is still unclear mechanistically how deletion of this gene would result in the 
complete silencing of synapses.  Notably, the genetic deletion of Munc18-1 in mice 
resulted in a phenotype stronger than that seen on deletion of either SNAP-25 or 
synaptobrevin—which suggests at least two possibilities: 1) Munc18-1 and syntaxin1 
may mediate a separate fusion pathway for “spontaneous” release events, independent 
of SNAP-25 and synaptobrevin; or 2) Munc18-1 may be at least, if not more important, in 
membrane fusion than some of the SNARE proteins themselves. 
 Another protein that has recently been implicated in regulation of the SNARE 
core complex assembly is tomosyn, a 130kDa soluble R-SNARE protein that was 
originally identified as a high affinity binding partner of syntaxin1 [136].  Tomosyn 
belongs to a family of proteins that includes the yeast proteins Sro7p and Sro77p, as 
well as the lethal giant larvae family of proteins in Drosophila [137].  Tomosyn consists of 
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a large N-terminal domain comprised of repeating WD-40 motifs, followed by a linker 
region known as the hypervariable domain, where most of the variability between 
tomosyn isoforms occurs.  At its C-terminus, tomosyn contains an R-SNARE domain 
similar to that in synaptobrevin.  The crystal structure of the yeast tomosyn homolog 
Sro7 was recently determined, and demonstrated that the N-terminal WD-40 motifs 
folded into two 7-bladed β-propellers, followed by a long tail that bound to the bottom of 
the N-terminal propeller.   (The C-terminal SNARE/helical region was not included in this 
crystal structure) [138].   
Much evidence exists to support an inhibitory role for tomosyn in regulated 
exocytosis.  First, overexpression of tomosyn in a number of different neuroendocrine 
cells resulted in an inhibition of regulated secretion [48, 136, 139-141].  In chromaffin 
cells, a specific role for tomosyn in inhibiting vesicle priming was identified, as 
overexpression of tomosyn resulted in a decrease in both the size and refilling kinetics of 
the readily releasable pool, with no effect on vesicle docking [48].  Moreover, loss-of-
function tomosyn mutants in C.elegans resulted in an increase in the size of the readily 
releasable pool at neuromuscular junctions, consistent with a role for tomosyn in 
inhibiting vesicle priming [142, 143].   
Tomosyn exhibits multiple modes of binding to SNARE proteins.  In one mode, it 
can form binary interactions with syntaxin1.  This binding mode is of high enough affinity 
that tomosyn can compete with Munc18-1 for binding to syntaxin1 and dissociate 
syntaxin1-Munc18-1 complexes [136, 144].  Tomosyn can also form into ternary SNARE 
complexes with syntaxin1 and SNAP-25; the crystal structure for this complex was 
nearly identical to that formed by syntaxin1-SNAP-25-synaptobrevin [139, 145].   The 
basis of tomosyn’s inhibitory action on secretion is widely believed to result from the 
formation of non-fusogenic tomosyn-SNARE core complexes, as tomosyn replaces 
synaptobrevin in this SNARE complex but is not actually anchored to a vesicle 
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membrane to be able to catalyze fusion.  Formation of tomosyn-SNARE ternary 
complexes would thus reduce the availability of syntaxin1 and SNAP-25 to form into 
functional SNARE complexes, thereby resulting in an inhibition of secretion.  
The experiments presented in Chapter 3 of this dissertation examine the 
spatiotemporal properties of the tomosyn-syntaxin1A interaction in response to a 
secretory stimulus, to test the hypothesis that tomosyn’s inhibitory function on secretion 
is regulated by secretory demand. 
 
Calcium Sensing for Neurotransmitter Release 
 How does the influx of calcium into the nerve terminal trigger synaptic vesicles to  
fuse with the plasma membrane?  Most evidence points to a role for Synaptotagmin-1 as 
the calcium sensor for fast neurotransmitter release.  Synaptotagmin-1 is a 65kDa 
integral vesicle protein, comprised of a short intravesicular domain and a 
transmembrane domain at its N-terminus, and two cytosolic C2 domains (C2A and C2B) 
connected by a linker at the C-terminus [146-148].  C2A and C2B are the calcium 
sensing portions of synaptotagmin-1, and bind 3 or 2 calcium ions, respectively.   
Importantly, the affinity of these domains for calcium greatly increases in the presence of 
anionic phospholipids.  Notably, it was determined in vitro that in response to calcium, 
both C2A and C2B become partially inserted into lipid bilayers [149-151]. 
Synaptotagmin-1 has also been reported to bind to syntaxin1 individually, as well as to 
the ternary SNARE complex [77].  The ability of synaptotagmin-1 to interact 
simultaneously with both SNAREs as well as with lipid bilayers in response to calcium is 
thought to be crucial to its role as a calcium sensor ((for review, see [152]).   
The role of synaptotagmin-1 as a calcium sensor for neurotransmitter release is 
suggested by studies demonstrating that point mutations of this protein within the C2 
domains alter the fourth-order calcium dependence of release [153, 154].  Some of the 
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first studies on synaptogamin-1 carried out in neuronal cultures suggested that this 
protein was required for normal levels of neurotransmitter release, as genetic deletion of 
this protein abolished the synchronous component of release, with no detected changes 
in the asynchronous component of release [155].  However, more recent studies at the 
Drosophila neuromuscular junction and in hippocampal neurons demonstrated that 
deletion of synaptotagmin-1 actually resulted in the same total amount of 
neurotransmitter being released in response to a stimulus compared to control neurons.  
However the rate of release was found to be decreased dramatically, and release 
occurred mostly asynchronously and was not tightly coupled to the stimulus [156, 157].  
Thus, it appears that synaptotagmin-1’s function is not absolutely required for 
neurotransmission.  Rather, this protein seems to be involved in synchronization and 
acceleration of release events in response to the calcium trigger. 
Of note, 16 mammalian isoforms for synaptotagmin have been identified to date, 
most of which are synthesized in neurons or neuroendocrine cells [158, 159].  
Synaptotagmins 1, 2, and 9 have been shown to localize to synaptic and secretory 
vesicles, whereas Synaptotagmins 3, 6 and 7 localize to the plasma membrane.  
Notably, not all synaptotagmins bind calcium and phospholipids.  Synaptotagmins 4 and 
11 contain conserved mutations within the C2A domain and therefore likely bind fewer 
than 5 calcium ions; synaptotagmins 8, 12, and 13 lack almost all of the aspartate and 
glutamate residues in C2A and C2B that coordinate calcium binding, and thus likely do 
not even bind calcium.  Why there exist so many synaptotagmin isoforms is unknown, 
but perhaps these proteins play complementary roles in calcium sensing at multiple sites 
of the cell, or allow for extremely fine control over the calcium sensitivity of 
neurotransmitter release [159].  The role for synaptotagmins that do not bind calcium is 




Lipids in Membrane Fusion 
 While the discussion thus far has focused largely on the role of proteins in 
mediating biological membrane fusion, it would hardly do justice to the topic of 
membrane fusion to exclude the importance of lipids in this process-- after all, this 
process by definition must involve lipids!  The tools for studying lipids in biological 
systems are still rather under-developed compared to those for studying proteins, but it 
is becoming increasingly apparent that lipids play important structural, electrostatic, and 
signaling roles in biological membrane fusion. 
 Membrane fusion is an intrinsically energy-demanding process.  In the aqueous 
context of a biological cell, the hydrophobic effect is paramount to the assembly of lipids 
into bilayers, whereby the phosphate headgroups of the lipids associate with the water, 
thus shielding the hydrophobic acyl chains of the lipids.  It is this powerful hydrophobic 
effect that must ultimately be overcome to rupture two bilayers to allow for their fusion.  
Any forces that are less powerful than the hydrophobic effect can result in bending and 
deformation of membranes, but will not result in fusion (for review, see [160, 161]).   The 
energy barriers that are encountered when two lipid bilayers undergo fusion, and the 
membrane intermediates that minimize these energetic requirements, have been 
modeled extensively [162, 163], and are illustrated in Figure 1.2.  Membranes must first 
be brought within close enough proximity (several nanometers) to establish a region of 
dehydrated contact; this requires surmounting the electrostatic forces repelling the two 
bilayers.  An initial connection between the two bilayers, termed a fusion stalk, is then 
formed.  Radial expansion of this stalk generates a hemifusion diaphragm, in which the 
contacting leaflets of the bilayers have merged, while the distal leaflets of the bilayers 
remain separate.  Importantly, in vitro fusion assays in bulk solution as well as on a 
single liposome level, demonstrated that SNARE-mediated fusion events indeed occur 
through a hemifusion intermediate [164, 165].  Following hemifusion, lateral tension must 
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be generated within the hemifusion diaphragm to allow for membrane rupture and 
formation of a fusion pore, the initial aqueous connection between the two 
compartments.  Expansion of this fusion pore results in membrane collapse and full 
fusion.  Notably, formation and expansion of the fusion pore are thought to be the most 
energetically demanding steps of this process [163]. 
The amount of work that must be performed on membranes to deform them into 
the intermediates described above depends largely on the spontaneous curvature of the 
membranes involved.  The spontaneous curvature of a membrane bilayer is the 
curvature that it naturally exhibits in the absence of any external forces acting upon it.  
The spontaneous curvature of a bilayer depends on the spontaneous curvatures of its 
individual monolayers, which in turn, depend on the individual lipid constituents of each 
monolayer.  Lipids can be classified based on spontaneous curvatures that they promote 
[166, 167]; in most cases, this is closely related to their overall structure and the 
electrostatic properties of their polar head groups.  Most lipids with two acyl chains, such 
as DOPC (dioleoylphosphatidylcholine), are termed cylindrical lipids, and favor the 
formation of flat bilayers with relatively little curvature.  Lysolipids, such as LPC 
(lysophosphatidylcholine), that contain only one acyl chain and relatively large polar 
headgroups, are termed inverted cone-shaped lipids.  These lipids favor strong positive 
spontaneous curvatures (membranes that bend toward the hydrocarbon tails of the 
lipid).  On the other hand, lipids such as DOPE (dioleoylphosphatidylethanolamine), that 
contain two acyl chains and relatively small polar headgroups, are termed cone-shaped 
lipids and favor strong negative spontaneous curvatures (membranes that bend away 
from the hydrocarbon tails).  In the model for membrane fusion described above, the 
energetic requirements for stalk and hemifusion formation can be greatly increased or 
decreased by the presence of positive or negative curvature-favoring lipids, respectively, 
in the proximal contacting leaflets of the two membranes [168].  On the other hand, 
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formation of a fusion pore is largely favored by the presence of positive curvature-
favoring lipids in the distal leaflets of the fusing bilayers.   
The importance of lipid shape in determining the energetics of membrane fusion 
can be highlighted by a family of snake neurotoxins termed SPANs (snake presynaptic 
phospholipase A2 neurotoxins), which are known to generate paralysis by the induction 
of neurotransmitter release and subsequent depletion of vesicle pools.  It was recently 
observed that the mechanism underlying this effect was the hydrolysis of phospholipids 
in the outer leaflet of the plasma membrane, into positive curvature-promoting 
lysophospholipids that favored the formation of fusion pores and the subsequent release 
of neurotransmitter [169].  Conversely, injection of these toxins into the cytosol of PC-12 
cells strongly inhibited secretion, likely because these toxins generated positive 
curvatures on the inner leaflet of the plasma membrane that were unfavorable for fusion 
[170].  The strong dependency on lipid shape for determining the energetic requirements 
of membrane fusion is also evident in in vitro liposome assays of SNARE-catalyzed 
fusion, and in many other biological fusion reactions including cell-cell fusion, organelle-
organelle fusion, and organelle-plasma membrane fusion [171, 172]. 
Given that work must be done on the lipid bilayers in order to induce fusion, and 
given that SNARE proteins are the machinery that carries out this task, how 
mechanistically might this occur?  The energy released upon SNARE core complex 
formation must somehow be transmitted to the lipid bilayers, and the anchoring of 
SNARE proteins to the lipid bilayers via transmembrane domains (TMDs) is crucial to 
this function.   However, it is becoming increasingly apparent that the SNARE TMDs 
may play a more active role in fusion than just acting as mechanical anchors that allow 
for close apposition of the fusing bilayers.  Indeed, targeted disruptions within the TMD 
of various SNARE proteins, including shortening of the TMD [173], replacement of the 
TMD with lipid anchors [174, 175], and mutation of the TMD to alter its helical structure 
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[176], have all been shown to adversely affect the fusion reaction.   As stated above, the 
most energetically demanding step in the process of membrane fusion is the formation 
and expansion of the fusion pore.   Interestingly, the TMD of syntaxin1 was recently 
suggested to form part of the fusion pore, based on amperometric studies that showed 
that mutation of key resides in syntaxin1’s TMD could alter the flux of catecholamines 
through the fusion pore in a size and charge-dependent fashion [116, 117].  Another role 
for SNARE proteins in membrane fusion could be to generate the lateral tension 
required for expansion of the fusion pore;  this could achieved through electrostatic 
interactions that might occur between the SNARE proteins and acidic phospholipids 
[160].  Notably, the juxtamembrane regions of both syntaxin1 and synaptobrevin contain 
clusters of basic residues which could mediate these effects.  Electron paramagnetic 
resonance studies demonstrated that the juxtamembrane regions of syntaxin1 and 
synaptobrevin were buried within the lipid bilayer.  However, synaptobrevin was unable 
to form into SNARE complexes while its juxtamembrane region was lipid-associated, 
implying that synaptobrevin-lipid interactions are a negative regulator of exocytosis [177-
180].  Interestingly, molecular dynamics studies of the juxtamembrane region and TMD 
of syntaxin1 suggested just the opposite case for syntaxin1, and demonstrated that 
interaction between the juxtamembrane region and acidic phospholipids in the 
membrane might result in an increase in the helicity and tilt angle of syntaxin1’s TMD, 
allowing for accelerated rates of fusion [181].  Further evidence suggesting that 
syntaxin1-lipid interactions might facilitate membrane fusion is that syntaxin1 was found 
to localize to cholesterol dependent clusters in the plasma membrane [182, 183], as well 
as to clusters which co-localized with PI(4,5)P2 clusters [71]; importantly, exocytosis 
seemed to occur preferentially at these syntaxin1-lipid microdomains.   
The experiments presented in Chapter 2 of this dissertation identify the specific 
lipids that directly interact with syntaxin1, and test the hypothesis that these protein-lipid 
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interactions play important functional roles with respect to the energetics of membrane 
fusion. 
 
Emerging Tools for the Study of Regulated Exocytosis:  FRET 
 For the most part, many of the key protein and lipid players for regulated 
exocytosis have now been identified.  Biochemical, genetic, and functional studies have 
further allowed for the elucidation of specific protein-protein interactions that are critical 
to each specific step of neurotransmitter release.  However, these experimental results, 
in many cases, provide just a single snapshot of how these proteins might interact over 
the course of the highly dynamic process of membrane fusion.  Clearly, an 
understanding of neurotransmitter release will require unraveling the spatial and 
temporal dynamics of the associations and dissociations of the many proteins and lipids 
that orchestrate this process.  One tool that has rapidly emerged to carry out such a task 
is FRET (fluorescence resonance energy transfer) imaging.  This approach is used in 
completion of the first two data chapters of this dissertation, and is further expanded and 
developed in the third data chapter, such as to open new avenues for discovery of 
specific protein interaction events occurring just proximal to the plasma membrane.  
What is presented below is an introduction to FRET methodology, starting from basic 
principles of fluorescence imaging and working up to the derivation of a sensitized 
emission FRET method termed FRET stoichiometry [184]. 
 Fundamental to the understanding of fluorescence imaging is a working 
knowledge of the processes that occur when fluorescent molecules in the ground state 
are excited to and decay from higher level energy states.  These processes can be 
visualized in a Jablonski diagram, as shown in Figure 1.3.  Upon the absorption of 
energy (usually in the form of a photon of wavelength λex), fluorescent molecules 
transition from an electronic ground state, s0, to a higher energy excited state, s1.   
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These excited fluorophores then rapidly (on the order of nanoseconds) decay back to 
the ground state via one of several pathways.  In the first pathway, termed nonradiative 
decay, the excited state energy is dissipated thermally or through collisional quenching.  
In the second pathway, termed radiative decay, the fluorophore decays to the ground 
state via emission of a photon of light (λem), which is always of a longer wavelength (ie, 
lower energy) than the photon of light used to excite the molecule.  The difference in 
wavelengths (and thus, energies) of the excitation and emission photons is termed the 
Stokes shift.   Notably, it is the radiative pathway of decay that is essential to the utility of 
fluorescence microscopy.   
 Several key terms should be defined at this point.  The extinction coefficient, ε(λ), 
is a measure of how easily a fluorophore can absorb (ie, be excited by) photons of a 
particular wavelength, λ.  The quantum yield, Q, of a fluorophore is a measure of the 
“brightness” of the fluorescence emission of a fluorophore.  More precisely, the quantum 
yield represents the fraction of excited state fluorophores that decay through the process 
of radiative emission.  As such, the quantum yield can be defined using rate constants: 
 
   
 , where  and  are the rate constants for radiative and nonradiative 
decay, respectively, for a fluorophore.  Notably, both the extinction coefficient and the 
quantum yield are properties unique to each and every fluorophore.   
 In the presence of an “acceptor” fluorophore, an excited state “donor” fluorophore 
can decay back to the ground state via a third pathway, termed fluorescence resonance 
energy transfer (FRET) (see Figure 1.4).   This process requires the presence of a 
suitable acceptor fluorophore, whose excitation spectrum overlaps with the emission 
spectrum of the donor fluorophore.  When an excited state donor fluorophore comes 
within close enough proximity (<10nm) to an acceptor fluorophore, the donor can 
transfer its excited state energy to the acceptor, via a dipole-dipole interaction.  When 
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this occurs, the donor decays back to its ground state without emitting a photon, and the 
acceptor transitions from its ground state to its excited state.  The excited state acceptor 
can then decay back to its ground state either radiatively or nonradiatively.    
The frequency with which FRET occurs between a donor-acceptor fluorophore 
pair can be described by the characteristic FRET efficiency, E, which represents the 
fraction of excited state donor molecules in complex with the acceptor, that decays back 
to the ground state via FRET.  The characteristic FRET efficiency is a physical property 
of each bimolecular interaction that exhibits FRET; in other words, its value is a constant 
that should be independent of the instruments used to measure it.  It is important to 
distinguish between the “true” or characteristic FRET efficiency and the “apparent” FRET 
efficiency, which, as described below, results from measurements in which neither the 
characteristic FRET efficiency nor the fraction of molecules in complex are known.   
Like quantum yield, the FRET efficiency can be defined in terms of rate 
constants:  
   
, where as before,  and  are the rate constants for 
radiative and nonradiative decay, and  is the rate of energy transfer.  It should be 
noted that  is remarkably sensitive to the distance between the donor and acceptor 
fluorophores (      ) as well as to the relative orientation of the donor and 
acceptor dipoles.  Importantly, for most genetically encoded fluorophores, the distances 
over which FRET is highly sensitive are on the order of tens of angstroms—precisely the 
distance scale over which bimolecular interactions within living cells might occur.    
The use of FRET to study molecular interactions within biological systems 
requires that the molecules of interest first be tagged with donor and acceptor 
fluorophores.  Interaction of these molecules is required to bring the donor and acceptor 
fluorophores within close enough proximity such that they can undergo FRET.  As such, 
FRET should only be observed when the labeled molecules directly interact; moreover, 
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changes in FRET can report on changes in the extent of this bimolecular interaction (ie, 
a change in the total number of molecules that are interacting), or in the orientation of 
molecules involved in the bimolecular interaction.  It is important to re-emphasize here 
that not all donor-acceptor complexes will undergo FRET; only a fraction (equal to the 
FRET efficiency, E) of the total number of donor-acceptor complexes undergoes FRET.   
 An understanding of how FRET is measured requires first understanding how 
fluorescence signals are measured.   The simplest case of a fluorescence measurement 
that will be considered here is shown in the left panel of Figure 1.5.  Here, light of 
wavelength λD, is used to directly excite either donor or acceptor molecules.  In either 
case, the total fluorescence intensity (FI) of the donor and acceptor molecules can be 
y  described b  the equations below:
      (1)   · ε · ·  
  ·  ε · ·       (2) 
In both cases, the fluorescence intensity takes into account the intensity of the 
excitation light, ; how easily the donor or acceptor molecules absorb light of this 
wavelength, given by the extinction coefficients of the donor and acceptor at λD, ε  
and  ε , respectively; the total number of donor or acceptor molecules present (  
and , respectively); as well as the brightness of the donor and acceptor fluorescence 
emission, given by their quantum yields,  and , respectively.  In practical terms, the 
intensity of the excitation light takes into consideration the intensity of the light source, as 
well as the extent to which this light is attenuated by filters and other optical elements in 
the path between the light source and the sample.  Similarly, the brightness of the donor 
or acceptor fluorescence emission takes into account not only the quantum yields of the 
donor and acceptor, but also the filters and other optical elements downstream of the 
sample that may attenuate the fluorescence emission, as well as the wavelength-
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dependent quantum efficiency of the camera that is used to detect the fluorescence 
emission.  To keep the equations simple, however, it is assumed that these factors are 
all accounted for in the variables above. 
 How does fluorescence intensity of the donor and acceptor molecules change 
when a fraction of these molecules (  or , respectively) undergoes FRET with 
characteristic efficiency E?  This example is illustrated in the right panel of Figure 1.5.  
When a donor molecule undergoes FRET, its fluorescence becomes quenched (as 
FRET precludes the excited state donor from decaying radiatively).  The donor 
molecules whose fluorescence is quenched are those that are both 1) in complex with 
acceptor, and 2) undergoing FRET.  (Recall that the former does not necessarily imply 
the latter).  As such, the total number of quenched donors is equal to · · , and the 
 h s  r  o  F  is: fluorescence intensity that is quenc ed a  a esult f RET
          ·  ε   ·     ·      (3) 
Subtracting equation (3) from equation (1), the total amount of donor fluorescence that 
h r n  of FRET is: would be observed in t e p ese ce
       · ε · 1   ·     (4) 
In contrast to the donor fluorescence decreasing in the presence of FRET, the 
acceptor fluorescence is enhanced in the presence of FRET.  This is because the 
acceptor can now be excited either directly by , or indirectly, through FRET.  The 
number of acceptor molecules that is excited indirectly through FRET is the same as the 
number of donor molecules whose fluorescence was quenched by FRET, and is equal 
to: · · .  As such, the enhanced fluorescence emission of the acceptor as a result 
o s n s: f FRET (also termed sensitized emission) can be repre e ted a
           ·  ε   ·     ·    (5) 
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Note that in comparison to equation (2) above, the donor’s extinction coefficient is used 
here rather than the acceptor’s extinction coefficient.  This is because the acceptor that 
is undergoing FRET is excited indirectly, via the excited-state donor, and thus it is the 
donor’s absorption of the excitation light that is relevant.  Equations (2) and (5) can be 
summed to determine the total fluorescence intensity of the acceptor in the presence of 
FRET: 
        · ε · ·    ·  ε ·     ·      (6)  
Armed with this basic understanding of the theory underlying FRET, we are now 
in a position to understand how FRET is measured experimentally.  The two most 
common methods to measure FRET in biological systems are termed donor 
dequenching, and sensitized emission.  Often in these experiments, two different 
molecules are labeled with donor and acceptor, respectively, and the fraction of donor or 
acceptor molecules in complex is unknown.  Moreover, it is also usually the case that the 
characteristic FRET efficiency of the specific bimolecular interaction is not known (as 
experimental determination of this value requires highly specialized equipment, eg, a 
fluorescence lifetime microscope).  As such, the FRET methods described here can be 
used to calculate only an “apparent” FRET efficiency, which represents the product of 
the “true” or characteristic FRET efficiency, with the fraction of donor or acceptor 
molecules in complex.    
 In the method of FRET by donor dequenching, the population of acceptor 
fluorophores is irreversibly destroyed via photobleaching, thus precluding FRET from 
occurring.  As such, FRET that was present before photobleaching is detected as an 
increase (dequenching) in donor fluorescence following photobleaching.  This situation is 
illustrated in the left panel of Figure 1.6.  Donor dequenching is usually performed on a 
confocal microscope (although it is possible to perform this technique on a conventional 
epifluorescence microscope as well).  While it is easy to perform (as no calibrations are 
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required), time lapse FRET imaging of the same subcellular location cannot be 
measured using this technique, due to the direct and permanent loss of the acceptor 
fluorescence.  In donor dequenching, the apparent FRET efficiency is usually calculated 
e intensity before and after photobleaching: by measurement of the donor fluorescenc
             
 
        (7) 
Note in equation (7) that the amount of dequenched donor is normalized to the total 
amount of donor, so that the apparent FRET efficiency is independent of differences in 
donor expression levels between cells.  Substituting equations (1) and (3) into equation 
(7) demonstrates that the apparent FRET efficiency as measured using donor 
dequenching is equal to the product of the characteristic FRET efficiency and the 
 omplex:   fraction of donor molecules in c
       · ε  ·  ·
·ε · ·
    ·    (8) 
While the apparent FRET efficiency obtained in donor dequenching is independent of 
donor expression levels, it is important to note that the degree of molecular interaction 
between the acceptor and donor, and hence, the apparent FRET efficiency, is still 
dependent upon acceptor expression levels.  Notably, donor dequencing provides little 
information as to what fraction of acceptor molecules are in complex with the donor. 
In contrast to donor dequenching, the method of sensitized emission FRET is 
non-destructive, and determines an apparent FRET efficiency by measuring the 
enhancement in acceptor emission (ie, sensitized emission) due to FRET.  This is shown 
in the right panel of Figure 1.6.  Sensitized emission can be performed on 
epifluorescence or confocal microscopes, and as it is non-destructive, can be used for 
time lapse FRET imaging.  However, sensitized emission FRET is more complicated to 
perform than donor dequenching FRET, because due to the nature of the optical filters 
and fluorophores used, the sensitized emission signal is often buried among other 
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spectral contaminants.  As such, this method requires the user to perform various 
calibrations for the imaging system and the fluorophores used, in order to specifically 
isolate the sensitized emission signal.  Apparent FRET efficiency under sensitized 
e s: mission is usually measured a
         
 
     (9) 
Note that in equation (9), the amount of sensitized emission fluorescence is normalized 
to the amount of total acceptor fluorescence, so that the apparent FRET efficiency is 
independent of differences in acceptor expression levels between cells.   Substitution of 
equations (2) and (5) into equation (9) demonstrates that the apparent FRET efficiency 
measured by sensitized emission FRET is the product of the “true” FRET efficiency with 
the fraction of acceptor molecules in complex, and the ratio of extinction coefficients of 
the donor to acceptor at the donor excitation wavelength, as shown in Equations (10) 
and (11) below: 
         · ε  ·    ·
· ·· ε
     (10) 
       ε
 ε
·   ·  ·      ε
 ε
  · ·        (11) 
While the apparent FRET efficiency obtained from sensitized emission measurements is 
independent of the expression levels of the acceptor, it is important to realize that the 
extent of the acceptor-donor interaction and hence, the apparent FRET efficiency, will 
still depend on donor expression levels.  However, the fraction of donor molecules in 
complex with the acceptor remains undetermined with this mode of analysis. 
Note from equations (8) and (11) that while donor dequenching provides an 
apparent FRET efficiency that is dependent upon the fraction of donor molecules in 
complex, the apparent FRET efficiency determined using sensitized emission is 
dependent upon the fraction of acceptor molecules in complex.  Thus, use of either of 
these methods alone yields information limited to either the donor alone, or the acceptor 
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alone.  However, a method of sensitized emission FRET termed FRET stoichiometry 
[184] operates as somewhat of a marriage between sensitized emission FRET and 
donor dequenching FRET.  In other words, FRET stoichiometry allows for the 
determination of the apparent FRET efficiency of both the donor, as well as the acceptor, 
in complex; moreover, this method allows for determination of the molar ratio of acceptor 
to donor. 
 In FRET stoichiometry, three images are taken of each cell and are background 
subtracted and shade corrected to yield CIDD, CIDA, and CIAA images (where CI = 
corrected image, and DD = donor excitation / donor emission; DA = donor excitation / 
acceptor emission; and AA = acceptor excitation / acceptor emission) (see Figure 1.7). 
Both the CIDD and CIAA images are relatively free of spectral contaminants and 
represent “clean” images of the donor and acceptor, respectively.  The CIDA image 
contains the sensitized emission FRET signal, but is contaminated by two other 
elements:  1) spectral bleeding (spillover of donor emission into the acceptor emission 
channel); and 2) cross-talk (direct excitation of the acceptor by the donor excitation 
wavelength).  Note that the extent of these spectral contaminants is dependent upon the 
fluorophores used, the bandwidths of the excitation lines, and the optical filters used.  
However, the contribution of each of these contaminants can be determined and 
subtracted out of the CIDA image, using proportionality constants.  For instance, the 
amount of spectral bleedthrough of the donor is equal to a certain fraction (β) of the total 
donor fluorescence:   
          ·       (12) 
Importantly, the value of β for a specific optical setup can be determined experimentally 
by imaging cells that express donor only, and taking the ratio of   .  
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Similarly, the amount of acceptor directly excited at donor wavelengths is equal to a 
certain fraction (α) of the total acceptor fluorescence intensity arising from excitation at 
acceptor wavelengths: 
            ·        (13) 
 The value of α for a particular optical setup can be determined experimentally by 
imaging cells that express acceptor only, and taking the ratio of .   Combining 
equations (12) and (13), the spectral contaminants can be subtracted from the CIDA 
 image to isolate the sensitized emission signal:
          ·    ·      (14) 
Recall from equations (9) a d (
        
 
n 11), that 
   ε
 ε
  · ·         (15) 
Using equation (14), and setting the total acceptor fluorescence equal to · , 
equation (15) can be rewritten to yield the equation for the apparent FRET efficiency of 
 in complex, EA: the acceptor
      ·     Uγ  · UCIDA –  U·UCIAA –  U·UCIDD
·CIAA
         (16) 
where γ    ε
 ε
.  Note that both the numerator and denominator of the latter portion of 
equation 16 are expressed in terms of fluorescence images where the molecules are 
excited with donor excitation wavelengths, and fluorescence intensity is determined 
using acceptor emission wavelengths; moreover, the constant γ normalizes for 
differences in the extinction coefficients of the acceptor and donor at donor excitation 
wavelengths.  (In other words, the “units” of the numerator and denominator match, and 
dividing them is physically meaningful).  Also note that γ, like α and β, is a constant that 
can be determined experimentally for the fluorophores and optical setup used.  This is 
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done by imaging a linked donor-acceptor construct (where 1 , and E has been pre-
ined), and solving equation (16) for γ: determ
      UE ·   U·UCIAA 
UCIDA –  U·UCIAA –  U·UCIDD
           (17) 
Importantly, while the linked probe must incorporate the same donor and acceptor 
fluorophores used in the experiment, the FRET efficiency of the linked probe need not 
match the apparent FRET efficiencies determined in the experiment.  In other words, the 
linked probe is simply used to calibrate the system, and knowing the FRET efficiency of 
the linked probe is required only so that the fluorescent properties of the acceptor and 
donor fluorophores, as measured under the user’s imaging system, can be determined. 
As mentioned earlier, FRET stoichiometry combines the benefits of sensitized 
emission with donor dequenching.  Recall from equation (7) that the apparent FRET 
efficiency in donor deqeunching is equal to the ratio of   
 
.   The 
complicated factor here is in obtaining the fluorescence intensity associated with the 
quenched donor; after all, how does one measure a signal that does not exist?  
Measuring the total amount of donor is equally complicated, as the total amount of donor 
is comprised of donor molecules that are fluorescing, as well as those whose 
fluorescence is quenched.  The key to solving this problem is in understanding that the 
“would-be fluorescence” of the quenched donor is closely related to the sensitized 
emission fluorescence; indeed, both result from the excitation of donor molecules that 
undergo FRET.  In the case of the quenched donor, it is the donor molecules that (would 
have) emitted photons; in the case of sensitized emission, the acceptor molecules emit 
photons.  (A comparison of equations (3) and (5) illustrates this principle nicely).  Thus, 
the sensitized emission signal from the acceptor can be converted to its equivalent in 
quenched donor fluorescence, by multiplying the sensitized emission signal with the ratio 
of brightness of the donor and acceptor fluorescence emission: 
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      .   ·      UCIDA – αU · UCIAA– βU · UCIDD U ·    (18) 
Equation (18) can be substituted into equation (7) to yield the equation for the apparent 
E i e  of the donor in co lex:   FR T eff ci ncy mp
  ·        
 
    U   CIDA –  U·UCIAA –  U·UCIDD
CIDD      CIDA –  ·CIAA –  ·CIDD
    (19) 
Again, as with γ, the value for ξ can be determined using the linked donor-acceptor 
FRET probe (where 1 , and E has been pre-determined), and solving equation (19) 
for ξ: 
      UE ·  CIDD 
E CIDA –  U·UCIAA –  U·UCIDD
        (20) 
 Lastly, FRET stoichiometry allows for the determination of the molar ratio of 
acceptor to donor in each cell.  This is possible, because the calibration constants allow 
for determination of the total amount of acceptor, as well as the total amount of donor, in 




CIDD      CIDA –  ·CIAA –  ·CIDD
      (21) 
 
Equation (21) is not quite correct, however, as the “units” of the numerator and 
denominator are not comparable.  The numerator is written in terms of excitation of the 
acceptor at donor excitation wavelengths, while measuring emission of the acceptor, 
whereas the denominator is written in terms of excitation of the donor at donor excitation 
wavelengths, while measuring emission of the donor.  Thus, Equation (21) must be 
corrected for 1) differences in extinction coefficients between the acceptor and donor at 
donor excitation wavelengths, and 2) differences in the brightness of the acceptor 
compared to the donor.  The first correction can be performed by dividing equation (21) 
by γ, and the second correction can be performed by multiplying equation (21) by ξ.  As 




CIDD      CIDA –  ·CIAA –  ·CIDD
  ·           (22) 
 
 In summary, the method of sensitized emission FRET via FRET stoichiometry 
can be performed using a widefield microscope, and involves taking 3 pictures (CIDD, 
CIDA, and CIAA).   Calculation of FRET parameters requires prior determination of 4 
calibration constants (α, β, γ, and ξ) that are specific to the fluorophores and the optical 
components of the imaging system used.  Importantly, the 3 images and 4 calibration 
constants can be used for determination of the apparent FRET efficiencies of the 
acceptor and donor in complex, as well as for determination of the molar ratio of total 
acceptor : total donor.  Determination of the molar ratio is especially important, as a low 
apparent FRET efficiency could either result from a low characteristic FRET efficiency, 
or a low fraction of molecules in complex.  The molar ratio can provide an idea as to 
which of these possibilities is occurring, as molar ratio values close to unity would tend 
to suggest the former, whereas very low or high ratio values would tend to suggest the 
latter.   
 
Preview to the Investigations of this Dissertation 
An understanding of SNARE protein function and the dynamic processes that 
regulate the activity of SNARE core complexes is clearly critical to understanding the 
molecular mechanisms that underlie neurotransmitter release.  These topics are the 
primary focus of investigations of this dissertation, which is comprised of three major 
studies. 
The first study of this dissertation tests the general hypothesis that there exist 
direct interactions between SNARE proteins and lipids, and that these interactions are 
functionally relevant to the ability of SNARE proteins to catalyze membrane fusion 
events.  As SNARE proteins form the minimal machinery required for membrane fusion, 
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they also therefore define the sites at which fusion can occur.  Moreover, the presence 
of specific fusogenic lipids in the membranes undergoing fusion has been shown to have 
profound effects on lowering the energy barrier for fusion.   We hypothesize that direct 
interactions between SNARE proteins and fusogenic lipids might provide a mechanism 
by which the energy barrier for membrane fusion could be reduced at sites of fusion.     
The second study of this dissertation tests the general hypothesis that the 
regulation of SNARE core complex assembly/disassembly is a dynamic process that is 
itself regulated by secretory demand.   Specifically, this study focuses on the soluble R-
SNARE protein, tomosyn, and tests the hypotheses that tomosyn’s interaction with the 
plasma membrane SNARE syntaxin1A occurs dynamically, is regulated by specific 
signaling pathways that occur downstream of secretory stimuli, and is functionally 
relevant to the regulation of neurotransmitter release.   
  The final study of this dissertation focuses on the development of an imaging 
technique that provides the unique capability to dynamically visualize, at the single 
vesicle level, molecular interactions that occur at or near the plasma membrane during 
the process of neurotransmitter release.  This approach combines the high sensitivity 
and high temporal resolution of sensitized emission FRET measurements with the 
unprecedented axial resolution afforded by TIRF microscopy.  Importantly, development 
and testing of this novel technical approach will allow for quantitative changes in 
molecular interactions to be directly correlated to a functional outcome, such as vesicle 
docking, priming, or fusion.  We believe that the ability to spatially and temporally match 
the dynamics of protein interactions in live cells with specific subcellular functions of the 
cell will herald in a new frontier in the study of cell biology.  
Taken together, these studies further our understanding of both lipid-mediated 
and protein-mediated processes that regulate the final stages of neurotransmitter 
release.  Moreover, they set the groundwork for the application of an imaging approach 
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likely to revolutionize the way in which we gain information on the temporal and spatial 
dynamics of molecular assemblies associated with specific cellular functions, and in 


















Figure 1.1.  The synaptic vesicle cycle (figure adapted from [185]).  (1) The synaptic 
vesicle, containing the R-SNARE synaptobrevin/VAMP2, must first approach the plasma 
membrane, where the Q-SNAREs syntaxin and SNAP25 reside, to become docked.  (2) 
Nucleation of a “loose” trans-SNARE core complex occurs, followed by (3) formation of 
SNAREs into a “tight” SNARE core complex.  (4) Upon calcium entry into the nerve 
terminal, complete zippering of the SNARE core complex catalyzes the membrane 
fusion event, resulting in formation of cis-SNARE complexes at the plasma membrane.  
(5) Hydrolysis of ATP by NSF/SNAP results in disassembly of cis-SNARE complexes 
into the individual SNARE constituents.   (6) The vesicle membrane is recycled by 













Figure 1.2.  Lipid intermediates in membrane fusion.  Fusion of two lipid bilayers first 
requires close apposition of the two membranes.  Fusion of the proximal contacting 
leaflets occurs first, resulting in hemifusion.  Expansion of the hemifusion diaphragm 
then results in the fusion of the distal leaflets of the bilayers, generating a fusion pore.  
Lateral tension results in widening of the fusion pore, and in full fusion of the 




















Figure 1.3.  Jablonski diagram illustrating the transitioning of a fluorophore between the 
electronic ground (so) and excited (s1) states.  The fluorophore is excited by absorption 
of a photon of wavelength λex, and can decay back to the ground state via nonradiative 
or radiative pathways, with rate constants knr and kr respectively.  In the radiative 














Figure 1.4.  Jablonski diagram illustrating the process of fluorescence resonance energy 
transfer (FRET).  The left panel demonstrates the transitioning of a donor fluorophore 
between its electronic ground and excited states, and is identical to Figure 1.3.  In the 
right panel, the excited state donor fluorophore decays back to its ground state by 
transferring its energy to an acceptor fluorophore via FRET (with rate constant kt).  This 
causes the acceptor fluorophore to transition from its ground state to its excited state.  














Figure 1.5.  Schematic of the excitation and emission of donor and acceptor 
fluorophores in the absence or presence of FRET.  Left panel, absence of FRET.  Right 
panel, FRET occurs.  In the right panel, E represents the characteristic FRET efficiency, 
or the fraction of excited-state donor molecules in complex with the acceptor that 
undergo FRET with the acceptor.  (1-E) represents the fraction of excited state donors in 
complex with the acceptor that do not decay through FRET (ie, they decay either 

















Figure 1.6.  Schematic of FRET as measured using donor dequenching or sensitized 
emission.  Left panel, schematic of donor dequenching.  Photodestruction of the 
acceptor fluorophore precludes the donor fluorophore from undergoing FRET.  This can 
be detected as an increase (ie, dequenching) in the donor fluorescence following 
photodestruction of the acceptor.  Right panel, schematic of sensitized emission.  FRET 
is visualized as an increase in acceptor fluorescence intensity upon excitation with the 




















Figure 1.7.  Schematic of the three images required for determination of apparent FRET 
efficiency, using the method of FRET stoichiometry.  CIDD, corrected image with donor 
excitation and donor emission; CIDA, corrected image with donor excitation and 
acceptor emission; CIAA, corrected image with acceptor excitation and acceptor 
emission.  Note that CIDA contains the sensitized emission signal, but is spectrally 
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SNARE-Catalyzed Fusion Events are Regulated by Syntaxin1A-Lipid Interactions 
 
Abstract 
Membrane fusion is a process that intimately involves both proteins and lipids.  While the 
SNARE proteins, which ultimately overcome the energy barrier for fusion, have been 
extensively studied, regulation of the energy barrier itself, determined by specific 
membrane lipids, has been largely overlooked.  Our findings reveal a novel function for 
SNARE proteins in reducing the energy barrier for fusion, by directly binding and 
sequestering fusogenic lipids to sites of fusion.  We demonstrate a high affinity 
interaction between the Q-SNARE Syntaxin1A and the fusogenic lipid, phosphatidic 
acid, and define a polybasic juxtamembrane region within Syntaxin1A as its lipid binding 
domain.  In PC-12 cells, Syntaxin1A mutations that progressively reduced lipid binding 
resulted in a progressive reduction in evoked secretion.  Moreover, amperometric 
analysis of fusion events driven by a lipid binding-deficient Syntaxin1A mutant (5RK/A) 
demonstrated alterations in fusion pore dynamics suggestive of an energetic defect in 
secretion.  Overexpression of the phosphatidic acid-generating enzyme, phospholipase 
D1, completely rescued the secretory defect seen with the 5RK/A mutant.  Moreover, 
knockdown of phospholipase D1 activity drastically reduced control secretion, while 
leaving 5RK/A-mediated secretion relatively unaffected.  Altogether, these data suggest 
that Syntaxin1A-phosphatidic acid interactions are a critical determinant of the 
energetics of SNARE-catalyzed fusion events. 
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Introduction 
Membrane fusion is a process that underlies compartmentalization within all 
eukaryotic cells, and allows for the many critical and diverse physiological functions in 
higher organisms.  Despite the essential and ubiquitous nature of this process, a 
considerable energetic expenditure is required to overcome the electrostatic repulsion 
between opposing lipid bilayers, and to deform and ultimately rupture these bilayers [1, 
2].  As a result, substantial effort has been placed on defining the molecular machinery 
that overcomes this energetic barrier to accomplish regulated and rapid membrane 
fusion. 
SNARE (soluble N-ethylmaleimide-sensitive fusion factor attachment protein 
receptor) proteins have now been identified as the minimal protein machinery required 
for membrane fusion [3].  Their critical role is supported by multiple lines of evidence, 
including that SNARE proteins are sufficient to drive membrane fusion when 
reconstituted into liposomes in vitro [4], and that cleavage of SNARE proteins by 
clostridial toxins [5-7] as well as genetic mutations resulting in loss of SNARE protein 
function [8-10], strongly inhibit neurotransmitter release.  Currently, the role of SNARE 
proteins in membrane fusion is believed to be predominantly mechanical.  During 
neurotransmitter release, nucleation and zippering of a highly stable SNARE core 
complex formed from two plasma membrane SNARE proteins, Syntaxin1A (Syn1A) and 
SNAP25, and a vesicle membrane SNARE protein, VAMP2, is believed to generate the 
energy required to bring opposing membranes to a state of proximity that initiates the 
fusion event [3].  As such, the majority of studies in this field have focused on 
characterizing SNARE protein-protein interactions, although the fusion process, by 
definition, must also involve lipids.   
That the specific lipid composition of the membrane can have profound 
consequences on the energetic barrier for membrane fusion has been demonstrated 
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both theoretically as well as in several in vitro membrane fusion systems [11-14], 
although this topic has been difficult to study in the context of secretion from live cells.  
Shapes of individual lipids can have dramatic effects on membrane curvature [1, 15].  
For example, cone-shaped lipids (e.g., phosphatidylethanolamine, diacylglycerol, or 
phosphatidic acid) spontaneously form negative membrane curvatures [16-18], and the 
presence of these lipids in the contacting leaflets of merging membranes has been 
shown to favor the formation of the stalk and hemifusion intermediates that underlie 
membrane fusion [19].  Effects of spontaneous curvature are a highly local phenomenon 
[1], however, and in order for fusogenic lipids to exert such effects on exocytosis, they 
must be directly localized to the sites at which membrane fusion occurs.  As the minimal 
machinery for membrane fusion, SNARE proteins physically define the sites at which 
exocytosis occurs, and therefore, would be ideal molecular partners to bind and 
sequester fusogenic lipids, thus reducing the energy barrier at exocytotic sites.  
The purpose of this study was to determine whether Syntaxin1A (Syn1A), a 
plasma membrane Q-SNARE, forms functional interactions with structural lipids which 
might then exert a controlling influence over the fusion event.  Syn1A [20] is a 35kDa 
SNARE protein that is fully-anchored to the plasma membrane via a C-terminal 
transmembrane domain.  Several recent reports suggest that Syn1A may form key 
interactions with lipids.  First, biochemical isolation of lipid rafts demonstrated that Syn1A 
localizes to cholesterol-dependent membrane microdomains; disruption of these rafts 
resulted in an inhibition of stimulated exocytosis in PC-12 cells [21, 22].  Second, optical 
studies in unroofed PC-12 cells [22], and TIRF studies in intact MIN6 cells [23], 
demonstrated that Syn1A forms cholesterol-dependent clusters within the plasma 
membrane, which were preferential sites at which vesicle docking and fusion occurs.  
Moreover, Syn1A clusters partially colocalized with PI(4,5)P2 clusters within the plasma 
membrane, and vesicle fusion could be correlated with the extent of cluster 
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colocalization [24].  Third, analysis of single fusion events by carbon fiber amperometry 
demonstrated that Syn1A’s transmembrane domain forms part of the fusion pore [25].  
Fourth, FRAP analysis of Syn1A in reconstituted polymer-supported lipid bilayers 
demonstrated an increase in the immobile fraction of Syn1A in the presence of acidic 
phospholipids [26].   Lastly, Syn1A contains a polybasic juxtamembrane region which, 
while unstructured, was recently found to be inserted into the lipid bilayer [27].  While 
these data indicate that Syn1A forms key interactions with acidic phospholipids, the 
specificity of these interactions and the physiological significance has not, to date, been 
directly evaluated. 
Here, we identify a novel, high affinity interaction between Syn1A and the 
fusogenic lipid phosphatidic acid, in addition to demonstrating interactions of Syn1A with 
multiple phosphoinositol lipids, including PI(4,5)P2.  Progressive neutralizing mutations 
within the conserved, polybasic juxtamembrane region in Syn1A reduce Syn1A’s affinity 
for acidic phospholipids in a graded fashion that correlates with the graded reduction in 
the secretory function of these mutants. Using carbon fiber amperometry, we 
demonstrate that this reduction in secretory function results from a decrease in fusion 
event frequency; moreover, successful fusion events that occurred demonstrated 
significantly longer fusion pore durations and smaller fusion pore diameters compared to 
control.  Importantly, the secretory defect seen with a lipid-binding-deficient Syn1A 
(5RK/A) could be completely rescued by overexpression of the phosphatidic acid-
generating enzyme, phospholipase D1 (PLD1), whereas knockdown of PLD1 activity 
strongly reduced control secretion without affecting secretion from Syn1A 5RK/A 
expressing cells.  We therefore propose that Syn1A’s interaction with phosphatidic acid 
is critical in determining the energetics of SNARE-mediated fusion events.  Sequence 
alignment across multiple SNARE protein families demonstrates a high level of 
conservation of the polybasic juxtamembrane region [28], suggesting that this lipid 
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binding role may be a common and important one for many SNARE proteins in 
membrane fusion.   
 
Materials and Methods 
Antibodies 
The following antibodies were used:  α-Syntaxin1A clone HPC-1 (Sigma); α-Syntaxin1A 
clone 78.3 (Synaptic Systems), α-GST (Pharmacia Biotech); α-GFP (Clontech), donkey 
α-mouse HRP and donkey α-rabbit HRP (Jackson Immunoresearch Laboratories).  
 
Clones 
Rat Syntaxin1A was used for all syntaxin constructs. Site-directed mutagenesis was 
carried out using the Quickchange Site-Directed Mutagenesis kit (Stratagene). The GST-
Syn1A(252-265) peptide construct was made by ligating an annealed oligo (F= 
TCGAAAGAAGGCCGTCAAGTACCAGAGCAAGGCACGCAGGAAGAAGTAG;  R= 
AGCTCTACTTCTTCCTGCGTGCCTTGCTCTGGTACTTGACGGCCTTCTT) with 5’ and 
3’ overhangs into the pGex-KG vector cut at the XhoI and HindIII sites of the MCS 
downstream of GST.  Fluorophore-tagged proteins were constructed using the Cre-
recombinase based Creator system (Clontech), in which syntaxin1A, SNAP25, and 
Munc18-1 were subcloned into recipient fluorophore vectors (pEGFP-C1, or monomeric 
mutants of pECFP-C1, pEcYFP-C1 (citrine), and RFP vectors) containing LoxP 
sequences at the C-terminal end of the fluorophore sequence.  For the mRFP-
Syntaxin1A-pHluorin construct, the pHluorin (with an associated N-terminal 17 amino 
acid linker) was PCR subcloned from synaptopHluorin, and ligated into the C-terminal 
end of syntaxin1A (with a mutated stop codon).    The PLD1 mammalian expression 
vector (pCGN-PLD1) encoding human wildtype PLD1 was as previously described [29].  
The siRNA-PLD1 construct used was a single bicistronic plasmid that expresses both 
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hGH and an siRNA targeted to PLD1, as previously described [30]. The sequence 
fidelity of all new constructs was confirmed by DNA sequencing (University of Michigan 
DNA Sequencing Core).   
 
Cell Culture 
PC-12 cells were cultured in 10% CO2, in DMEM supplemented with 10% horse serum, 
5% fetal bovine serum, penicillin (100 units/ml), streptomycin (100 μg/ml), and 1% 
gentamicin (10 μg/ml).  HEK293-S3 cells were cultured in 5% CO2, in RPMI 1640 with L-
glutamine, supplemented with 10% fetal bovine serum, penicillin (100 units/ml), 
streptomycin (100 μg/ml), 0.4 mg/ml of hygromycin and 0.6 mg/ml of geneticin.  PC-12 
cells and HEK293-S3 cells were transfected using Lipofectamine 2000 (Invitrogen) 
according to manufacturer’s protocol.  Bovine adrenal chromaffin cells were isolated and 
cultured as described previously [31].   
 
Purification of GST-Fusion Proteins 
BL21 DE3 cells were transformed with pGex KG vectors coding for the soluble forms of 
Syn1A (aa 1-267, or aa 252-267) or specific soluble mutants of Syn1A. Cells were grown 
to an OD600 of 0.4-0.6, induced with 0.1mM IPTG, and grown for 5-8 hours with shaking 
at 23C.  Cells were harvested by centrifugation for 15 minutes at 5000xg (Beckman JA-
14 rotor), and resuspended in PBST buffer (in mM: 16 Na2HPO4, 4 NaH2PO4, 150 NaCl, 
2 EDTA, 1% TX-100, pH 7.3) supplemented with protease inhibitors and 1% β-
mercaptoethanol.  Cells were then mechanically lysed using a French Press at 
15000psi.  GST-fusion proteins were purified from the cell lysate using Glutathione-
Sepharose 4B beads (Amersham), according to the manufacturer’s protocol. For select 
experiments, the fusion protein was cleaved from the GST moiety with 1.4 NIH units of 
thrombin (Amersham) for 30 minutes at 25C, and the cleaved GST was removed by 
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incubation with Glutathione-Sepharose beads for 1 hour at room temperature.  Purity of 
each protein was determined by fractionation by SDS-PAGE followed by Coomassie 
staining and estimated to be ~90%.   
 
Protein Lipid Overlay 
“PIP Strips” (nitrocellulose membranes pre-spotted with 100pmoles each of 15 defined 
lipids) were purchased from Echelon Biosciences and binding overlay experiments were 
carried out according to the manufacturer's protocol.  For phosphatidic acid (PA) binding 
overlay experiments, stock solutions of Dipalmitoyl-PA (Avanti Polar Lipids) solubilized in 
2:1:0.8 MeOH:chloroform:H2O were spotted onto Hybond C nitrocellulose and allowed 
to dry.  The nitrocellulose was then blocked for 1 hour in TBS-T + 0.1% ovalbumin prior 
to initial protein-lipid binding, and then incubated with a molar excess of specific Syn1A 
mutants or control protein in TBS-T + 0.1% ovalbumin overnight at 4C.  The 
nitrocellulose was then washed extensively with TBS-T + 0.1% ovalbumin, and the 
bound protein was detected using antibodies followed by an ECL reaction.  Digital 
images were taken using a BioRad Fluor-S-Max Imager.  Integrated densities at each 
PA spot (4 replicates for each PA spot, for each mutant or control protein tested) were 
measured and normalized to the maximum integrated density for each protein treatment.   
 
Liposome Flotation Binding Analysis 
All lipids were purchased from Avanti.  Liposomes (small unilamellar vesicles) were 
made by mixing stock solutions of porcine brain phosphatidylcholine (PC), porcine brain 
phosphatidylethanolamine (PE), and dipalmitoyl-phosphatidic acid or oleoyl-
lysophosphatidic acid (PA/LPA) in chloroform at a 3:2:1 (w/w) ratio (in mole % 
composition, equivalent to 49% PC, 33% PE, and 18% PA for PA-containing liposomes;  
for LPA-containing liposomes, mole % composition is 45% PC, 30% PE, and 25% LPA).  
 67
Lipid mixtures were spun dry at 25C in a tabletop centrifuge and resuspended in 
liposome buffer (in mM: 50 HEPES, 250 Sucrose, 150 potassium acetate).  The 
suspended liposome solution was placed in a bath sonicator for 30 minutes at 4C 
followed by incubation on a thermomixer to equilibrate overnight at 4C.  For assaying 
binding of protein to the liposomes, 100ng of purified soluble Syn1A or specific Syn1A 
mutants (aa 1-267) was mixed with liposomes and liposome buffer in a total reaction 
volume of 20μL, and the reaction mixture was placed on a thermomixer at 37C for 1 hour 
at 800rpm.  Reaction mixtures were loaded under a 40/30/20/10% sucrose density 
flotation gradient and centrifuged at 390,000 x g for 1 hour at 4C (Beckman rotor TLA-
100) to separate liposomes from unbound protein. Equal volume fractions were collected 
from the top of each flotation gradient, loaded onto an SDS-PAGE gel, and Syn1A 
immunoreactivity in each fraction was detected via western blot analysis.    
 
Co-Immunoprecipitations 
HEK 293-S3 cells were plated into 6-well plates and transiently transfected with WT or 
mutant Syntaxin1A, Munc18-1, and EGFP-SNAP25.  Control transfections used 
Munc18-1 and EGFP-SNAP25, but excluded the Syntaxin1A.  Following 48 hours of 
expression, cells were rinsed in ice-cold physiological saline solution (PSS1, in mM:  140 
NaCl, 5 KCl, 10 HEPES, 10 glucose, 5 NaHCO3, 1 MgCl2, 2.2 CaCl2, pH 7.3), scraped 
into ice-cold lysis buffer (in mM: 20 Tris pH 7.4, 1 EDTA, and 2% sucrose, supplemented 
with a Mammalian Protease Arrest protease inhbitor cocktail (G-Biosciences)), dounce 
homogenized by 35 strokes, and centrifuged at 800xg to remove the nuclei.   
Subsequently, 1.5 volumes IP buffer (in mM: 150 Tris pH 7.4, 1 MgCl2, 0.1 EGTA, 2% 
Triton X-100, with protease inhibitors) were added to each tube and tubes were 
incubated on ice for 30 minutes to allow solubilization of membranes.  Protein 
concentrations and volumes of the lysates were then equalized across conditions, and 
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immunoprecipitation was carried out with a 2 hour incubation with α-Syntaxin1A (clone 
78.3) at 4C with rotation.   Immunopure protein G beads (Pierce) were then added to 
each sample and the incubation continued for 1 hour.  The beads were pelleted by 
centrifugation (1500xg for 2 minutes at 4C), washed twice in IP buffer, and washed a 
final time in PBS. Syntaxin1A and EGFP-SNAP25 immunoreactivity was determined in 
each sample using SDS-PAGE fractionation and Western blot analysis, probing with α-
Syntaxin1A (clone HPC-1) and α-GFP, followed by an ECL reaction.  Digital images 
were taken using a BioRad Fluor-S-Max Imager, and integrated densities of the EGFP-
SNAP25 and Syn1A signals were determined.  For each transfection condition, the ratio 
of the integrated densities of EGFP-SNAP25 to Syn1A in the immunoprecipitated 
fraction was determined.  All ratios were then normalized to the ratio from the condition 
containing WT Syn1A, to allow comparison and quantification across experiments.   
 
Human Growth Hormone Secretion Assay 
PC-12 cells were plated onto 24-well plates and co-transfected with specific constructs, 
including human growth hormone (hGH), the light chain of the Botulinum C neurotoxin 
(BoNT-C), Munc18-1, and full-length Syntaxin1A (wild-type or mutant forms).  The total 
DNA concentration was held constant across treatments, by addition of a neomycin 
control plasmid.  At 48-72 hours post-transfection, cells were rinsed for 6 minutes in a 
physiological saline solution (PSS2, in mM:  145 NaCl, 5.6 KCl, 15 NaHEPES, 0.5 
MgCl2, 2.2 CaCl2, 5.6 Glucose, 0.5 NaAscorbate, 2mg/mL BSA, pH 7.3), followed by a 6 
minute stimulation with 70mM K+ (same as PSS2, with equimolar substitution of K+ for 
Na+).  PSS2 containing the secreted hGH was collected, and cells were lysed (lysis 
buffer, in mM:  0.2 EDTA, 10 HEPES, 1% Triton X-100, pH 7.4) to determine percent of 
total hGH content secreted.  hGH content was measured using an hGH ELISA kit 
(Roche Diagnostics).  Each experiment was performed with quadruplicate replicates for 
 69
each treatment, and each experiment was repeated a minimum of 3 independent times.   
hGH secretion experiments using LPC, PLD1 overexpression, and siRNA-PLD1 were 
completed in France and thus were carried out on a different strain of PC-12 cells than in 
all other experiments.  For experiments utilizing external application of LPC, 1µM 
palmitoyl-lysophosphatidylcholine (Avanti Polar Lipids) was added during both the rinse 
and the stimulation period.   
 
Imaging 
Conventional Fluorescence Microscopy:  Cells were transferred from media to PSS1 for 
imaging.  Cellular fluorescence was imaged at 25C using an Olympus 60x 1.2NA 
PlanApo water objective on an Olympus IX71 microscope coupled to a TILL polychrome 
monochromator for illumination.  Appropriate dichroic mirrors and emission filters were 
used for each fluorophore imaged.  Image capture was performed using a TILL-Imago 
QE camera under the control of TILL software. 
Confocal Imaging: Confocal images were taken on an Olympus FluoView 500 Laser 
Scanning Confocal Microscope, using an LD405 laser, 60x 1.2NA objective, and a 
pinhole aperture of 260μm.   
FRET Imaging:  A detailed description of the FRET 3-cube sensitized emission imaging 
methodology can be found in our previous publication [32].  In addition to 3 different 
excitation/emission images (excitation/emission in nm): 436/465 (donor excitation, donor 
emission); 436/535 (donor excitation, acceptor emission), and 500/535 (acceptor 
excitation, acceptor emission), background and shade correction images were also 
taken.  Image correction and analysis were performed offline using the method of FRET 
stoichiometry [32, 33], and implemented with a custom written IGOR macro 
(Wavemetrics).    
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FURA Imaging:  PC-12 cells transfected with full-length Syn1A (K253I or K253I-5RK/A), 
Munc18-1, BoNT-C, and RFP (to allow identification of transfected cells) were loaded for 
20 minutes at 37C with 3μM Fura2-AM (Molecular Probes) in PSS1 for calcium imaging.  
Cells were then rinsed with PSS1, and following 15 minutes, time-lapse fluorescence 
images were acquired with excitation fluorescence alternating between 340nm and 
380nm, and emission acquired at 510nm.  Fura ratios were calculated as F340/F380.   
 
Amperometry 
At 48 hours before recording, bovine chromaffin cells were transfected with Syn1A 
(K253I or K253I-5RK/A), BoNT-C light chain, and GFP, using biolistic bombardment 
(Gene Gun, Biorad). Conditions for biolistic transfection, and preparation of gold beads 
were as suggested by the manufacturer, with 2μg DNA/mg gold beads.  Cells were 
replated onto poly-L-lysine coated glass coverslips 24 hours prior to recording.  5μm 
carbon fiber electrodes (ALA Scientific) held at +650mV were used for amperometric 
recordings.  Cells were bath perfused with PSS1. Secretion was stimulated by local 
application of 100mM K+ (same composition as PSS1, with K+ substituted equimolar for 
Na+) for 60 seconds, and currents were recorded during these 60 seconds, in addition to 
a 5 second pre-stimulus baseline recording.  Currents were collected using an Axopatch 
200A amplifier modified for extended voltage output (Axon Instruments), filtered at 2kHz, 
and sampled at 4kHz.   No digital filtering was applied.  Currents were analyzed using an 
Igor XOP written by Eugene Mosharov (Columbia University) and available online 
(http://cumc.columbia.edu/dept/neurology/sulzer/download.html) [34].  For spike 
frequency analysis, only spikes with amplitudes > 10pA above the RMS noise level were 
used.  Pre-spike foot (PSF) analysis was limited only to those PSF whose amplitudes 
were <30pA and whose durations were >1ms (>4x sampling frequency).   
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Data Analysis and Statistics 
Statistical analyses were carried out using GraphPad Prism software.  For most 
comparisons, unpaired t-tests were used; statistical significance was designated at a p-
value < 0.05. 
 
Results 
Syn1A binds with high affinity to the fusogenic lipid phosphatidic acid    
We initially set out to determine whether Syn1A specifically interacts with lipids 
that might decrease the energetic requirements for membrane fusion.  In these 
experiments, bacterially expressed soluble Syn1A (aa1-267) was overlaid in decreasing 
concentrations onto nitrocellulose spotted with equimolar amounts of given lipids.  Figure 
2.1A demonstrates that Syn1A bound to multiple acidic phospholipids in a dose-
dependent manner.  Importantly, Syn1A bound with highest apparent affinity to the 
fusogenic lipid, phosphatidic acid (PA), although lower apparent affinity interactions with 
several phosphatidylinositol phosphates (PIPs), including PI(3)P, PI(4)P, PI(5)P, 
PI(3,4)P2, PI(4,5)P2, and PI(3,4,5)P3, were also observed (Figure 2.1B).  Notably, all of 
the lipids to which Syn1A bound were acidic, although Syn1A did not interact with every 
acidic phospholipid tested (e.g., phosphatidylserine (PS) or lysophosphatidic acid 
(LPA)).  Furthermore, Syn1A exhibited a greater apparent affinity for the monophosphate 
lipid PA than the polyphosphate inositol lipids, which contain a greater negative valence 
compared to PA.  These data suggest that while electrostatic interactions have an 
important role in mediating Syn1A’s lipid interactions, other structural features ultimately 
underlie the specificity.   
A correlative series of liposome flotation binding experiments was also 
performed, in which Syn1A was mixed with liposomes of defined composition and 
loaded under a sucrose density gradient.  Following ultracentrifugation, Syn1A bound to 
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liposomes floats to the top of the gradient with the liposome fraction.  Figure 2.1C shows 
Syn1A immunoreactivity in the collected gradient fractions of a representative 
experiment, and demonstrates that Syn1A specifically bound to liposomes containing PA 
but not to those containing LPA.  Furthermore, Syn1A did not bind to control liposomes 
(containing only PC and PE).   Together, the data demonstrate that Syn1A specifically 
binds the fusogenic lipid, PA. 
 
The polybasic juxtamembrane region in Syn1A comprises a lipid interaction domain 
Sequence analysis of Syn1A revealed a polybasic juxtamembrane region within 
Syn1A that is highly conserved across multiple species (Figure 2.2A, top).  To determine 
if this region is responsible for Syn1A’s interactions with acidic phospholipids, a series of 
progressive neutralizing mutations was generated within this region, in which one 
(R262A), two (R262A/R263A), or all five (5RK/A) basic residues were neutralized to 
alanines (Figure 2.2A, bottom).  Mutant proteins were purified and tested for lipid binding 
capacity using nitrocellulose blots on which PA had been spotted in increasing amounts.  
Binding curves were fit using the Hill equation, which allowed determination of the 
apparent binding affinity (EC50) of each protein for PA (Figure 2.2B).  Progressive 
neutralizing mutations resulted in a progressive reduction in apparent binding affinity to 
PA, with the 5RK/A mutant demonstrating the greatest reduction in apparent binding 
affinity (EC50 ~ 3.2x105 fmoles), followed by the R262A/R263A mutant (EC50 ~ 6.1x104 
fmoles), and lastly, the R262A mutant (EC50 ~ 2.9x103 fmoles), which demonstrated 
binding similar to the wild-type (WT) protein (EC50 ~ 2.0x103 fmoles).  Thus, complete 
neutralization of the polybasic juxtamembrane region in Syn1A resulted in a greater than 
2 log shift in EC50.   
Qualitatively similar results were obtained using liposome flotation assays, in 
which the relative affinities of the WT and 5RK/A Syn1A proteins for PA-containing 
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liposomes was tested.  Figure 2.2C shows that 24.3 ± 3.4% (n=5) of the total WT 
protein, versus 6.1 ± 2.0 % (n=3) of the total 5RK/A mutant protein, bound to the 
liposomes (p<0.01).   Moreover, the 5RK/A mutation eliminated binding to all acidic lipids 
as demonstrated by the protein-lipid overlays shown in Figure 2.2D.  Thus, Syn1A’s 
juxtamembrane basic residues are critical in mediating Syn1A’s interactions with acidic 
phospholipids.   
 
Additional structural determinants underlie Syn1A’s lipid binding properties 
 To determine whether structure within the juxtamembrane basic region was 
important for lipid binding, we constructed a Syn1A RKRK mutant, in which the order of 
the juxtamembrane basic residues was rearranged, while the overall charge was 
maintained. The apparent PA binding affinity of the RKRK mutant (EC50 ~ 2.6x103 
fmoles) was indistinguishable from WT, indicating that Syn1A-lipid interactions can 
tolerate small structural changes within the juxtamembrane region (Figure 2.2B).  
To establish whether domains outside the polybasic juxtamembrane region affect 
Syn1A’s lipid binding specificity, we synthesized a peptide corresponding to this region 
(aa 252-265), as well as the corresponding 5RK/A peptide.  Protein-lipid overlays 
demonstrated that the WT peptide closely recapitulated Syn1A’s lipid binding profile, 
while the 5RK/A mutation abrogated the peptide’s ability to bind acidic phospholipids 
(Figure 2.2E).  One notable difference between the WT peptide and Syn1A (1-267) was 
that the WT peptide demonstrated a high apparent affinity for PS, a lipid for which Syn1A 
(1-267) exhibited almost no binding (compare Figures 2.2D&E).  Importantly, lipid 
binding to Syn1A (1-259), in which the polybasic juxtamembrane region had been 
truncated, was largely eliminated (data not shown).  Thus, while other regions in Syn1A 
may modify its lipid binding profile, the basic juxtamembrane residues are clearly 
required for these interactions. 
 74
 Full-length Syn1A juxtamembrane mutants traffic normally to the plasma membrane in 
live cells 
 To assess the relevance of Syn1A-lipid interactions in an in vivo situation, full-
length, juxtamembrane mutant Syn1A proteins were next studied in living cells.  Initial 
experiments examined whether these mutant Syn1A proteins were expressed and 
targeted properly.  ECFP-tagged, full-length Syn1A mutants were generated and 
transiently transfected into PC-12 cells.  All Syn1A constructs were co-transfected with 
Munc18-1, which facilitated high levels of targeting of Syn1A to the plasma membrane 
regions.  Figure 2.3A demonstrates that the fluorescence signal associated with both the 
WT and 5RK/A ECFP-Syn1A proteins trafficked normally to the plasma membrane 
region, as determined by confocal microscopy.   
To quantify the extent of surface labeling between mutants, we next used dual-
fluorophore-labeled Syn1A constructs, which were tagged with mRFP at the N-terminus 
and pHluorin at the C-terminus.  pHluorin is a pH-sensitive variant of GFP, whose signal 
is quenched within acidic intracellular compartments, but becomes highly fluorescent 
upon exposure to the neutral, extracellular solution (which in this case, occurs upon 
insertion of Syn1A’s C-terminal transmembrane domain into the plasma membrane).  
We thus reasoned that the pHluorin signal would report only on the pool of exogenous 
Syn1A that had been correctly inserted into the plasma membrane, whereas the mRFP 
signal would report on the entire pool of exogenous Syn1A expressed within a cell.  
Figure 2.3B shows representative epifluorescence images of PC-12 cells transiently co-
transfected with the mRFP-Syn1A-pHluorin constructs and Munc18-1.  The notable 
fluorescence of the pHluorin label at the plasma membrane region demonstrates that 
both the WT and 5RK/A Syn1A constructs were correctly trafficked and inserted into the 
plasma membrane.  Importantly, measurements of the average pHluorin and mRFP 
fluorescence intensities across a large number of cells were comparable between the 
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WT and 5RK/A conditions, demonstrating that both the surface levels and total 
expression levels of WT and 5RK/A Syn1A proteins were similar (Figure 2.3C).  Figure 
2.3D shows a scatterplot in which the mean pHluorin intensity was plotted against the 
mean mRFP intensity for each individual cell.  Notably, there occurred a large overlap in 
the distribution of points between the WT and 5RK/A cells, and linear fits of these data 
for cells expressing moderate levels of the Syn1A (RFP mean intensities between 20 
and 170) were not significantly different.   Thus, the WT and 5RK/A Syn1A constructs 
demonstrate not only comparable expression levels, but also similar abilities to traffic 
and insert within the plasma membrane.   
 
Full-length Syn1A juxtamembrane mutants demonstrate intact protein-protein 
interactions within live cells 
Having determined that the full-length juxtamembrane neutralization mutants of 
Syn1A were capable of trafficking correctly, we next asked whether these mutants were 
capable of forming appropriate protein-protein interactions in vivo.  The above data 
suggested that both WT and 5RK/A Syn1A constructs interacted similarly with Munc18-
1, as co-expression of these constructs with Munc18-1 greatly facilitated trafficking of 
both constructs to the plasma membrane.  To confirm the normal Munc18-1 interaction 
properties between these Syn1A constructs, we used a sensitized emission FRET 
approach to compare binding of the CFP-tagged WT Syn1A or 5RK/A mutant to citrine-
Munc18-1 in live cells.  That this FRET stoichiometry approach is an accurate reporter of 
the Syn1A-Munc18-1 interaction was established in our earlier publication [32].  Figure 
2.4A demonstrates that both WT and 5RK/A proteins associated with Munc18-1 
similarly, across a wide range of molar ratios.  This result is quantified in Figure 2.4B, 
where at equimolar ratios (molar ratio between 0.9 – 1.1), the 5RK/A mutant exhibited a 
FRET efficiency (ED) with Munc18-1 that was similar to that of the wild-type protein 
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(WT= 24.2±0.01, 5RK/A= 24.8±0.01).  In contrast, a Syn1A mutant (I233A) that was 
previously shown to have reduced binding to Munc18-1 [35], demonstrated a reduced 
FRET efficiency (I233A = 5.6±0.01) compared to WT.  Thus, neutralizing mutations 
within the juxtamembrane region of Syn1A do not appear to affect Syn1A’s interaction 
with Munc18-1.  
We next asked whether Syn1A 5RK/A possessed the ability to interact normally 
with SNARE proteins, in particular, the Q-SNARE SNAP25.  For these experiments, 
HEK293-S3 cells were transiently transfected with Syn1A (WT or mutant), Munc18-1, 
and EGFP-SNAP25.  Co-immunoprecipitation experiments were performed to determine 
whether the 5RK/A mutant was capable of pulling down equal amounts of EGFP-
SNAP25 compared to the WT Syn1A.  Figure 2.4C shows a blot from a representative 
experiment, which demonstrates that both the WT and 5RK/A Syn1A proteins bound a 
similar amount of EGFP-SNAP25.  In contrast, a mutant of Syn1A (L205A/E206A) which 
was previously shown to have reduced binding to SNARE proteins [36], demonstrated a 
marked reduction in binding to EGFP-SNAP25.  To quantify these results, we measured 
the integrated densities of the Syn1A and EGFP-SNAP25 bands, and determined the 
ratio of EGFP-SNAP25 to Syn1A in the immunoprecipitated fractions for each condition.  
For each experiment, the ratio for each treatment was normalized to the ratio from the 
WT treatment, to allow comparison of treatments across experiments.  Figure 2.4D 
shows the average results for 3 independent experiments, and again demonstrates that 
the 5RK/A Syn1A displays similar interactions with SNAP25 as compared with the WT 
Syn1A. 
 Taken together, these data demonstrate that, despite profound differences in 
lipid binding capabilities, the 5RK/A mutant Syn1A behaves nearly identically to the WT 
Syn1A in live cells, with respect to expression levels, membrane trafficking, and forming 
appropriate protein-protein interactions. 
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Use of BoNT-C knockdown of Syn1A to specifically isolate the functional phenotypes of 
exogenous Syn1A constructs 
 To test whether disruption of Syn1A-lipid interactions would have a functional 
effect on regulated exocytosis, we transfected Syn1A juxtamembrane neutralization 
mutant constructs into live secretory cells (PC-12 cells or bovine adrenal chromaffin 
cells).  To reduce potentially confounding effects from endogenous Syn1A in these cells, 
we transfected the cells with the light chain of the Botulinum C neurotoxin (BoNT-C), 
which cleaves Syn1A and precludes it from mediating membrane fusion [37].  Syntaxin 4 
was previously reported to be resistant to cleavage by BoNT-C and to contain an Ile in 
place of Lys at residue 253 of the BoNT-C cleavage site [37].  We therefore tested 
whether a similar mutation (K253I) in Syn1A, would generate a BoNT-C-resistant Syn1A.  
For this analysis, PC-12 cells were co-transfected with an N-terminally tagged CFP-
Syn1A and Munc18-1, with or without BoNT-C.  Cells were then imaged using 
conventional fluorescence microscopy.  In the absence of BoNT-C, both the WT Syn1A 
and Syn1AK253I constructs targeted to plasma membrane regions (Figure 2.5A).  In the 
presence of BoNT-C, however, the WT Syn1A signal was redistributed as a diffuse 
cytosolic signal within the cells, indicating cleavage by BoNT-C, whereas the Syn1AK253I 
signal distributed to the plasma membrane, indicating resistance to cleavage by BoNT-C 
(Figure 2.5A).   These experiments were quantified by scoring at least 100 random cells 
from each condition (while blinded to the conditions) as demonstrating either a cytosolic 
or membrane fluorescence distribution.  Importantly, in the presence of BoNT-C, the 
percent of cells demonstrating a cytosolic fluorescence distribution was 63% for WT 
Syn1A, compared to only 5% for Syn1AK253I.     
 We next tested whether a BoNT-C resistant Syn1AK253I construct could rescue 
secretion in BoNT-C treated cells.  Human growth hormone (hGH) secretion assays [38] 
were performed on PC-12 cells transfected with various combinations of the BoNT-C 
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light chain, Munc18-1, and either WT Syn1A or Syn1AK253I.  Figure 2.5B shows that 
transfection of the BoNT-C light chain into PC-12 cells effectively reduced secretion to 
30% of control secretion.  Importantly, Syn1AK253I rescued secretion in BoNT-C-
transfected cells, to roughly 78% of control secretion, but only when co-transfected with 
Munc18-1.  This requirement for Munc18-1 was likely the result of enhanced membrane 
targeting of Syn1A, as Munc18-1 itself was insufficient to rescue the BoNT-C knockdown 
of secretion (35% of control secretion).  Importantly, WT Syn1A was also unable to 
rescue secretion in BoNT C-transfected cells, even when co-transfected with Munc18-1 
(29% of control secretion).  This clearly indicates that rescue of the BoNT-C knockdown 
is specific to the expression and proper targeting of a functional BoNT-C-resistant Syn1A 
to the plasma membrane region in these cells.  Of note, while higher expression levels of 
BoNT-C were sufficient to achieve a more complete knockdown of secretion (reduction 
to <10% of control secretion), we were often unable to rescue this phenotype by 
coexpression of Syn1AK253I and Munc18 (data not shown).  We attribute this to the fact 
that at higher concentrations, BoNT-C may also cleave SNAP25 in addition to Syn1A 
[39]. 
 
Neutralizing mutations within Syn1A’s polybasic juxtamembrane region result in a 
progressive inhibition of Syn1A’s secretory function 
To compare the ability of full-length Syn1A juxtamembrane neutralization 
mutants to rescue secretion, we used the BoNT-C knockdown assay in cotransfected 
PC-12 cells.   Figure 2.6A demonstrates that neutralizing mutations within Syn1A’s 
polybasic juxtamembrane domain resulted in a progressive decrease in secretory 
function.  When normalized to the extent of rescue seen with Syn1AK253I, the 
Syn1AK253I(5RK/A) mutant was only capable of rescuing secretion to 67 ± 3% of the 
Syn1AK253I control level (n=20).  The Syn1AK253I(R262A/R263A) mutant rescued 
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secretion to 77 ± 4% of the Syn1AK253I control level (n=16), whereas the 
Syn1AK253I(R262A) mutant exhibited a phenotype similar to Syn1AK253I, rescuing 
secretion to 97 ± 4% (n=16) of the Syn1AK253I control level.  Considering that the residual 
baseline secretion following BoNT-C knockdown accounts for roughly 45% of the 
rescued control secretion (Figures 2.5B and 2.6A left, dotted line), the actual deficit in 
secretion resulting from neutralization of Syn1A’s juxtamembrane region was quite 
substantial, with the Syn1AK253I(5RK/A) mutant rescuing secretion to only 43% of the 
Syn1AK253I control (Figure 2.6A, right).  Importantly, this decline in secretory function of 
the juxtamembrane Syn1A mutants correlates well with the decrease in apparent affinity 
of these mutants for binding phosphatidic acid (Figure 2.2B) and presumably, with their 
affinity for other acidic phospholipids as well.    
 
Neutralizing mutations within Syn1A’s polybasic juxtamembrane region result in a 
reduction in fusion event frequency 
We next sought to determine the mechanism by which neutralization of Syn1A’s 
juxtamembrane region resulted in secretory inhibition.  Importantly, both Syn1AK253I and 
Syn1AK253I(5RK/A) cells demonstrated comparable calcium fluxes upon depolarization, 
as measured using the calcium indicator Fura-2 (Figure 2.6B).  PC-12 cells were 
transfected with BoNT-C, Syn1AK253I or Syn1AK253I(5RK/A), Munc18-1, and RFP (to 
identify transfected cells), pre-loaded with the Fura-2 AM ester, and depolarized using a 
brief, 5 second local perfusion with 100mM K+.  Changes in intracellular [Ca2+], reported 
by a change in F340/F380, were comparable between Syn1AK253I (control) and 
Syn1AK253I(5RK/A) cells in all parameters analyzed, including the baseline calcium levels 
(control: 0.91±0.01, n=51; 5RK/A: 0.91±0.01, n=59), the peak change in calcium 
(control: 0.20±0.02, n=51; 5RK/A: 0.19±0.01; n=59), as well as the kinetics of the 
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calcium fluxes.  This suggests that the decrease in evoked secretion seen in the 5RK/A 
cells occurs downstream of calcium influx.        
To probe the temporal resolution and analyze the dynamics of individual fusion 
events, we next used carbon fiber amperometry.  For these single-cell experiments, 
bovine adrenal chromaffin cells were used rather than PC-12 cells, as we found the 
exocytotic responses produced by these cells to be far more robust than those of PC-12 
cells.  Chromaffin cells were biolistically transfected with BoNT-C, either Syn1AK253I 
(control) or Syn1AK253I(5RK/A), and GFP.  Co-expression of Munc18-1 was not 
necessary in these experiments, as we have previously shown that Syn1A can traffic to 
the plasma membrane in chromaffin cells without the need for Munc18-1 overexpression 
[40].   Transfected cells were stimulated to secrete by local perfusion of 100mM K+ for 60 
seconds, during which time amperometric spikes were recorded.  Representative 
amperometric traces are displayed in Figure 2.6C.  In agreement with the hGH data 
above, the average number of spikes (fusion events) per cell was substantially reduced 
in the 5RK/A cells compared to control (control:  33.6 ± 4.0 spikes/cell, n=86; 5RK/A: 
24.3 ± 2.6, n=82) (Figure 2.6D).  However, the frequency distribution of the spikes, when 
normalized to the total number of spikes for each condition, was identical between 
control and 5RK/A cells (Figure 2.6E).  This suggests that, rather than affecting a 
specific subpopulation of vesicles, the decrease in fusion events observed in the 5RK/A 
condition results from a generalized decrease in fusogenicity.   
 
Syn1A’s polybasic juxtamembrane region regulates fusion pore dynamics 
We hypothesized that the generalized decrease in fusogenicity seen in 5RK/A 
cells might also be manifest in individual fusion events, particularly with regards to fusion 
pore dynamics.  Many amperometric spikes contain a pre-spike foot (PSF), which is 
believed to represent the initial flux of catecholamine through the fusion pore, prior to 
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dilation of the fusion pore and full fusion of the vesicle with the plasma membrane [41, 
42].  Analysis of pre-spike feet can thus elucidate details surrounding the late stages of 
vesicle fusion, especially those regarding the formation and expansion of the fusion 
pore.  Changes in PSF amplitudes are believed to represent changes in fusion pore 
diameter, whereas changes in PSF duration are thought to represent changes in stability 
of the fusion pore and kinetics of fusion pore expansion. 
Representative pre-spike feet are shown in Figure 2.7A.  Interestingly, the 
Syn1AK253I(5RK/A) cells demonstrated decreased PSF amplitudes, in addition to 
increased PSF durations, compared to control Syn1AK253I (control) PSF (Figure 2.7B and 
C).   In other words, the fusion pores in the 5RK/A cells were not only smaller in 
diameter, but also took longer to expand to full fusion.  The mean PSF amplitude for 
control cells was 7.66 ± 0.27pA, which was slightly reduced to 6.18 ± 0.24pA for 5RK/A 
cells (n=584 control PSF, n=576 5RK/A PSF) (Figure 2.7B, left).  The mean PSF 
duration for control cells was 7.28 ± 0.74ms, which was lengthened to 12.33 ± 1.05ms in 
5RK/A cells (n=584 control PSF, n=576 5RK/A PSF) (Figure 2.7C, left).  Qualitatively, 
these results also held true under a more stringent analysis scheme, in which the 
median PSF parameters for each cell were first determined, and the medians then 
averaged across cells.  Median PSF amplitudes were 6.16 ± 0.43pA and 4.42 ± 0.22pA 
for control and 5RK/A cells, respectively (n=66 control cells, n=78 5RK/A cells) (Figure 
2.7B, right).  Median PSF durations were 5.44 ± 0.54ms for control, compared to 8.23 ± 
0.95ms for 5RK/A cells (n=66 control cells, n=78 5RK/A cells) (Figure 2.7C, right).  In all 
analysis schemes, the differences between control and 5RK/A PSF parameters were 
statistically significant (p<0.05).  Thus, neutralization of Syn1A’s polybasic 
juxtamembrane region results in a decrease in fusion pore diameter, as well as a delay 
in fusion pore expansion.  As formation and expansion of the fusion pore have been 
modeled to be among the most energetically expensive steps in the membrane fusion 
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process[1, 2], these data suggest that energetic inefficiencies in the fusion process may, 
in part, account for the secretory defects observed with the 5RK/A mutant.    
 
Manipulation of intracellular phosphatidic acid levels differentially regulates secretion 
from control and 5RK/A cells 
Thus far, we have demonstrated that Syn1A binds multiple acidic phospholipids, 
including the fusogenic lipid, phosphatidic acid, and that these interactions are mediated 
through Syn1A’s polybasic juxtamembrane domain.  Moreover, we have shown that 
neutralization of Syn1A’s polybasic juxtamembrane domain (5RK/A mutant) results in a 
significant decrease in stimulated secretion, in addition to effects on fusion pore 
amplitude and duration that are suggestive of an energetic defect in the fusion process.  
To determine whether the functional effects seen with the 5RK/A mutant are a direct 
result of the inability of this mutant to bind lipids, we performed hGH secretion assays to 
test how various alterations in membrane lipid composition affected the abilities of the 
Syn1AK253I(control) or Syn1AK253I(5RK/A) mutant to rescue BoNT-C mediated knockdown 
of secretion in PC-12 cells.  As in prior experiments, all results have been normalized to 
the level of rescued secretion observed in the Syn1AK253I control cells in the absence of 
any lipid manipulations, and are reported as a % rescued secretion.  
To determine whether the secretory defect in the 5RK/A cells might be related to 
the energetics of fusion, we first tested the effects of externally applied 
lysophosphatidylcholine (LPC, 1 µM), an inverted-cone-shaped lipid that facilitates fusion 
pore formation and expansion by inducing positive curvature to the outer leaflet of the 
membrane bilayer.  In these experiments, using an LPC concentration that was low 
enough so as not to affect stimulated secretion from the Syn1AK253I control cells, we 
observed a statistically significant and substantial (>50%) increase in secretion from the 
Syn1AK253I(5RK/A) cells (38.6% vs 59.8% rescued secretion in the absence or presence 
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of LPC, respectively) (Figure 2.8).  This result suggests that the exocytotic defect in the 
5RK/A mutant occurs at a late step in fusion and is likely energetic in nature.    
The partial rescue of the 5RK/A secretory phenotype by externally applied LPC 
(which induces positive curvature on the outer bilayer leaflet) nicely complemented our 
previous result demonstrating that Syn1A binds with high apparent affinity to 
phosphatidic acid, a cone-shaped, fusogenic lipid (which induces negative curvature on 
the inner bilayer leaflet).  We then investigated whether specific Syn1A-phosphatidic 
acid interactions are important for regulated exocytosis.  For these experiments, the 
BoNT-C knockdown and rescue assay was repeated, while overexpressing either 
phospholipase D1 (PLD1), or an siRNA construct previously demonstrated to target 
PLD1 [30].  PLD1 is a stimulus-activated enzyme which cleaves phosphatidylcholine to 
generate free choline and phosphatidic acid.  Overexpression of PLD1 has been shown 
to enhance regulated exocytosis, whereas knockdown of PLD1 activity results in a 
decrease in secretion [30, 43-46].  While the extent to which PLD1 overexpression and 
knockdown affected control secretion in our BoNT-C knockdown experiments (Figure 
2.8) was slightly less than has been previously reported, this likely resulted from the 
BoNT-C knockdown assay’s requirement for simultaneous overexpression of multiple 
constructs.  As such, changes in PLD1 levels achieved in this system were likely more 
limited than when PLD1 or siRNA-PLD1 are the only constructs being overexpressed (as 
in prior studies).   
Importantly, we found that overexpression of PLD1 resulted in a near complete 
phenotypic rescue of the 5RK/A mutant (117% vs 103% rescued secretion, for PLD1-
treated Syn1AK253I control cells or PLD1-treated Syn1AK253I(5RK/A) cells, respectively) 
(Figure 2.8).  Also of substantial interest was the finding that siRNA-mediated 
knockdown of PLD1 drastically reduced secretion from Syn1AK253I control cells, while 
having little effect on secretion from Syn1AK253I(5RK/A) cells (74% reduction in secretion 
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for Syn1AK253I control cells, compared to a 24% reduction for Syn1AK253I(5RK/A) cells, in 
the presence of siRNA-PLD1) (Figure 2.8).  These data provide strong evidence that the 
loss of interaction between Syn1A and phosphatidic acid primarily accounts for the 
secretory defects seen with the Syn1A 5RK/A mutation and largely rule out the 
possibility that this secretory defect resulted from disruption of untested Syn1A-protein 
interactions or from alterations in Syn1A structure.   More importantly, these results 
demonstrate that the Syn1A - phosphatidic acid interaction is critically important in 
regulating the overall levels of evoked secretion in live neuroendocrine cells.    
 
Discussion 
SNARE complexes comprise the minimal protein machinery required for 
membrane fusion, hence most studies have focused on defining the regulation of their 
assembly and disassembly.  However, the fusion process also involves lipids, and the 
specific lipid composition of membranes undergoing fusion has profound consequences 
on the energetic barrier for fusion [11].  A central and unresolved issue is whether 
specific mechanisms exist to recruit and sequester fusogenic lipids at preferential sites 
of membrane fusion.   
In this study, we establish that the Q-SNARE Syntaxin1A (Syn1A) forms 
functional interactions with acidic phospholipids and that these interactions facilitate 
membrane fusion.  Syn1A formed a high apparent affinity interaction with the fusogenic 
lipid, phosphatidic acid, in addition to lower apparent affinity interactions with 
polyphosphoinositides, including PI(4,5)P2.  Neutralizing mutations within a highly 
conserved, polybasic juxtamembrane region of Syn1A (aa252-265) progressively 
reduced Syn1A’s ability to bind lipids, while leaving intact these mutants’ abilities to 
traffic correctly to the plasma membrane and to form appropriate protein-protein 
interactions.  Development of a novel BoNT-C knockdown and rescue assay allowed the 
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secretory function of exogenous mutant Syn1A constructs to be studied in isolation from 
endogenous WT Syn1A, and demonstrated that progressive neutralization of Syn1A’s 
juxtamembrane region resulted in a progressive decrease in secretory function.  
Moreover, amperometric analysis uncovered a lengthening in fusion pore duration and a 
decrease in fusion pore diameter in fusion events catalyzed by a lipid-binding-deficient 
Syn1A (5RK/A), suggesting an energetic defect in fusion.  Importantly, we found that the 
inhibition of secretion observed with the Syn1A 5RK/A mutant could be completely 
rescued by overexpression of PLD1, and that knockdown of PLD1 activity strongly 
inhibited control secretion, while having little effect on 5RK/A secretion.  Altogether, 
these data suggest that Syn1A-lipid interactions play a key role in regulating the 
energetics of membrane fusion. 
We propose that Syn1A-lipid interactions function both structurally as well as 
electrostatically to reduce the energetic barrier for fusion specifically at sites of 
exocytosis.  This energy barrier can be modeled as a series of membrane intermediates 
formed during the merging of two lipid bilayers [1, 2]. First, the membranes are brought 
within proximity to establish a region of dehydrated contact. A fusion stalk forms as the 
initial connection between the membranes, and radial expansion of this stalk yields a 
hemifusion diaphragm, where contacting leaflets of the bilayers have merged, while the 
distal leaflets remain separate. Importantly, the presence of negative curvature-favoring 
lipids in the contacting leaflets greatly reduces the energetic requirements for stalk and 
hemifusion formation [19].  PA, under physiological conditions, exhibits negative 
spontaneous curvature approaching that of PE [17, 47]. Thus, a first structural function 
of the Syn1A-lipid interaction may be to localize PA to sites of fusion, thereby generating 
negative curvature to facilitate stalk formation and stabilize the hemifusion intermediate. 
Beyond hemifusion, generation of lateral tension within the hemifusion 
diaphragm leads to membrane rupture and formation of a fusion pore, whereby the distal 
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leaflets of the two bilayers merge. Expansion of this fusion pore results in full membrane 
collapse and fusion.  These steps are believed to be the most energetically expensive in 
membrane fusion [1, 2].  It has been proposed that the lateral tension required for 
formation and expansion of the fusion pore may be generated by electrostatic 
interactions between fusogenic proteins and acidic lipids [14]. Indeed, generation of the 
lateral tension to drive fusion pore expansion may be a second electrostatic function of 
the Syn1A-lipid interaction.  This is supported by our amperometry results, which 
demonstrated that neutralization of Syn1A’s polybasic juxtamembrane region resulted in 
a delay in fusion pore expansion and a decrease in fusion pore diameter. 
Among the lipids tested in this study, Syn1A bound with highest apparent affinity 
to PA, a lipid known to exert substantial effects on regulated exocytosis.  Phospholipase 
D1 (PLD1), an enzyme which generates PA from PC, potently enhances regulated 
exocytosis at a late stage in vesicle fusion, in a variety of cell types including PC12 cells, 
adrenal chromaffin cells, adipocytes, and neurons [30, 43-46]. While specific effectors 
for the PLD1-generated PA have remained elusive, our results strongly suggest that the 
facilitatory effects of PLD on secretion may be mediated in part by Syn1A-PA 
interactions. Namely, we found that the Syn1A 5RK/A mutant, which lacks the ability to 
bind PA, demonstrated reduced levels of secretion.  Overexpression of PLD1 rescued 
this defect, presumably because the increased local concentrations of PA generated by 
PLD1 compensated for the 5RK/A’s inability to sequester PA. Similarly, knockdown of 
PLD1 activity resulted in the inhibition of control secretion, because in the absence of 
PA, Syn1A’s function becomes similar to that of the 5RK/A mutant.  Accordingly, 
knockdown of PLD1 activity had little effect on Syn1A 5RK/A, since this mutant cannot 
normally bind PA.   
We have focused largely on Syn1A-PA interactions, but our finding that Syn1A 
directly binds PI(4,5)P2 is also of interest. PI(4,5)P2 is perhaps the most notable lipid 
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signal for regulated exocytosis, given its requirement in the ATP-dependent priming of 
vesicles [48-50]. Endogenous PI(4,5)P2 clusters partially colocalize with Syn1A clusters 
in membrane sheets of PC12 cells, and exocytosis was promoted at sites of Syn1A-
PI(4,5)P2 cluster co-localization [24]. Of substantial interest is that PA and PI(4,5)P2 
participate in a positive feed-forward cycle that results in the local generation of both 
lipids:   PA positively regulates PIP5KI, an enzyme which generates PI(4,5)P2 [51], and 
in turn, PI(4,5)P2 positively regulates PLD1, which generates PA [52]. That such specific 
membrane microdomains can have profound implications on the energetics of SNARE-
mediated fusion events is a concept conserved down through yeast. Indeed, it was 
shown that a yeast SNARE complex (Spo20p- Sso1p-Snc1p) that normally mediates 
fusion at the prospore membrane was insufficient to drive fusion at the plasma 
membrane [53]. This insufficiency could be overcome by 
overexpression of MSS4p (a yeast PI5K). Interestingly, the effect of MSS4p was 
mediated via recruitment of Spo14p (a yeast PLD), to the plasma membrane. It was 
suggested that Spo14p-mediated generation of PA at the plasma membrane reduced 
the energetic requirements for fusion such that the energy released by the Spo20p-
Sso1p-Snc1p complex became sufficient to drive fusion at the plasma membrane. 
While the current report is the first to establish the identity of specific Syn1A-lipid 
interactions, map the interacting domain, and determine direct functional effects of these 
interactions, it is clear that SNARE-lipid interactions are emerging as significant 
functional interactions that underlie membrane fusion [13, 54-57].  Of substantial 
importance is that sequence alignment across multiple families of SNARE proteins 
demonstrates high conservation of the lipid-interacting polybasic juxtamembrane region 
[28]. Therefore, the concept of membrane fusion driven by SNARE proteins must be 
enlarged to encompass the possibility that SNAREs also function to spatially sequester 





Figure 2.1.   Syn1A directly binds a subset of acidic phospholipids that includes the 
fusogenic lipid phosphatidic acid.  (A) Protein-lipid overlay demonstrating concentration-
dependent binding between soluble Syn1A(1-267) and multiple acidic phospholipids. 
Left:  Schematic representing the arrangement of lipids spotted on the nitrocellulose.  
Filled circles indicate those lipids for which an interaction was demonstrated.  Right:  α-
Syn1A immunoreactivity from four representative protein-lipid overlay experiments, in 
which decreasing concentrations of Syn1A were overlaid onto nitrocellulose membranes 
spotted with 100pmoles each of indicated phospholipids.  (B)  Averaged level of 
interaction of Syn1A for each phospholipid relative to that of PA.  Integrated 
immunoreactive density associated with each lipid on the overlays was averaged from 3 
independent experiments where [Syn1A] = 3nM, and normalized to the integrated 
density for PA.  Bars show means ± SEM.   (C)  Representative Western blots of Syn1A 
immunoreactivity in fractions collected from liposome flotation assays.  Bound Syn1A 






Figure 2.2.  A polybasic juxtamembrane sequence in Syn1A comprises the lipid binding 
domain.  (A) Top:  Sequence alignment of juxtamembrane regions of Syn1A across 
species.  Note the five highly conserved basic residues between positions 260-265.  
(NCBI accession numbers:  HS: AAA53519; MMul: NP_001028037; RN: AAF23017; 
MMus: NP_058081; LP: AAK70494; LS: AAO83845; DM: A55673; CR: AAY54265).  
Bottom:  Sequence alignments of Syn1A juxtamembrane mutants used in this study.  (B)  
Progressive neutralization of Syn1A juxtamembrane basic residues correlates to a 
progressive reduction in apparent binding affinity for PA.  Binding between Syn1A 
mutants and PA was determined using protein-lipid overlays (n=4), in which increasing 
amounts of PA were spotted on nitrocellulose.  Soluble Syn1A(1-267) was at a 5-fold 
molar excess to PA.  Integrated Syn1A immunoreactivity was measured at each PA 
spot, normalized for each mutant, and the data fitted with a Hill equation.  (C) The 5RK/A 
Syn1A mutant exhibits significantly reduced binding to PA-containing liposomes 
compared to WT Syn1A.  % of Syn1A bound to liposomes was defined as the % of 
Syn1A immunoreactivity in the top 3 gradient fractions relative to the total Syn1A 
immunoreactivity.  (D) Representative protein-lipid overlay demonstrating that Syn1A 
5RK/A has reduced binding to all acidic phospholipids tested.  (E)  Representative 
protein-lipid overlay demonstrating that a peptide of Syn1A’s juxtamembrane region 







Figure 2.3.  Syn1A 5RK/A targets to plasma membrane regions in PC-12 cells. (A)  
Representative confocal fluorescence and corresponding DIC images of PC-12 cells 
transiently transfected with eCFP-tagged Syn1A(WT) and Syn1A (5RK/A) together with 
Munc18-1.  (B) Representative epifluorescence images of PC-12 cells transiently 
transfected with mRFP-Syn1A-pHluorin (WT or 5RK/A) and Munc18.  The pHluorin 
signal (left) reports only on the pool of Syn1A present at the cell surface, whereas the 
mRFP signal (right) reports on the entire pool of exogenous Syn1A within the cell. (C)  
Average pHluorin and mRFP fluorescence intensity for PC-12 cells transfected as in (B).  
Bars represent means ± SEM.  Numbers above each bar represent the number of cells 
used to calculate the average for each condition.  (D)  Scatterplot of mean pHluorin 
intensity vs mean mRFP intensity for each individual cell.  Cells demonstrating moderate 
Syn1A expression levels (defined as a mean RFP signal between 20 and 170, a range 
within which >85% of the cells analyzed fell) were used to generate linear fits for each 
data set, as indicated by the solid lines.  Dotted lines represent the 95% confidence 






Figure 2.4.   Syn1A 5RK/A interacts normally with Munc18-1 and SNAP25.  (A)  
Analysis of direct CFP-Syn1A-citrine-Munc18-1 interactions by sensitized emission 
FRET imaging. Graph shows a pixel-by-pixel plot of FRET efficiency vs molar ratio 
(Syn1A:Munc18-1).  Both Syn1A (WT) and Syn1A (5RK/A) bind Munc18-1 with similar 
FRET efficiency.  By comparison, Syn1A I233A demonstrates strongly reduced FRET 
efficiencies with Munc18-1 compared to WT.  Solid horizontal line demonstrates 
background FRET values determined from coexpression of CFP and citrine 
fluoroproteins.  (B)  Average FRET efficiency for each Syn1A construct, at equimolar 
ratios of Syn1A and Munc18-1 (0.9 < ratio < 1.1; see vertical lines in (B)).  Bars 
represent the mean ± SEM.  (C) Representative immunoblot demonstrating co-
immunoprecipitation of EGFP-SNAP25 with Syn1A from HEK293-S3 cells transiently 
transfected with Syn1A (WT, L205A/E206A, or 5RK/A), Munc18-1, and EGFP-SNAP25.   
Note that Syn1A 5RK/A pulls down similar amounts of EGFP-SNAP25 compared to WT 
Syn1A.  In contrast, a mutant of Syn1A (L205A/E206A) previously shown to have 
reduced binding to SNARE proteins, demonstrates a reduced amount of EGFP-SNAP25 
pulldown.  (D)  Integrated densities of Syn1A and EGFP-SNAP25 bands were measured 
to determine a ratio of EGFP-SNAP25 to Syn1A for each condition.  Ratios within a 
single experiment were then normalized to that of WT Syn1A to allow for comparison 










Figure 2.5. BoNT-C knockdown allows isolation of functional effects of exogenous 
Syn1A constructs in live secretory cells.  (A) Top:  Representative epifluorescence 
images demonstrating that Syn1A (K253I) is resistant to cleavage by BoNT-C.  Images 
compare the subcellular distribution of fluorescent signal in PC-12 cells transfected with 
CFP-Syn1A (WT) and CFP-Syn1A (K253I) with/without the light chain of BoNT-C.  
Munc18-1 was coexpressed in each condition.  Bottom: Normalized fluorescence 
intensity profiles, as determined by averaging line scans taken from the outside to the 
middle of each cell, corresponding to the expression conditions shown above.  Line 
scans were normalized, the peaks were aligned, and scans were averaged for each 
condition.  (B) Functional rescue of BoNT-C knockdown in elevated K+ evoked (70mM, 
6min) hGH secretion, by co-transfection with Syn1A (K253I) and Munc18-1.  Note that 
S1A (K253I) or Munc18-1 alone did not rescue secretion, nor did Syn1A (WT) co-














Figure 2.6.  Neutralization of Syn1A’s polybasic juxtamembrane region results in a 
decrease in evoked secretion.  (A) Progressive neutralizing mutations of Syn1A’s 
polybasic juxtamembrane domain result in a graded reduction in evoked hGH secretion. 
Transfected PC-12 cells were stimulated with 70mM K+ for 6 min.  Data was normalized 
to control rescue (Syn1AK253I) for each experiment and pooled across at least 3 
independent experiments for each condition.  Dotted line represents the baseline level of 
remaining secretion following BoNT-C treatment. Bars represent means ± SEM.  
Asterisks indicate statistical significance (p<0.001) from control Graph at right shows the 
same data as on the left, but with the average residual BoNT-C baseline secretion for 
each experiment subtracted from each condition prior to normalization to control rescue.  
Note that when the data is corrected for residual BoNT-C secretion, the actual effect of 
the Syn1A neutralization mutants becomes substantially larger. (B) Evoked [Ca2+] 
dynamics reported by changes in Fura-2 fluorescence intensity ratio (F340nm/380nm) 
demonstrate that depolarization-induced (100mM K+ for 5 sec) calcium fluxes are similar 
between control and 5RK/A cells.   Left:  Averaged ratio traces for control and 5RK/A 
cells.  Horizontal bar indicates period of stimulus application.   Averaged baseline 
(Middle) and evoked change (Right) in F340nm/380nm ratio for control and 5RK/A cells.   
(C) Representative amperometric recordings from bovine adrenal chromaffin cells 
transfected with Syn1AK253I or Syn1AK253I (5RK/A) together with BoNT-C.  Exocytotic 
secretion was evoked by a 60s application of locally perfused 100mM K+.  Amperometric 
spikes were detected and quantified by an automated analysis software program written 
by Eugene Mosharov (Columbia University).  (D)  Comparison of averaged number of 
spikes per cell in control and 5RK/A cells.  Bars show mean ± SEM. Only spikes >10pA 
in amplitude above rms baseline were considered for analysis. (E)  Cumulative spike 
frequency distribution, normalized for the total number of spikes for control (Syn1AK253I) 
























Figure 2.7.  Neutralization of Syn1A’s polybasic juxtamembrane region results in a 
decrease in fusion pore diameter and a lengthening of fusion pore duration.  (A) 
Representative pre-spike feet for control (Syn1AK253I) or Syn1AK253I (5RK/A) expression 
conditions (+ BoNT-C) during stimulation by 60s application of locally perfused 100mM 
K+.  (B) Left, Mean PSF amplitudes for control and 5RK/A cells, from all PSF >1ms in 
duration and <30pA in amplitude (n=584 control PSF analyzed, n=576 5RK/A PSF 
analyzed).  Right, Averaged median PSF amplitudes (n=66 control cells analyzed, n=78 
5RK/A cells analyzed).  In both cases, the PSF from 5RK/A cells demonstrate 
statistically significant decreases in amplitude (p<0.05). Bars represent the mean ± SEM.  
(C) Left, Mean PSF durations for control and 5RK/A cells, from all PSF >1ms in duration 
and <30pA in amplitude (n=584 control PSF analyzed, n=576 5RK/A PSF analyzed).  
Right, Averaged median PSF durations (n=66 control cells analyzed, n=78 5RK/A cells 
analyzed).  In both cases, the PSF from 5RK/A cells demonstrate statistically significant 







Figure 2.8.  Functional phenotypes of Syn1AK253I control and 5RK/A mutant are 
differentially regulated by manipulation of phosphatidic acid levels in live PC-12 cells.  
Graph demonstrates averaged results from hGH secretion assays utilizing the BoNT-C 
knockdown and rescue.  External application of 1µM LPC has no effect on control 
secretion, but results in a partial rescue of the 5RK/A phenotype.  Overexpression of 
PLD1 results in near-complete rescue of the 5RK/A phenotype to control secretion 
levels.  On the other hand, knockdown of PLD1 activity via a targeted siRNA construct 
results in a drastic decrease in control secretion, while having little to no effect on 
secretion from 5RK/A cells.  Results are normalized to the untreated Syn1AK253I control 
rescue in each experiment to allow comparison across multiple experiments, and data 
was pooled from at least 3 independent experiments.   Bars represent the mean ± SEM.  
Letters above bars indicate pairs of conditions in which the differences are statistically 
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Chapter 3 
 
Receptor-Mediated Regulation of Tomosyn-Syntaxin1A Interactions  
in Bovine Adrenal Chromaffin Cells 
 
Abstract 
Tomosyn, a soluble R-SNARE protein identified as a binding partner of the Q-
SNARE syntaxin1A, is thought to be critical in setting the level of fusion-competent 
SNARE complexes for neurosecretion.  To date, there has been no direct evaluation of 
the dynamics in which tomosyn transits through tomosyn-SNARE complexes or of the 
extent to which tomosyn-SNARE complexes are regulated by secretory demand.   Here, 
we employed biochemical and optical approaches to characterize the dynamic 
properties of tomosyn-syntaxin1A complexes in live adrenal chromaffin cells.  We 
demonstrate that secretagogue stimulation results in the rapid translocation of tomosyn 
from the cytosol to plasma membrane regions, and that this translocation is associated 
with an increase in the tomosyn-syntaxin1A interaction, including increased cycling of 
tomosyn into tomosyn-SNARE complexes.  The secretagogue-induced interaction was 
strongly reduced by pharmacological inhibition of the Rho-associated coiled-coil forming 
kinase (ROCK), a result consistent with findings demonstrating secretagogue-induced 
activation of RhoA.  Stimulation of chromaffin cells with LPA, a non-secretory stimulus 
that strongly activates RhoA, resulted in effects on tomosyn similar to that of application 
of the secretagogue.  In PC-12 cells overexpressing tomosyn, secretagogue stimulation 
in the presence of LPA resulted in reduced evoked secretory responses, an effect that 
was eliminated upon inhibition of ROCK.  Moreover, this effect required an intact  
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interaction between tomosyn and syntaxin1A.  Thus, modulation of the tomosyn-
syntaxin1A interaction in response to secretagogue activation is an important 
mechanism allowing for dynamic regulation of the secretory response. 
 
Introduction 
Regulated neurotransmitter release requires the well-orchestrated spatial and 
temporal actions of many presynaptic proteins [1]. Although the primary molecular 
entities in the release pathway have been identified, the exact mechanics of synaptic 
vesicle fusion and its precise regulation is still not established. Central to the fusion 
process is the transient formation of SNARE core complexes that include the target 
membrane SNARE proteins syntaxin1A and SNAP25 and the vesicle SNARE protein 
synaptobrevin/VAMP [2-4].  A SNARE core complex is a highly stable, four-α-helix 
parallel bundle consisting of one SNARE motif from each of syntaxin1A and 
synaptobrevin/VAMP, and two SNARE motifs from SNAP25 [5, 6].  Although these 
proteins alone are sufficient to induce a slow fusion when reconstituted into liposomes 
[7], additional proteins are necessary to establish the properties that describe fast, Ca2+-
dependent neurotransmitter release [8].  For example, assembly of SNARE core 
complexes is subject to temporal and spatial regulation by a variety of protein families, 
including Rab-GTPases [9-13], Sec/Munc18s [14-16], exocyst tethering complexes [17-
20], and Munc13s [21-24].  In addition, recent evidence suggests that the temporal and 
spatial availability of SNAREs for membrane fusion may be subject to precise regulation 
by the presence of soluble R-SNARE motif containing proteins, such as amisyn [25, 26], 
and tomosyn [27-29].    
Tomosyn was originally identified in neurons as a binding partner of the Q-
SNARE, syntaxin1A [27], and belongs to a larger family of proteins that includes the 
yeast proteins Sro7p and Sro77p, the Drosophila tumor suppressor lethal giant larvae 
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family, and the mammalian MglI family [30-33].  Tomosyn homologues also appear in 
the Fungi and Plantae kingdoms [34].      Structurally, tomosyns are soluble proteins that 
contain two distinguishable domains. An R-SNARE homology motif near the C-terminus 
defines tomosyn’s primary interaction with the Q-SNARE syntaxin1A, while the 
remaining N-terminal region contains 7 to 9 repeating β-transducin-like WD40 motifs that 
form additional protein-protein interaction sites  [27, 35, 36].  In the mouse genome, two 
paralogous genes for tomosyn exist (tomosyn-1 and 2) and lead to the expression of 7 
tomosyn isoforms  [37].    Variability between these tomosyn isoforms is clustered within 
a hypervariable domain that separates the N-terminal WD-40 repeats from the C-
terminal SNARE domain.   Functional actions of tomosyn family members have been 
ascribed to their interaction with cognate Q-SNAREs; however, as the lethal giant larvae 
family and Sro7p and Sro77p proteins do not possess a well-defined C-terminal R-
SNARE homology domain, interactions between these families and their cognate Q-
SNAREs has been proposed to involve alternative interaction motifs [30, 31, 38].    
Increasing evidence demonstrates that tomosyn and its homologues are critical 
regulators in vesicular trafficking and membrane fusion processes.  Overexpression of 
tomosyn in PC-12 and adrenal chromaffin cells negatively regulates neurotransmitter 
secretion [27, 29], which, in chromaffin cells, results from inhibition in priming of large 
dense-core vesicles and decreased readily releasable pool (RRP) pool size [28].  
Tomosyn has also been shown to exert an important role in polarized exocytosis in yeast 
and epithelial cells [30, 39], to negatively modulate insulin release from pancreatic β- 
cells[40], and to interact with syntaxin4 and SNAP23 and inhibit insulin-induced fusion of 
GLUT4-containing vesicles in 3T3-L1 adipocytes [41].  Recent genetic studies in C. 
elegans have also clearly established that tom-1, the ortholog of mammalian tomosyn, 
exerts an inhibitory role on neurotransmitter secretion by negatively regulating synaptic 
vesicle priming [42, 43] 
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The inhibitory effects of tomosyn have been proposed to result from the 
formation of specific tomosyn-protein complexes that reduce the availability of interacting 
proteins to perform functional roles in exocytosis.   For example, tomosyn has been 
shown to compete with Munc18 for binding to syntaxin, and likely of greater significance, 
tomosyn competes with synaptobrevin for binding to syntaxin/SNAP25 dimers to form 
tomosyn-SNARE complexes [27].  The latter complexes, as shown by their resolved 
crystal structure, are almost identical to the synaptobrevin/VAMP-containing SNARE 
complexes [34], including a required action by the ATPase NSF for complex 
disassembly and reuse of the interacting proteins [29].  However, while tomosyns can 
participate in the formation of stable tomosyn-SNARE complexes, the absence of a 
membrane anchor in all tomosyn family members precludes them from acting as 
fusogenic synaptobrevin/VAMP analogues.  Rather, formation of these non-fusogenic 
tomosyn-SNARE complexes diminishes the availability and formation of fusion 
competent SNARE complexes between membrane-anchored SNAREs, and it is this 
feature that has been proposed to underlie tomosyn’s negative regulation of exocytotic 
activity. 
The interaction of tomosyn with syntaxin1A has recently been reported to be 
differentially regulated by the Rho/ROCK [44] and protein kinase A signaling pathways 
[45].  Activation of RhoA and its signaling effector ROCK facilitated syntaxin1A 
phosphorylation and formation of tomosyn-SNARE complexes at the palms of growth 
cones in extending neurites in NG108 neuroblastoma cells and cultured neurons [44].  
This resulted in the localized inhibition of functional SNARE complex formation in these 
areas, and spatially directed fusion of plasmalemmal precursor vesicles to the leading 
edge of growth cones.  On the other hand, PKA-catalyzed phosphorylation of tomosyn 
decreased tomosyn’s interaction with syntaxin1A and thereby upregulated SNARE 
complex formation and enhanced neurotransmitter release in cultured superior cervical 
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ganglion neurons [45].  Thus, while tomosyn is not essential for neurotransmitter 
release, its complex regulation suggests that it may play a critical role in integrating 
multiple receptor-mediated signaling pathways to ultimately achieve a fine modulatory 
control over the site and extent of secretory responses.   
To date, there has been no direct evaluation in living cells of the time course or 
extent to which the assembly/disassembly of tomosyn-SNARE complexes is regulated 
by secretory demand for neurotransmitter release.   Furthermore, although a Rho 
signaling pathway has been demonstrated to alter tomosyn-SNARE interactions during 
neurite development, it remains unknown whether this signaling pathway operates to 
direct tomosyn-SNARE complex assembly during regulated neurotransmitter release.   
In this paper, we evaluated the spatiotemporal dynamics and regulation of the tomosyn-
syntaxin1A interaction during stimulated secretion in neuroendocrine chromaffin cells.  
We show that activation of nicotinic acetylcholine receptors (nAChR), as occurs normally 
during neural-evoked secretory responses, as well as treatment with lysophosphatidic 
acid (LPA), activates Rho-GTPase and increases tomosyn-syntaxin1A complex 
formation at the plasma membrane in chromaffin cells.  These effects of secretagogue 
stimulation and LPA treatment were inhibited by Y27632, a specific inhibitor of the Rho-
GTP effector ROCK. We also show using dynamic FRET measurements between CFP-
tomosyn and cYFP-syntaxin1A that the formation of these complexes is strongly 
augmented under conditions where NSF action is inhibited, suggesting that a rapid and 
dynamic cycling of tomosyn-syntaxin1A interactions occurs in vivo. Finally, we present 
functional data to demonstrate that LPA activation of the RhoA/ROCK pathway during 





Materials and Methods 
Chemicals and expression constructs  
pEGFP-C1, and monomeric mutants (A206K) of pECFP-C1 and pEcYFP-C1 (citrine) 
vectors containing the LoxP sequence were used as recipient vectors for subcloning 
using the Cre-recombinase-mediated Creator system (Clontech). Rat syntaxin1A, m-
tomosyn, SNAP25 and Munc18-1 were merged to the C terminus of the EGFP, ECFP 
and EcYFP.  Effector binding mutants of syntaxin1A (I209A and I233A), a soluble mutant 
of SNAP25 (SNAP25c/a, C-80, 88, 90, 92-A), as well as a carboxy terminal deletion of 
tomosyn1-1067 (tomosyn ∆CT, glutamate at residue 1068 changed to stop codon) were 
constructed using the PCR-based Quickchange site-directed mutagenesis kit 
(Stratagene).  The sequence fidelity of all constructs was confirmed by DNA sequencing 
(University of Michigan DNA Sequencing Core).  RhoA activation was measured using 
an ELISA-based kit (Cytoskeleton). HEK293 cells stably expressing the rat α1B and 
human β2B and α2δ voltage gated calcium channel subunits (HEK293-S3 cells) were a 
gift from D. Rock (Warner-Lambert Parke Davis, Ann Arbor, MI).  All other chemicals 
were obtained from Sigma, unless specifically indicated otherwise.   
 
Cell culture and transfection 
HEK293-S3 cells were plated and cultured in RPMI 1640 with L-glutamine supplemented 
with 10% fetal bovine serum, 1% penicillin/streptomycin (Life Technologies, Inc.), 0.4 
mg/ml of hygromycin and 0.6 mg/ml of geneticin at 37oC in 95% O2/5% CO2 for 2 days 
on coverslips (thickness 1) attached to the bottom of 35 mm culture dishes before 
transfection. Transfections were performed using Lipofectamine 2000 (Invitrogen) 
according to manufacturer instructions. One hour before transfection, cells were placed 
into DMEM lacking antibiotics and supplemented with 1% L-glutamine, 1% non-essential 
amino acids and 10% fetal bovine serum.  4-6 hours after the transfection, cells were 
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returned to the RPMI 1640 medium. Cells were used for imaging 24-48 hours after 
transfection. 
Chromaffin cells were isolated from bovine adrenal glands using divalent metal 
ion-free rinse, collagenase digestion and gradient centrifugation as described previously 
[46]. Cells were cultured in 6-well plates in DMEM/F12 supplemented with 10% fetal 
bovine serum, 100 units/ml penicillin/streptomycin, 10 µg/ml gentamicin, and 10 µM 
cytosine arabinofurosemide.  Three days following isolation, cells were transfected using 
biolistic particle bombardment according to manufacturer instructions with plasmid DNA 
laden (2µg/mg beads) 1 µm diameter gold beads (Bio-Rad).  Cells were replated 4 to 24 
hours before imaging onto collagen coated glass coverslips.   
 PC-12 cells were cultured in 10% CO2, in DMEM supplemented with 10% horse 
serum, 5% fetal bovine serum, penicillin (100 units/ml), streptomycin (100 μg/ml), and 
1% gentamicin (10 μg/ml).  PC-12 cells were transfected using Lipofectamine 2000 
(Invitrogen) according to manufacturer’s protocol.  30 minutes before transfection, cells 
were placed in Optimem media; cells were returned to the DMEM media 4-6 hours 
following transfection.   
 
Tomosyn translocation assay 
Cells were serum starved in DMEM/F-12 medium for 4 hours prior to treatment with 
selected receptor agonists or signaling antagonists.  Following the serum starve period, 
medium was changed to physiological saline (PSS) containing (mM): NaCl, 140, KCl, 5, 
CaCl2, 2.2, MgCl2, 1, glucose, 10 and HEPES, 10 (pH 7.4 adjusted with NaOH). 
Treatments included incubation with lysophosphatidic acid (LPA, 10 µM, Biomol) or the 
nicotinic acetylcholine receptor agonist 1,1-dimethyl-4-phenylpiperazinium iodide 
(DMPP, 20 µM), alone or in combination with the Rho kinase inhibitor, (Y27632, 20 µM, 
Calbiochem).  In Rho kinase inhibitor experiments, the Y27632 was applied during the 
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serum deficient preincubation period and to the PSS during agonist treatment.  Each 
treatment was followed by an additional incubation (10 min) with the NSF alkylating 
agent N-ethylmaleimide (NEM, 100 µM) prior to cell lysis.  Cells were then scraped into 
the ice-cold lysis buffer containing 2% sucrose, 1 mM EDTA, 20 mM Tris-HCl (pH 7.4) 
and 100 µM NEM, with a mixture of protease inhibitors (1 µg/µL each of PMSF, 
leupeptin, pepstatin, aprotinin and benzamidine). The collected lysis buffer was then 
subjected to Dounce homogenization (20 strokes) followed by centrifugation (800g, 2 
min, 4oC) to remove nuclei.  A membrane fraction was then extracted by ultra-
centrifugation of the samples at 100,000g, for 30 min at 4oC, with the pellets 
resuspended in immunoprecipitation (IP) buffer containing (mM): NaCl, 150, Tris (pH 
7.4), 50, and EDTA, 2 supplemented with 1% Triton and the above-mentioned protease 
inhibitor mixture. Immunoprecipitation using a monoclonal α-tomosyn antibody 
(Transduction Laboratories) was then performed on all samples that had been initially 
adjusted to contain equal starting amounts of protein and volume.  Immunoprecipitation 
was carried out by overnight incubation with the antibody at 4oC with rotation, after which 
Immunopure protein G beads (Pierce) were added and the incubation continued another 
90 min.  The beads were then pelleted by centrifugation (1,000g for 2 min at 4oC) and 
washed in TNM buffer containing (mM): NaCl, 50, MgCl2, 50, Tris-HCl (pH 7.5), 50.  
Tomosyn immunoreactivity in the resulting samples was determined by SDS-PAGE 
fractionation and immunoblotting.  Blots were probed with monoclonal α-tomosyn 
antibody and subsequently with HRP-conjugated goat α-mouse antibody 
(Developmental Studies Hybridoma Bank, Iowa City, IA). Immunoreactive signals were 
developed by ECL detection (Amersham), visualized using a FluoroMax Imager (Bio-




Rho activation assay 
Cells in 6-well plates (1.5 x 106 cells/well) were serum starved in DMEM/F-12 medium 
for 12 hours prior to use.  Following the serum starve period, medium was changed to 
physiological saline (PSS) that contained lysophosphatidic acid (LPA, 10 µM, Biomol), 
nicotinic acetylcholine receptor agonist 1,1-dimethyl-4-phenylpiperazinium iodide 
(DMPP, 20 µM), or, for control, PSS alone.  Following either a 2 or 10 min period of 
receptor activation the medium was rapidly removed and the cells were rinsed once in 
ice cold PBS.  Lysis buffer was then rapidly added and the cells scraped and lysates 
collected and immediately frozen in liquid N2.  The relative level of RhoA activation with 
respect to control conditions was then measured using an ELISA based assay according 
to the manufacturer’s instructions (Cytoskeleton).  Each sample was assayed in 
duplicate and each condition was repeated on at least three individual cell preparations.  
The level of Rho activation was calculated with respect to that of the control condition 
following subtraction of the assay blank.   
 
Human Growth Hormone Secretion Assay 
PC-12 cells were plated onto 24 well plates and co-transfected with plasmids coding for 
human growth hormone (hGH), in addition to full-length tomosyn, tomosyn∆CT, or a 
neomycin control.  The total concentration of DNA was held equal across all treatments.  
hGH was used as a reporter for regulated secretion specifically from transfected 
cells[47].  Secretion assays were performed 48-72 hours following transfection.  16-20 
hours before the start of the assay, cells were placed in serum-free media; where 
applicable, cells were pre-treated with Y27632 (20 µM) 4 hours prior to the start of the 
assay.  To test secretion, cells were rinsed for 10 minutes in a physiological saline 
solution (in mM: NaCl, 145, KCl, 5.6, NaHEPES, 15, MgCl2, 0.5, CaCl2, 2.2, Glucose, 
5.6, NaAscorbate, 0.5, 2mg/mL fatty acid-free BSA, pH 7.3) in the presence or absence 
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of Y27632.  Cells were then stimulated to secrete by a 6 minute treatment with 70mM K+ 
(same saline solution but with equimolar substitution of K+ for Na+).  Where applicable, 
10μM LPA and/or (20 µM) Y27632 were added to the stimulus solution.  The saline 
solution containing the secreted hGH was collected, and cells were lysed to determine 
the percent of total hGH content secreted.  hGH content was measured using an hGH 
ELISA kit (Roche Diagnostics).  Each experiment was performed with quadruplicate 
replicates for each treatment.   
 
GST-Syntaxin1A-tomosyn binding in vitro and immunoblotting 
Soluble syntaxin1A (residues 1-264) was expressed in E. coli as a glutathione-S-
transferase (GST)-fusion protein.  GST was expressed in a similar manner.  Both 
proteins were purified by glutathione-Sepharose (Sigma) binding and extensive washing.  
The bound GST or GST-syntaxin1A were then incubated for 16 hours at 4oC with lysates 
prepared from PC-12 cells expressing EGFP-tomosyn or EGFP-tomosyn ∆CT.  The lysis 
buffer contained (100 mM KCl, 20 mM HEPES-KOH, 2 mM EDTA, 1% Triton-X100, 1 
mM DTT) with protease inhibitor cocktail (Roche, PI Complete).  The beads were then 
collected by centrifugation and washed 4 times with PBS and bound proteins were 
analyzed by SDS-PAGE and immunoblotting with anti-GFP antibody (Stressgen).      
 
Fluorescence photobleaching in subcellular localization of EGFP-tagged proteins 
Chromaffin cells were plated onto collagen-coated glass-bottom 35 mm culture dishes 
and cultured for 24 hours prior to use and imaged in PSS.  Localization of expressed 
EGFP-tagged soluble proteins to plasma membrane regions was determined following a 
spatially directed laser-induced (488 nm line of the argon laser) photobleach of EGFP 
fluorescence in a rectangular region of the cytosol of live cells using a Zeiss LSM 510 
confocal microscope. A targeting factor (TF) for distribution of EGFP-tagged proteins to 
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the plasma membrane region was determined from images of the cell taken pre- and 
post-application of the photobleach. Initially, averaged fluorescence intensities of the 
whole cell (Itot) and its cytosolic (ICyt) and membrane (IMem) regions in pre- and post-
bleach images where measured along with the corresponding total (Acyt), membrane 
(Amem) and cytosolic (Acyt) areas. The value of membrane targeting of a protein was 
defined as fraction of membrane-bound EGFP-tagged protein in total fluorescence of the 
cell before the photobleach.  For each photobleached cell, relative membrane 
fluorescence parameter M=(Ipost/Ipre)totMem  was determined. Assuming that total intensity 
in a membrane region consists of contributions from that of membrane-bound and near-
membrane cytosol fluorescence (Imemtot = ITrueMem + ICyt⋅Amem),  and that ITrueMem does not 
change with photobleach, the targeting factor value was calculated as TF = 
ITrueMem/(Itot)pre, where ITrueMem = [(Ipre)cyt⋅M-(Ipost)cyt] ⋅Amem/(1-M). 
 
Confocal and conventional fluorescence microscopy of ECFP and EcYFP tagged 
proteins and imaging of FRET 
Chromaffin cells were cultured for 36 hours after transfection, then plated and cultured 
for 4 to 24 hours on collagen-coated glass coverslips prior to fluorescence imaging.  For 
fluorescence imaging of fixed cells, the cells were fixed in 4% paraformaldehyde in 
physiological saline solution (PSS) for 20 min, rinsed with PSS, and quenched with 50 
mM NH4Cl-PSS for 12 min.  After rinsing with PSS, cells were submerged in 75% 
glycerol-PSS and subjected to fluorescence imaging on a Zeiss LSM 510 META 
confocal microscope. Imaging and morphological analysis of subcellular localization of 
expressed fluorophore-tagged proteins was primarily performed on the Zeiss confocal 
microscope.  Imaging of FRET was carried out using acceptor photobleach (i.e. donor 
dequenching) methodology on the Zeiss confocal microscope and by detection and 
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analysis of sensitized EcYFP emission on a conventional Olympus fluorescence 
microscope.   FRET imaging with the Zeiss LSM 510 META relied on pixel-by pixel linear 
unmixing calculations (Meta software) performed prior and following photobleach of the 
acceptor.  This software utilizes control emission spectra of the fluoroproteins to 
completely decompose or digitally separate the contribution from the ECFP and EcYFP 
tagged signals in the mixed emission spectrum recorded from cotransfected cells. 
Relative FRET efficiency by acceptor photobleach was calculated as (1-[ECFP Ipre-bleach/ 
ECFP Ipost-bleach]) X 100%.  Sensitized emission FRET was detected using a Olympus 
microscope coupled to a Till-Photonics Polychrome IV xenon lamp based 
monochrometer (Till-Photonics, Grafelfing, Germany), a polychroic mirror that allowed 
detection of multiple fluorophores (436-500 nm, Chroma Technology Corp. Brattleboro, 
VT), a Planapo 60X water immersion objective (1.2 NA), a multispec microimager 
(Optical Insights, Sante Fe, NM) containing a dichroic splitter (505dcxr) and emission 
filters (D465/30 and HQ535/30) and a cooled digital CCD camera (TILL-IMAGO QE).  
Images corresponding to three excitation/emission wavelength settings (ex/em, 436/465, 
436/535, and 500/535) were collected. Quantification of sensitized emission FRET 
efficiency from shade and background corrected images was determined according to a 
method termed FRET stoichiometry [48].  Analysis of the acquired cell images 
determined three parameters for each pixel of an image.  The first parameter is the 
apparent FRET efficiency EA, which is the product of the FRET efficiency of the specific 
bimolecular interaction, termed characteristic FRET efficiency (EC), and the fraction of 
acceptor in complex with the donor.  The second parameter is ED, which is the apparent 
donor efficiency and is the product of Ec and the fraction of donor in complex.  The third 
parameter is the acceptor-donor molar ratio (Ratio).  Ratio indicates the mole fraction of 
acceptor to donor in each pixel of the cell image.  Because EA and ED are proportional 
to the fraction of acceptor and donor in complex, respectively, they can be used to 
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measure time- or agonist-dependent changes in the fraction of acceptor and donor in 
complex.   Full details concerning controls performed for validation of FRET signals, 
acquisition parameters of background and shade images, methods used for 
determination of proportionality constants required for complete separation of ECFP and 
EcYFP and FRET signals and of the specific calculations performed to quantify FRET 
efficiency values are given in our recent report [49]. 
 
Data analysis and statistics – Data were analyzed and statistical analysis performed 
using IGOR PRO (Wavemetrics Inc) and GraphPad Instat (GraphPad Software Inc. San 
Diego, CA, USA) software.  Population data were expressed as means ± S.E.M., and 
statistical significance was determined using Student’s unpaired t tests, or for multiple 
comparisons using ANOVA with Dunnett’s post hoc test on normally distributed data.  In 
the case of non-parametric data, a Mann-Whitney U test was performed using the 
original calculated values.  Significant differences were defined by p ≤ 0.05 and indicated 
by an asterisk. 
 
Results 
Expression and targeting of fluorescently-tagged tomosyn, syntaxin1A and Munc18-1 in 
HEK-293 cells 
HEK-293 cells were initially used to demonstrate expression and targeting of the 
recombinant fluoroprotein-tagged tomosyn, syntaxin1A and Munc18-1 proteins and to 
test for specific interactions between these proteins in an in vivo situation. The HEK-293 
cell line does not demonstrate endogenous expression of these proteins [50] and, 
therefore, provides a clean background upon which to test interactions. Figure 3.1A 
shows confocal fluorescence images that compare the subcellular distribution of cYFP-
tomosyn, cYFP-syntaxin1A, and CFP-Munc18-1 when individually expressed.  While 
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both the cYFP-tomosyn and CFP-Munc18-1 showed a diffuse distribution in the cytosol 
typical of soluble proteins, syntaxin1A was observed to accumulate primarily in 
perinuclear membrane regions, and in some cells in a number of highly localized sites in 
the cytosol characterized by intense fluorescence.  By comparison, coexpression of 
cYFP-syntaxin1A with CFP-Munc18-1 resulted in efficient targeting of cYFP-syntaxin1A 
to the plasma membrane region (Figure 3.1B), and cells were remarkably devoid of 
perinuclear fluorescence.  The coexpression of CFP-tomosyn with cYFP-syntaxin1A did 
not result in a similar dramatic targeting consequence, as strong perinuclear cYFP-
syntaxin1A labeling was retained with little enrichment of fluorescence at the plasma 
membrane.  Thus, tomosyn and Munc18-1 are functionally distinct with regard to their 
ability to facilitate syntaxin1A targeting to the plasma membrane in HEK-293 cells. 
We next determined whether overexpressed CFP-tomosyn directly interacted 
with syntaxin1A in this cell line.  For this purpose we used fluorescence resonance 
energy transfer (FRET) between the CFP/cYFP pair to visualize and quantify direct CFP-
tomosyn/cYFP-syntaxin1A interactions.  FRET measurements were performed by 
acceptor photobleach on fixed cells using a LSM Zeiss 510 META confocal microscope, 
which was optimal for acquiring images in a single optical plane coincident with FRET 
and analysis of its subcellular compartmentation. Figure 3.2A compares images 
acquired prior to and following a localized photobleach of the cYFP acceptor from a 
representative HEK-293 cell.  A marked increase in CFP fluorescence occurred following 
photobleach that was restricted to the bleached perinuclear membrane region, a result 
indicative of FRET between CFP-tomosyn and cYFP-syntaxin1A.  The increased CFP 
signal following photobleach was readily apparent on comparison of spectrally 
pseudocolored images of this cell region prior and following photobleach (shown below 
cell images).   Averaged relative FRET efficiency values for photobleached and non-
photobleached cell regions are presented in Figure 3.2C and clearly establish that a 
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CFP-tomosyn/cYFP-syntaxin1A interaction occurred in HEK-293 cells.  Thus, the 
compartmentalization of CFP-tomosyn observed in the presence of syntaxin1A 
coexpression is reflective of a colocalization of these proteins that results from a direct 
protein-protein interaction. As we have previously reported, analysis of non-
photobleached regions of CFP-expressing cells also demonstrates a slight increase in 
CFP signal of approximately 9% following the laser photobleach protocol, which we 
define as background [49].  The cause of this small and consistent change remains 
undetermined, and has not been subtracted from the relatively large FRET values 
determined for photobleached regions of the cells.    
As Munc18-1 and tomosyn both interact with syntaxin1A, we next determined 
whether overexpression of Munc18-1 altered the interaction between syntaxin1A and 
tomosyn.   As shown in Figure 3.2B, coexpression of tomosyn, syntaxin1A and Munc18-
1 resulted in targeting of syntaxin1A to plasma membrane regions, indicative of Munc18-
1 facilitation of syntaxin1A targeting.  Of specific importance, with these coexpression 
conditions, CFP-tomosyn retained significant FRET with cYFP-syntaxin1A, although it 
was now present spatially at plasma membrane regions (Figure 3.2B), versus the 
perinuclear/ER and Golgi localization that was observed in the absence of Munc18-1 
coexpression.  In addition, the averaged relative FRET efficiency was reduced slightly 
but significantly from that measured in the absence of Munc18-1 coexpression (Figure 
3.2C).  These results are complementary to prior reports for the HEK-293 cell line in 
establishing that Munc18-1 is important for the distribution of overexpressed syntaxin1A 
to the plasma membrane region [50-52]. The present FRET results demonstrate that, 
while tomosyn is capable of interacting with syntaxin1A in multiple subcellular 
compartments, it is likely to preferentially associate with syntaxin1A at the plasma 
membrane in neurons where munc18-1, syntaxin1A and tomosyn are endogenously 
expressed.   
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In additional experiments we tested whether the tomosyn/syntaxin1A 
heterodimeric complex at the plasma membrane in HEK-293 cells was capable of 
progression to a SNARE core complex by the incorporation of a cognate t-SNARE, 
SNAP25.   For these experiments we used a SNAP25 mutant that contained EGFP 
fused to the N-terminus of a SNAP25 mutant in which the four normally palmitoylated 
cysteine residues that direct SNAP25 membrane targeting were mutated to alanine 
(EGFP-S25 c/a).  We have previously demonstrated that this SNAP25 mutant becomes 
membrane localized only if it is capable of pairing its SNARE motifs with that of 
syntaxin1A [50], or presumably, a syntaxin1A/tomosyn complex.  The subcellular 
distribution of EGFP-S25 c/a was determined by calculating a targeting factor (TF) that 
compares EGFP fluorescence at the plasma membrane region relative to that in the 
cytosol from confocal images taken prior to and following a laser-induced photobleach 
(488 nm line of Argon laser) of the cytosolic fluorescence using the Zeiss LSM confocal 
microscope.  Figure 3.2D shows that EGFP-S25 c/a expressed alone in HEK-293 cells 
show little labeling of the plasma membrane, but that its coexpression with syntaxin1A 
resulted in a substantial increase in targeting.  Under these coexpression conditions, 
targeting of syntaxin1A to the plasma membrane occurred in the absence of Munc18-1. 
Notably, the syntaxin1A induced increase in EGFP-S25 c/a targeting was completely 
inhibited with the added expression of Munc18-1, likely as a result of stabilizing 
syntaxin1A in an inactive SNARE complex forming conformation.   Coexpression of 
EGFP-S25 c/a with syntaxin1A and tomosyn also resulted in significant targeting of 
EGFP-S25 c/a to the plasma membrane and this targeting was unaffected by the 
additional expression of Munc18-1.  These data, taken together with the prior FRET 
results (Figure 3.2C), indicate that tomosyn competes with Munc18-1 for binding to 
plasma membrane localized syntaxin1A in vivo and permits formation of SNARE 
complexes.  
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Location and properties of tomosyn interaction with syntaxin1A in adrenal chromaffin 
cells 
To establish the components that normally regulate tomosyn/syntaxin1A 
interactions and to relate changes in their interaction to functional consequences within 
the exocytotic pathway, the properties of the interaction were further investigated in 
bovine adrenal chromaffin cells, where these proteins are endogenously present and 
demonstrated to be functionally important [26, 28].  In these cells, exogenously 
expressed CFP-tomosyn and cYFP-syntaxin1A localized to the plasma membrane 
region without exogenous coexpression of Munc18-1 (Figure 3.3A).  To establish that 
the colocalized CFP-tomosyn and cYFP-syntaxin1A at the plasma membrane region 
was indicative of a direct bimolecular interaction, we examined the properties of 
colocalization using both acceptor photobleach and sensitized emission FRET 
approaches.  Sensitized emission FRET was performed on live chromaffin cells using a 
conventional fluorescence microscope, and was beneficial for examining FRET under 
low protein overexpression conditions.  Both FRET approaches demonstrated that CFP-
tomosyn bound directly to cYFP-syntaxin1A at the cell periphery (Figure 3.3A and 3.3D).   
Relative FRET efficiency at the plasma membrane region by acceptor photobleach 
averaged 42.9 ± 3.6% (n= 5), which was > 5 fold over that of background, as calculated 
from the non-photobleached region of the same cells (Figure 3.3B).   The averaged 
apparent FRET efficiency (EA, ED) values determined by sensitized emission (14 ± 
2.9%) were lower than those calculated by acceptor photobleach FRET.   The values 
differ as a result of the specific analysis schemes applied, particularly as the expression 
levels of the fusion protein constructs which define the degree of FRET interaction were 
not accounted for in the analysis of acceptor photobleach FRET.   Indeed, a plot of molar 
ratio (cYFP/CFP) against corresponding apparent efficiency of donor in complex ED for 
each imaged pixel of a single cell as determined by sensitized emission illustrates the 
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sensitivity of FRET efficiency to the relative expression of acceptor and donor proteins 
(Figure 3.3E).  Therefore, all subsequent comparisons between FRET values by 
sensitized emission have included only those FRET values where the molar ratio fell 
within 0.9 to 1.1 Ratio range.  
  
Requirement of SNARE/SNARE interaction for CFP-tomosyn/cYFP-syntaxin1A FRET  
The R-SNARE homology domain near the C-terminus of tomosyn is believed to 
be primarily responsible for tomosyn’s interaction with the Q-SNARE motif of syntaxin1A. 
Therefore, to define the extent to which the in vivo interaction of tomosyn with 
syntaxin1A is dependent upon formation of an R-SNARE/Q-SNARE complex, we 
measured, using FRET, the effect of specific Q-SNARE mutations of syntaxin1A on the 
interaction. Two site-directed mutants of cYFP-syntaxin1A were tested: cYFP-
syntaxin1A (I209A) and cYFP-syntaxin1A (I233A). The I209A mutation occurs within the 
SNARE motif of syntaxin1A, and it has been shown to strongly reduce syntaxin1A’s 
binding to its cognate t-SNARE, SNAP25 [53].  By comparison, the I233A mutation lies 
within the N-terminal domain of the SNARE motif that normally occupies the central 
cavity of Munc18 during syntaxin1A interaction with Munc18. Correspondingly, the 
syntaxin1A (I233A) mutant has been shown to reduce syntaxin1A/Munc18 binding in 
vitro without reduction in syntaxin1A/SNAP25 binding [54].  As shown in Figure 3.3B and 
Figure 3.3F, expression of cYFP-syntaxin1A (I209A) with CFP-tomosyn resulted in a 
significant reduction in FRET (by approximately 50%) with respect to control.  These 
results are consistent with the R-SNARE/Q-SNARE interaction being critically important 
to the tomosyn/syntaxin1A interaction.  The retention of measurable binding may be 
representative of the lowered affinity of interaction with the mutant syntaxin1A or may 
result from interacting sites beyond the SNARE motifs that may also be important for the 
tomosyn/syntaxin1A interaction in vivo.  By comparison, FRET between CFP-tomosyn 
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and cYFP-syntaxin1A (I233A) measured by sensitized emission was similar to that of 
control (Figure 3.3F).   Evaluation of the syntaxin1A (I233A)/tomosyn interaction was 
limited to sensitized emission as a result of low levels of exogenous expression of the 
cYFP-syntaxin1A (I233A) protein.  A central interaction of tomosyn with syntaxin1A is, 
therefore, similar to that of SNAP25 with syntaxin1A, which is mediated by 
SNARE/SNARE motif interactions. 
 Tomosyn and Munc18-1 have also been reported to interact with structurally 
distinct conformations of syntaxin1A.  In addition, these differences in binding 
interactions are proposed to reflect the important functional differences these proteins 
exert on the exocytotic pathway.  To determine if tomosyn and Munc18-1 compete for 
syntaxin1A within chromaffin cells, we analyzed the effect of Munc18-1 coexpression on 
CFP-tomosyn/cYFP-syntaxin1A FRET.  The results showed that Munc18-1 
overexpression reduced CFP-tomosyn binding to cYFP-syntaxin1A, as evidenced by an 
approximately 40% reduction in apparent FRET efficiency (Figure 3.3B and 3.3F).  In 
complementary experiments, overexpression of tomosyn was found to reduce the 
apparent FRET efficiency between coexpressed CFP-Munc18-1 and cYFP-syntaxin1A 
(Figure 3.3C and 3.3G), as would be expected for a competitive binding reaction.  
 
Tomosyn association with a membrane fraction is enhanced by a secretory stimulus and 
activation of Rho-GTPase 
Interaction of syntaxin1A with Munc18-1 is essential for regulated exocytosis, 
while its interaction with tomosyn is believed to negatively impact exocytotic activity 
through the formation of fusion incompetent SNARE core complexes. Therefore, a key 
question is whether the level of tomosyn-SNARE complexes is subject to dynamic 
regulation as would be required to fine-tune secretory responses.  As an initial test for 
dynamic regulation, we determined if stimulation of chromaffin cells for secretion by 
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activation of ACh receptors with DMPP induced changes in the association of 
endogenous tomosyn with the plasma membrane.  Figure 3.4 shows that the amount of 
membrane-localized tomosyn significantly increased upon treatment of the chromaffin 
cells with DMPP (30 min, 10 µM), a stimulus that normally evokes a strong secretory 
response.  In these experiments, tomosyn was immunoprecipitated from a membrane 
fraction prepared from control or DMPP-treated chromaffin cells.  In each case, cells 
were subjected to N-ethylmaleimede (NEM, 100 µM, 10 min) treatment prior to lysis to 
inhibit NSF-mediated disassembly of formed tomosyn-SNARE complexes  (100 µM NEM 
was also included in the lysis buffer).  Immunoprecipitation was required in these 
experiments as the level of tomosyn associated with the membrane fraction under 
control and secretagogue stimulation conditions represented a small fraction of total 
tomosyn within the chromaffin cell lysate.  
 We next sought to establish the signaling mechanism that mediates the increase 
in tomosyn association with the membrane in response to a secretory stimulus in 
chromaffin cells. Previous studies have established that activation of Rho-
GTPase/ROCK signaling pathways can enhance formation of tomosyn-SNARE 
complexes in cultured embryonic neurons.   Therefore, we investigated whether DMPP 
stimulation of chromaffin cells may act via the Rho-GTPase signaling pathway to alter 
tomosyn association with the plasma membrane.  As an initial experiment, we 
determined whether lysophosphatidic acid (LPA), a well-known receptor-mediated 
activator of Rho-GTPase signaling pathways in many cell types, induced measurable 
Rho activation (Rho-GTP) in chromaffin cells.  As shown in Figure 3.4B, LPA treatment 
(10 µM) resulted in a rapid increase (< 2min) in activated Rho, and remained elevated 
throughout a sustained stimulus (10 min).   In corresponding experiments, LPA 
treatment also was found to elicit a translocation of tomosyn to the membrane fraction 
with respect to control chromaffin cells (Figure 3.4A).  Additional experiments 
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determined that DMPP-stimulation (20 µM) also activated Rho-GTPase, although the 
level of activation was substantially less than that observed to LPA stimulation (Figure 
3.4B).  Of particular importance, preincubation of the cells with Y27632 (4 hours, 20 µM), 
a specific Rho-kinase (ROCK) inhibitor, completely eliminated both the DMPP and LPA 
mediated increase in tomosyn within the membrane fraction (Figure 3.4A).  These data 
suggest that enhancement of tomosyn association with the membrane in response to 
DMPP stimulation of chromaffin cells occurred via activation of the Rho-GTPase/ROCK 
signaling pathway.  
 
 Photobleaching of Freely Diffusible EGFP Fluorescence Reports DMPP- and LPA-
Induced Targeting of EGFP-Tomosyn to Cell Periphery in Live Chromaffin Cells 
The previous studies established that DMPP and LPA treatment of adrenal 
chromaffin cells promoted tomosyn association with a membrane particulate fraction 
prepared by ultracentrifugation of cell lysates.   Our expectation was that in response to 
these stimulation conditions, tomosyn translocated and localized to the plasma 
membrane prior to cell lysis through direct interactions with syntaxin1A.   However, cell 
lysis disrupts subcellular integrity, thereby precluding direct assignment of tomosyn in a 
particulate fraction to have been specifically associated with the plasma membrane.  In 
addition, syntaxin1A may form protein complexes following cell lysis, which 
compromises interpretations on physiological relevance of immunoprecipitated 
tomosyn/syntaxin1A complexes. To overcome these problems, a fluorescence 
photobleach approach was used to visualize and quantify the subcellular distribution of 
overexpressed EGFP-tomosyn in confocal images of living chromaffin cells that were 
exposed to DMPP or LPA stimulation.  As a soluble protein, the contribution of cytosolic 
EGFP-tomosyn to the fluorescent image of the cell was selectively removed by 
application of brief laser photobleaching within a discrete area in the cell’s cytoplasm.  
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The remaining EGFP fluorescence reflected EGFP-tomosyn that was diffusionally 
restricted, presumably through its specific interaction with proteins or lipids associated 
with membrane delimited organelles or the plasma membrane.  As shown in the images 
of Figure 3.5A, and the averaged TF data (Figure 3.5B), this approach was able to 
detect EGFP-tomosyn that was specifically localized to the plasma membrane region in 
response to a series of specific treatments. The results showed that expression of 
EGFP-tomosyn alone demonstrated little specific EGFP fluorescence at the membrane 
region while, by comparison, a strong EGFP-tomosyn signal was observed at the 
plasma membrane region when it was coexpressed with exogenous syntaxin1A.  The 
difference in plasma membrane localized fluorescence to these conditions indicated that 
it is EGFP-tomosyn’s interaction with syntaxin1A that brings EGFP-tomosyn to the 
plasma membrane.  Most importantly, the results demonstrated that application of 
DMPP or LPA led to a significant increase in EGFP-tomosyn membrane targeting over 
control.  Furthermore, the LPA-induced increase was inhibited by preincubation of the 
cells the Rho kinase inhibitor, Y27632 (Figure 3.5B).  
 
Kinetics of receptor-mediated change in tomosyn-syntaxin1A interaction and 
involvement of Rho/ROCK signaling pathways 
Our next goal was to use the developed sensitized emission FRET assay 
between CFP-tomosyn and cYFP-syntaxin1A together with time-lapse fluorescent 
imaging to define the kinetics of the receptor-mediated targeting of tomosyn to the 
plasma membrane and to establish that this targeting resulted in a direct interaction of 
tomosyn with syntaxin1A.  For these FRET experiments we optimized our ability to 
detect changes in the fraction of cYFP-syntaxin1A in complex with CFP-tomosyn 
(proportional to ∆EA) by transfection with a DNA ratio of cYFP-syntaxin1A to CFP-
tomosyn that resulted in a low cYFP/CFP molar ratio of protein expression (cYFP/CFP 
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ratio ~ 0.3).  As shown in Figure 3.6A, application of 20µM LPA to the CFP-
tomosyn/cYFP-syntaxin1A expressing chromaffin cells resulted in a rapid step-increase 
from the baseline FRET EA value that was sustained throughout the application period.  
Subsequent addition of NEM, while continuing LPA treatment, resulted in a marked 
further time-dependent increase in EA from baseline.  As shown in Figure 3.6B, 
preincubation of chromaffin cells for 4 hours with the Rho kinase inhibitor Y27632 (10 
µM) eliminated the effect of LPA to increase an interaction between CFP-syntaxin1A-
cYFP-tomosyn.  This was evidenced by no significant change in the EA values from 
baseline over the time frame of the recordings.  These data are consistent with LPA-
mediated activation of Rho-ROCK pathway in chromaffin cells promoting a steady-state 
increase in tomosyn-syntaxin1A SNARE complexes. In additional experiments, FRET 
measurements were also used to examine the effect of DMPP stimulation on the kinetics 
of direct interaction of CFP-tomosyn/cYFP-syntaxin1A in transfected chromaffin cells.  
As shown in Figure 3.6C, DMPP stimulation resulted in an increased interaction between 
these proteins similar to that observed with LPA stimulation, and the interaction was 
further increased upon application of NEM.  Preincubation with the Rho kinase inhibitor 
abolished the DMPP-induced increase in FRET (Figure 3.6D). The substantial increase 
in FRET from baseline by addition of NEM occurred only in LPA or DMPP stimulated 
cells (Figure 3.6E), thereby indicating that it likely resulted from an inhibition of NSF-
mediated disassembly of tomosyn-SNARE complexes and that LPA and DMPP strongly 
enhance cycling of tomosyn-SNARE complexes. 
 
Stimulus-induced secretion is modulated by Rho-mediated regulation of tomosyn.  
 In a final series of experiments we investigated whether there was a functional 
link between Rho/ROCK signaling pathways and tomosyn on regulation of evoked 
secretion. For these experiments we compared the effects of tomosyn with that of a 
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tomosyn mutant that lacks the R-SNARE motif (tomosyn ∆CT) on secretion from PC-12 
cells.  Our rationale was that if Rho/ROCK pathways augment tomosyn’s inhibitory 
action on secretion by promoting a direct tomosyn-syntaxin interaction, then these 
effects should be mitigated by a tomosyn mutant (tomosyn ∆CT) which lacks the 
syntaxin1A interacting SNARE motif.  The lack of a direct high-affinity interaction 
between the tomosyn ∆CT construct and syntaxin1A was confirmed using GST-
syntaxin1A pull-down experiments (Figure 3.7A). By comparison, considerable 
interaction was observed between GST-syntaxin1A and wild-type tomosyn. For the 
secretion experiments we used PC-12 cells cotransfected with the regulated secretory 
pathway reporter human growth hormone (hGH) to report on effects of the exogenously 
expressed tomosyn constructs on regulated secretion only from transfected cells.  As 
shown in Figure 3.7B, transfection with tomosyn or tomosyn ∆CT inhibited elevated K+-
induced secretion by approximately 25% with respect to control transfected (neo 
plasmid) PC-12 cells. Moreover, LPA, applied at the onset of the elevated K+ stimulus, 
increased the extent of secretory inhibition in tomosyn, but not tomosyn ∆CT expressing 
cells, with respect to control cells.  Importantly, the effect of LPA to increase secretory 
inhibition in tomosyn transfected cells was reversed by preincubation of the cells with the 
Rho kinase inhibitor (Y27632).    Preincubation with the Rho kinase inhibitor had no 
effect on the secretory inhibition mediated by tomosyn ∆CT.  The differences to LPA 
treatment on secretion between tomosyn and tomosyn ∆CT were unlikely to have 
resulted from differences in relative levels of expression of these constructs, as no 
significant difference in levels of expression of CFP-tagged variants of the constructs 
was observed from measurements of CFP intensity (Figure 3.7C and D).  Taken 
together, these data demonstrate that LPA exposure augments tomosyn inhibition of 
stimulus-induced secretion from PC-12 cells, and that this likely occurs as a result of 
tomosyn interaction with syntaxin1A.  That is, the ability of LPA to augment inhibition of  
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secretion was absent in the tomosyn ∆CT mutant expressing cells.      
   
Discussion 
      Recent studies suggest that tomosyn exerts regulatory control over specific 
presynaptic pathways including neurite extension and neurotransmitter release [27, 29, 
44]. Furthermore, the activity of tomosyn in these pathways has been reported to be 
fine-tuned by the phosphorylation state of tomosyn, as well as that of its immediate 
effectors (e.g., syntaxin1A) [44, 45].  We hypothesized that physiological regulation of 
these key tomosyn-protein interactions during neurosecretion might occur rapidly in 
response to receptor-mediated signals of secretory demand.  In this study, we examined 
the spatiotemporal dynamics of tomosyn’s interaction with the t-SNARE syntaxin1A, both 
in the non-secretory HEK293 cell line, as well as in neurosecretory bovine adrenal 
chromaffin cells.  Our findings establish that the tomosyn-syntaxin interaction is 
upregulated in response to secretory demand, and that under these conditions, there is 
a substantial increase in the rate of tomosyn-SNARE complex cycling (i.e., formation 
and dissolution).  Moreover, modulation of the tomosyn-syntaxin1A interaction by 
secretagogue stimulation provides for dynamic regulation of the secretory response.  
Our characterization of the tomosyn-syntaxin1A interaction in HEK293 cells 
illustrates an important difference between Munc18-1-syntaxin1A and tomosyn-
syntaxin1A heterodimer complexes.  In HEK293 cells, targeting of syntaxin1A to plasma 
membrane regions is dramatically facilitated by co-expression and direct interaction with 
Munc18-1 [50-52].  Although facilitating, the Munc18-1-syntaxin1A interaction is not, 
however, essential for syntaxin1A targeting, as has been identified in several recent 
studies [55-57]. Indeed, SNAP25, as well as other syntaxin1A interacting proteins, may 
enhance syntaxin1A membrane localization [50]. Here, we have extended those findings 
to show that, unlike the Munc18-1-syntaxin1A interaction, syntaxin1A’s interaction with 
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tomosyn does not promote the targeting of either syntaxin1A or tomosyn to plasma 
membrane regions.  Rather, coexpression of tomosyn and syntaxin1A results in 
localization of these proteins to perinuclear compartments, whereas coexpression of 
these proteins with Munc18-1 results in the targeting of syntaxin1A and tomosyn to the 
plasma membrane region.   We propose a model whereby an initial interaction of 
Munc18-1 with syntaxin1A facilitates syntaxin1A targeting to the plasma membrane; 
once syntaxin1A localizes to the plasma membrane, tomosyn can effectively compete 
with Munc18-1 to interact with syntaxin1A.  Indeed, our FRET data indicate that the 
tomosyn-syntaxin1A interaction is reduced on overexpression of Munc18-1, and 
likewise, that the Munc18-1-syntaxin1A interaction is reduced on overexpression of 
tomosyn.  The competition between Munc18-1 and tomosyn for binding to syntaxin1A at 
the plasma membrane may comprise a critical site of regulation over the location and 
extent of regulated exocytosis.     
While there is substantial evidence for the effects of tomosyn on regulating 
neurotransmitter release, to date, there has been no direct evaluation in live cells of the 
dynamics or extent to which tomosyn transits through tomosyn-SNARE complexes or of 
the extent to which tomosyn-SNARE complexes are regulated by secretory demand.   
Here, we demonstrate that treatment of adrenal chromaffin cells with DMPP (a secretory 
stimulus that activates nAChR’s) resulted in the rapid translocation of EGFP-tomosyn 
from the cytosol to the plasma membrane, as shown in our photobleach experiments.  
Moreover, the translocation of tomosyn to the plasma membrane in response to DMPP 
was associated with an increase in the bimolecular interaction between tomosyn and 
syntaxin at the plasma membrane, as established by time-lapse imaging experiments of 
FRET between CFP-tomosyn and cYFP-syntaxin1A.    The FRET signal was a relevant 
reporter of tomosyn-syntaxin1A interactions in vivo, as control experiments 
demonstrated predictable changes in FRET efficiency with site directed mutations within 
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syntaxin1A’s SNARE motif.   Interestingly, the DMPP-induced interaction between 
tomosyn and syntaxin1A was markedly increased by addition of the NSF inhibitor, NEM.  
Tomosyn-syntaxin1A interactions were not, however, increased by treatment with NEM 
in non-receptor activated chromaffin cells. As tomosyn-SNARE (i.e., tomosyn-
syntaxin1A-SNAP25) complexes, but not the heterodimeric tomosyn-syntaxin1A 
complexes, are sensitive to NSF inhibition by NEM [29], these data demonstrate that 
secretagogue receptor activation results in a rapid and substantial increase in the cycling 
of tomosyn-containing ternary SNARE complexes.  In addition, using membrane 
localization of soluble EGFP-SNAP25 c/a as a reporter of a syntaxin1A-SNAP25 
interaction we show that tomosyn can compete with Munc18-1 to promote the formation 
of EGFP-SNAP25 c/a containing SNARE complexes.   
Importantly, we determined that secretagogue-induced interaction between 
tomosyn and syntaxin1A occurs downstream of the Rho-GTPase/ROCK signaling 
pathway.  First, we demonstrated that DMPP stimulation results in activation of the Rho 
signaling pathway in chromaffin cells.  Second, treatment of chromaffin cells with LPA, a 
non-secretory stimulus that also activates the Rho pathway, was sufficient to recapitulate 
the effects of DMPP both on translocation of tomosyn to the plasma membrane region, 
as well as on the increased interaction between tomosyn and syntaxin1A.  Notably, while 
DMPP stimulation induced only a modest increase in RhoA activation relative to that 
induced by LPA, it resulted in a substantially larger change in CFP-tomosyn/cYFP-
syntaxin1A FRET.  Both the DMPP and LPA induced increases in FRET were mitigated 
by Y27632. The differences in tomosyn/syntaxin1A association likely result from the 
diversity in the extent and type of signaling pathways activated by these different stimuli, 
and suggest that additional signaling pathways may be activated by DMPP that facilitate 
the RhoA/ROCK pathway.   Taken together the data are consistent with a model 
whereby the level of tomosyn-syntaxin1A interaction rapidly responds to activation of 
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receptors mechanistically linked to RhoA and is likely mediated by signaling via 
RhoA/ROCK phosphorylation of syntaxin1A.  While certain of the experiments 
necessitated the overexpression of a fluorophore-tagged tomosyn, the effects seen in 
these overexpression studies were corroborated in a non-overexpression system, by 
biochemical assays establishing that endogenous tomosyn also translocated to 
membrane fractions in response to both DMPP and LPA and that this translocation was 
similarly blocked by Y27632.  
While a Rho signaling pathway was previously demonstrated to alter tomosyn-
SNARE interactions during neurite development in NG108 cells and cultured 
hippocampal neurons [44], it was unknown whether the Rho signaling pathway also 
modulated tomosyn-SNARE complex assembly during regulated neurotransmitter 
release.  Members of the Rho GTPase family are primary regulators of actin 
cytoskeleton organization, although they regulate a wide range of cellular processes 
including exocytosis [58-60].  A potential role for GTPases in regulated exocytosis in 
chromaffin cells was initially suggested from in vitro observations indicating their 
presence on purified chromaffin granule membranes [61-63]. Several distinct GTPases 
were found, including heterotrimeric Go protein, ARF6, Rab3 and, importantly, RhoA.  
Most of the RhoA in chromaffin cells is associated with secretory granules, and selective 
activation of the trimeric G-protein Go on chromaffin granules was found to inhibit 
priming steps of exocytosis  [64, 65].    This inhibition was significantly reduced in cells 
treated with Clostridium botulinum C3 exoenzyme, which selectively inactivates the 
small G-protein Rho [66, 67].  Activation of Go thus induces RhoA activation, which acts 
through an effector pathway to decrease vesicle priming.  While phosphatidylinositol 4-
kinase has been proposed as a RhoA effector, no direct link of it to vesicle priming has 
been demonstrated, and other mediators such as ROCK have not been tested.  Our 
data indicate that tomosyn must be considered as a target for agonist activation of the 
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Rho/ROCK signaling pathway in chromaffin cells, and that this pathway may contribute 
to the previously reported effect of RhoA-GTP to inhibit vesicle priming.     
A central and important question that remains is whether the increased cycling of 
tomosyn-SNARE complexes exerts a positive or negative role on the maintenance of 
exocytotic secretion.   Our present results indicate that the increase in tomosyn-SNARE 
cycling in response to receptor activation functions as a negative feedback system that 
ultimately limits the extent or sites of secretion.  Moreover, comparison of the wild-type 
and ∆CT tomosyn suggests that the Rho-mediated augmentation of tomosyn’s inhibitory 
effects on secretion is mediated primarily via the tomosyn-syntaxin1A interaction.  It 
should be noted that overexpression of the tomosyn ∆CT mutant resulted in secretory 
inhibition only slightly less than that of full-length tomosyn.  As tomosyn ∆CT does not 
bind syntaxin, these data suggest that the tomosyn SNARE motif, while not critical for 
tomosyn’s inhibitory effect, might be involved in activity-dependent regulation of the 
inhibition imposed by tomosyn.  Interactions of tomosyn’s R-SNARE with syntaxin1A 
could designate spatial information, while the N-terminal WD40 domains, or the 
hypervariable linker region in tomosyn could carry out the actual inhibitory function on 
exocytotic activity.  Interestingly, a prior report [26] demonstrated that overexpression of 
a tomosyn mutant with reduced syntaxin1A interaction, still resulted in secretory 
inhibition. 
The participation of the N-terminal motifs and the hypervariable domain in 
tomosyn must be considered along with the R-SNARE motif as a regulator of tomosyn’s 
protein interactions or as a scaffold for additional protein interactions important for 
tomosyn’s inhibitory function. Tomosyn’s N-terminus contains 7 to 9 repeating β-
transducin-like WD-40 motifs that comprise approximately 90% of the protein sequence 
and represent the region of highest conservation among tomosyn homologues.  
Moreover, tomosyn also contains a hypervariable region that separates the N-terminal 
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WD-40 repeats and the C-terminal SNARE domain. Serine phosphorylation by protein 
kinase A within this region has recently been reported to exert negative regulatory action 
on tomosyn-syntaxin1A interaction [45]. In addition, tomosyn homologues such as the 
lethal giant larvae family and yeast Sro7p and Sro77p and the mammalian Lgl1 (Mlgl), 
which do not possess well defined SNARE motifs [34], still interact with SNARE proteins.  
Importantly, deletion of the yeast proteins Sro7p and Sro77p results in a strong cold-
sensitive block in exocytosis [30].  
In summary, these present studies are among the first to illustrate, in real-time 
and in live cells, a physiological and dynamic modulation of tomosyn’s localization and 
interaction with syntaxin1A in response to secretagogue activation.  Moreover, they 
demonstrate the functional relevance of this modulation in enhancing tomosyn’s 
inhibitory effect on secretion.  Thus, the functions of proteins that regulate the secretory 
exocytotic pathway may themselves be regulated by secretory demand.  Further work 
remains to elucidate the structural roles of tomosyn’s N-terminal and hypervariable linker 




Figure 3.1.  Expression of fluoroprotein-tagged syntaxin1A, Munc18-1 and m-tomosyn in 
HEK293 cells and selective action of Munc18-1 to facilitate syntaxin1A targeting the 
plasma membrane.  A, representative confocal fluorescence images of cells transfected 
with cYFP-tomosyn,CFP-Munc18-1 or cYFP-syntaxin1A.  Lower right panel shows 
cYFP-syntaxin1A fluorescent signal and differential interference contrast (DIC) image 
overlay, which demonstrates localization of the majority of the fluorescent signal to a 
perinuclear region.   B, confocal fluorescence images of representative cells transfected 
with cYFP-syntaxin1A, along  with CFP-Munc18 (upper image set) or CFP-tomosyn 
(lower image set).   Right column of each image set shows overlay of cYFP-syntaxin1A 







































Figure 3.2. Interaction and surface distribution of cYFP-syntaxin1A and CFP-tomosyn 
as defined by acceptor photobleach FRET in fixed HEK293 cells.  Representative sets of 
unmixed CFP and cYFP confocal fluorescent images taken from cells cotransfected with 
CFP-tomosyn and cYFP-syntaxin1A (A) or CFP-tomosyn, cYFP-syntaxin1A and 
Munc18-1 (B).   Left and right image columns show images taken before and following, 
respectively, photobleach (at 514 nm argon laser line) of the region above the line. 
Increased post-bleach CFP intensity in photobleached region indicates FRET between 
CFP-tomosyn and cYFP-syntaxin1A.  A spectrally pseudocolored representation of CFP 
intensity (blue to red, low to high intensity) in the photobleached region is shown below 
the image sets for pre and post-bleach conditions.  In absence of Munc18 coexpression 
the bulk of fluorescent signal is restricted to perinuclear region and localized intensities 
of fluorescence in cytosol.  C, averaged FRET efficiency in bleached (black bars) and 
unbleached (grey bars) regions in cells cotransfected with CFP-tomosyn and cYFP-
syntaxin1A or CFP-tomosyn, cYFP-syntaxin1A and Munc18-1. D, comparison of EGFP-
SNAP25 C/A targeting factors in cells (co)transfected with the conditions indicated.  
Targeting factor (see methods) describes the relative proportion of EGFP-SNAP25 at 
plasma membrane region with respect to total EGFP-fluorescence of cell.  
Representative cell images for each condition pre- and post-photobleach are shown 
below graph.  Arrow on left-most image set indicates cell subjected to photobleach.  
Number of observations for the averaged data in this and all subsequent plots is 
indicated above bars. Asterisks indicate significant difference (p<0.05) from the control 



































Figure 3.3.  Interaction of CFP-tomosyn to cYFP-syntaxin1A in bovine chromaffin cells 
is sensitive to mutations in syntaxin1A SNARE motif and subject to competitive inhibition 
by Munc18-1.  A, representative set of unmixed CFP-tomosyn and cYFP-syntaxin1A 
confocal images of fixed chromaffin cells taken before and following photobleach of 
cYFP-fluorescence below the plotted line. Increased post-bleach CFP intensity in 
photobleached region indicates FRET between CFP-tomosyn and cYFP-syntaxin1A. B, 
averaged FRET efficiency measured by acceptor (cYFP) photobleach in bleached (black 
bars) and unbleached (grey bars) regions of cells transfected with CFP-tomosyn 
together with cYFP-syntaxin1A, cYFP-syntaxin1A (I209A) or cYFP-syntaxin1A + 
Munc18-1.  C,  averaged FRET efficiency between CFP-Munc18-1 and cYFP-
syntaxin1A in the absence or presence of coexpressed tomosyn.  FRET efficiency was 
determined using acceptor photobleach method.  D, representative image set comparing 
cYFP-syntaxin1A distribution (cYFP-S1A), apparent FRET efficiency (EA,ED), and molar 
ratio as detected by sensitized cYFP emission in living chromaffin cells.  Transfection 
condition, CFP-tomosyn + cYFP-syntaxin1A.   E, plot of apparent FRET efficiency (ED) 
determined by sensitized emission for all pixels of an imaged cell cotransfected with 
CFP-tomosyn and cYFP-syntaxin1A against its corresponding RATIO values.  The box 
outlined (red) indicates the RATIO interval 0.9 to 1.1 over which ED values were 
averaged for each treatment condition.    F, averaged ED for cells transfected with CFP-
Tomosyn and with coexpression of cYFP-syntaxin1A (wt), cYFP-syntaxin1A (I233A), 
cYFP-syntaxin1A (I209A), cYFP-syntaxin1A + Munc18-1. G, Averaged ED determined 
by sensitized emission FRET approach for the cells cotransfected with cYFP-syntaxin1A 








Figure 3.4.  Agonist activation of nAChR and application of LPA induce translocation of 
endogenous tomosyn to a membrane fraction in chromaffin cells and activate 
endogenous RhoA.  A, averaged level of endogenous tomosyn immunoreactivity in a 
membrane fraction of cultured chromaffin cells incubated with DMPP or LPA relative to 
that in control (C, non-stimulated) conditions.  Translocation induced by receptor 
agonists was specifically blocked by co-incubation with the Rho kinase inhibitor.  Serum 
starved chromaffin cells were treated with DMPP (30 min, 20 µm) or LPA (10 min, 10 
µm) with subsequent NEM treatment (10 min, 100 µm).  The Rho kinase inhibitor 
(Y27632, 20 µm) when included, was added to the serum starving medium 4 hours prior 
to stimulation and maintained throughout stimulation. Following  treatment, cells were 
lysed, membrane fractions were extracted by ultra-centrifugation and tomosyn 
immunoprecipitated.  Samples were then analyzed by SDS-PAGE and immunoblotting.  
Number of individual determinations comprising average shown above bars.  Panel 
above plot shows representative immunoblot.  B,  level of activated RhoA (RhoA-GTP) in 
chromaffin cells treated with LPA (10 µM, 2 min or 10 min) or DMPP (20 µM, 2 min or 10 
min) relative to control (C, non-stimulated, 10 min) conditions.   Data shown is the 














Figure 3.5. Monitoring targeting of EGFP-tomosyn to cell periphery in live chromaffin 
cells by photobleach of diffusible EGFP fluorescence.  A, confocal images of EGFP 
fluorescence in serum starved chromaffin cells transfected with EGFP-tomosyn or 
cotransfected with EGFP-tomosyn and syntaxin1A.  Images were taken before (left 
column) and after (right column) photobleach (using 488 nm line of Argon laser) of a 
square region in the cytosol with area of about a third of the total area of the cell’s 
image.   Treatments include stimulation with DMPP (30 min, 20 µm) or LPA (10 min, 10 
µm), each followed by NEM treatment (10 min, 100 µm) as indicated.  For Rho kinase 
inhibitor experiments, cells were preincubated for 4 hours with 20 µm Y27632, which 
was maintained throughout the stimulation period. The ring of EGFP fluorescence in the 
post-bleach images indicates the presence of the membrane-bound tomosyn.   B, 
averaged membrane targeting factors of EGFP-tomosyn (see Methods section) for 





















Figure 3.6.  Time-lapse imaging of receptor-mediated changes in tomosyn-syntaxin1A 
interactions using dynamic FRET measurements in living chromaffin cells.  Chromaffin 
cells were transfected with CFP-tomosyn and cYFP-syntaxin1A and imaged for FRET 
using the sensitized emission method.  Images were analyzed offline using FRET 
stoichiometry calculations to determine EA (apparent efficiency of acceptor in complex) 
[48].  A, changes in the apparent FRET efficiency parameter EA in response to 
application of LPA, followed by LPA +NEM relative to the control period are plotted as a 
function of time. B, time-dependent changes in EA for cells preincubated with the Rho 
kinase inhibitor (Y27632, 10 µM) for 4 hours prior to exposure to LPA and then LPA + 
NEM for the intervals indicated above the plot. C, time-dependent effect of DMPP 
followed by DMPP + NEM on EA relative to the control period.   D, preincubation with 
Y27632 (10 µM, 4 hrs) strongly inhibits DMPP-induced changes in FRET (EA).  E, effect 
of NEM treatment alone on EA.  For all treatments: Time-dependent changes in EA were 
determined relative to the averaged EA values for the initial 6 min period in PSS (or 
PSS+Y27632); LPA was 10 uM, DMPP 20 µM, NEM 100 µM and Y27632 20 µM.  Data 
for each time point represent the average of measurements on A, 14; B, 4; C, 4; D, 3; E, 





Figure 3.7.  Effect of tomosyn translocation induced by LPA treatment on evoked hGH 
secretion from PC-12 cells.  A, GST-syntaxin pull down assay of EGFP-fused tomosyn 
(upper panel) or EGFP-tomosyn ∆CT (lower panel).  Lysates from PC-12 cells 
expressing EGFP-tomosyn or EGFP-tomosyn ∆CT were bound to GST  or GST-
syntaxin1A containing beads.  Bound proteins were analyzed by SDS-PAGE and 
immunoblotted with anti-EGFP antibody.  B, PC-12 cells were transfected with control 
empty plasmid (C, encodes only neomycin resistance), tomosyn (T), or a tomosyn 
construct (∆CT) in which the SNARE motif at the C-terminus was deleted.  Following two 
days expression, secretion was induced by application of elevated K+ saline alone (left 
set of bars), with co-application of LPA (10 uM, middle set of bars) or in cells 
preincubated with Y27632 (4 hrs) prior to co-application of elevated K+ saline and LPA.  
In each case the stimulus period lasted 10 min after which the media was collected for 
analysis of secreted hGH and cell lysates were prepared for determination of total cell 
hGH content.  For each experiment hGH secretion was calculated as a percent of the 
total cell content using quadruplicate samples and then normalized to the control 
condition of each treatment.   C,  Averaged ECFP fluorescent intensity in tomosyn and 
tomosyn ∆CT  transfected PC-12 cells (± SEM, N=184 and 207 cells for tomosyn and 
tomosyn ∆CT respectively). Cells were imaged 48 hours post-transfection and images of 
at least 50 random fields of cells were taken for each condition.  D, Frequency 
distribution of spatially averaged ECFP intensity values for tomosyn (upper) and 
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Theory and Application of Sensitized Emission TIRF-FRET in Living Cells 
 
Abstract 
 Biological processes are inherently rife with spatially and temporally regulated 
sequences of molecular interactions that must occur in order for cells to function 
properly.  Unraveling each of these sequences in a functionally meaningful manner will 
undoubtedly shed new light onto our understanding of how these processes occur.   To 
achieve the high temporal and spatial resolution required to visualize such sequences of 
interactions in living cells, we have implemented sensitized emission FRET 
(fluorescence resonance energy transfer) measurements using TIRF (total internal 
reflection fluorescence) microscopy.  Importantly, sensitized emission FRET 
measurements allow for highly-sensitive visualization of bi-molecular interactions as they 
occur in real-time, while TIRF microscopy allows for the high spatial resolution of 
individual organelles closely apposed to the plasma membrane.  A combination of these 
approaches would allow for changes in bi-molecular interactions to be directly correlated 
with the functional state of an organelle.  Here, we have taken both an experimental and 
a theoretical approach to gain a quantitative understanding of the effects of evanescent 
illumination on sensitized-emission FRET calibrations and measurements, under a 
variety of conditions (ie, for multiple sub-cellular localizations of the molecules of 
interest).  Importantly, our results define several parameters that are critical to the 




 One of the major goals of biology is to be able to understand, in exact molecular 
detail, the dynamic and regulated processes that occur within cells to drive the many 
functions essential for life.  Inherent in all of these processes are the dynamic and 
regulated associations and dissociations of a plethora of molecular binding partners, eg, 
proteins, lipids, nucleic acids, and small chemical metabolites.  For many biological 
processes, biochemical and genetic techniques, coupled with assays to gauge biological 
function, have allowed for identification of key molecules and interactions that regulate 
each of these processes.    However, in most cases, what remains lacking is an integral 
understanding of how all of these molecular interactions come together, both in 
subcellular space and time, to carry out these important cellular functions.   
 FRET (fluorescence resonance energy transfer) imaging has rapidly become a 
common tool to study protein-protein interactions in living cells (for recent reviews, see 
[1, 2]).  One of the key advantages of FRET imaging lies in its flexibility in being able to 
monitor not only protein-protein interactions, but also a wide range of cellular 
parameters, including (and certainly not limited to) protein activation states [3, 4], 
enzymatic activity [5], and even concentrations of small metabolites [6, 7].   FRET occurs 
when an excited-state donor fluorophore comes within close enough proximity (<10nm) 
to an acceptor fluorophore to transfer resonant energy to the acceptor.  When this 
occurs, the donor decays back to the ground state nonradiatively (ie, without emission of 
a photon), and the acceptor fluorophore is raised from the ground state to the excited 
state.   FRET can therefore be observed as a simultaneous quenching of donor 
fluorescence, and enhancement of the acceptor fluorescence (termed sensitized 
emission).   Several methods have been employed to detect FRET in living cells, the 
most common of which are donor dequenching and sensitized emission.  In donor 
dequenching, the acceptor fluorophore is rapidly destroyed by photobleaching, thus 
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precluding FRET from occurring.  FRET that was present before photodestruction of the 
acceptor is detected as an increase (ie, dequenching) in donor fluorescence following 
photodestruction of the acceptor.   While donor dequenching is the simplest method by 
which to detect FRET and can be performed on a confocal microscope to achieve high 
spatial resolution, photodestruction of the acceptor complicates, and often precludes, the 
use of donor dequenching for time-lapse FRET imaging.   Another commonly used 
method to detect FRET is sensitized emission, which quantifies the enhancement in 
acceptor fluorescence that occurs as a result of FRET.  Measurement of sensitized 
emission FRET is more complex in that it requires the user to perform specific 
calibrations for the optical system and probes being used, to be able to isolate the 
sensitized emission signal from other spectral contaminants, and to normalize this signal 
to correct for variations in donor and acceptor concentrations between cells.  FRET by 
sensitized emission, however, is fast, can be performed on an epifluorescence 
microscope, and most importantly, can be used to track spatial changes in FRET that 
occur over time, for example, to monitor changes in a protein-protein interaction that 
occur in response to a stimulus.  Despite the high temporal resolution afforded by 
sensitized emission FRET imaging performed under an epifluorescence microscope, the 
approach is limited by poor axial resolution due to fluorescence from out-of-focus planes. 
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  More recently, TIRF (total internal reflection fluorescence) microscopy has been 
applied to study processes occurring at or near the cell membrane, with unprecedented 
axial resolution (for review, see [8-11]).  TIR results when light traveling through a 
medium of high refractive index, n1 (such as glass) reaches an interface with a medium 
of lower refractive index, n2 (such as water), at an angle of incidence that exceeds a 
critical angle,   sin / .   When this occurs, the light undergoes total internal 
reflection, and an evanescent field is generated at the glass-water interface, whose 
intensity decays exponentially with distance from the interface:      /  (where z 
is the distance from the glass-water interface, and D is the characteristic TIRF depth, 
i.e., the distance at which the evanescent field decays to 37% of its initial value).  To 
achieve high axial resolution, TIRF microscopy takes advantage of this exponentially 
decaying evanescent wave, to illuminate a thin (roughly 100-300nm thick) ‘footprint’ of a 
cell, that includes only those regions of the cell that are closely apposed to the glass 
coverslip.    Importantly, combination of the axial resolution afforded by TIRF imaging, 
with the sensitivity and high temporal resolution afforded by sensitized emission FRET 
imaging, could provide a powerful tool to be able to sequence the dynamics of molecular 
interactions occurring near the plasma membrane, and to spatially and temporally 
correlate these interactions to functional consequences.   
 Thus far, TIRF-FRET has only recently begun to be implemented.  Most of the 
TIRF-FRET studies in living cells utilize the donor dequenching FRET method to 
examine proteins that localize specifically to the plasma membrane [12-15].  While 
sensitized emission TIRF-FRET has also been used, this method has been applied 
mainly to the study of in vitro interactions of single molecules adherent to glass 
coverslips [16, 17], and to limited situations in living cells, where a plasma-membrane 
protein is labeled with both donor and acceptor molecules [18].    This paper represents 
a first step in being able to implement sensitized emission TIRF-FRET under a variety of 
conditions in living cells.  Parameters critical to the approach are defined experimentally 
and matched with theoretical predictions tested by mathematical models.  The results 
provide guidelines regarding quantitative application of this method for cell biology.   
Importantly, the methods described here can be applied to proteins localized not only to 
the plasma membrane, but also to intracellular compartments (e.g., secretory granules, 





Materials and Methods 
Cell culture and transfection 
MIN6 cells were cultured in 5% CO2, in DMEM containing 4.5g/L glucose and glutamine 
(Gibco, Carlsbad, CA), supplemented with 15% fetal bovine serum, penicillin (50U/mL), 
streptomycin (50µg/mL), and 0. 0005% β-mercaptoethanol.   MIN6 cells were 
transfected using Lipofectamine 2000 (Invitrogen), according to the manufacturer’s 
protocol.   For TIRF experiments, MIN6 cells were plated onto poly-L-lysine coated #1.5 
thickness coverslips 36-48 hours prior to use, and transfected 16-18 hours before 
imaging.   Immediately prior to imaging, cells were switched from culture media to a 
physiological saline solution (PSS:  137mM NaCl, 3.4mM KCl, 1.6mM KH2PO4, 1.2mM 
MgSO4, 2mM CaCl2, 4.8mM NaHCO3, 10mM HEPES, 2.5mM glucose, pH 7.4).    
 
Molecular biology and generation of recombinant DNA constructs 
All fluorescent constructs utilized the monomeric versions of the fluoroproteins cerulean 
(a cyan fluorescent protein mutant that exhibits a higher extinction coefficient and higher 
quantum yield) [19] and citrine (a yellow fluorescent protein derivative that exhibits 
reduced pH sensitivity and longer Forster distance) [20, 21].  A linked citrine-cerulean 
construct was generated by ligating sequence coding for cerulean onto the C-terminal 
end of citrine, with a 15 amino acid linker (linker sequence:  SGLRSRDPLALPVAT) in 
between the two fluoroproteins.    To generate a plasma membrane targeted linked 
FRET construct, the PH domain of PLC delta was PCR subcloned from a YFP-PH 
construct (a gift from Kees Jalink, Netherlands Cancer Institute) and ligated onto the C-
terminal end of the linked citrine-cerulean sequence (with a flexible 11 amino acid linker  
(linker sequence: SGFSGGSGGSG) between the cerulean and the PH domain).    To 
target the linked FRET probe to secretory granule compartments, a citrine-cerulean-
VAMP2 construct was made by PCR subcloning the VAMP2 domain from 
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synaptopHluorin [22] and ligating it to the C-terminal end of the linked citrine-cerulean 
sequence with the same 11 amino acid linker.   The single fluorophore-labeled citrine-
PH, cerulean-PH, citrine-VAMP2, and cerulean-VAMP2 constructs were generated from 
the citrine-cerulean-PH domain or –VAMP2 constructs, via restriction digests and 
ligations that removed either the citrine or cerulean coding regions from each construct.   
The sequence fidelity of all constructs was confirmed by DNA sequencing (University of 
Michigan DNA Sequencing Core). 
 
Optical Rig Setup 
A through-the-objective TIRF system (TILL Photonics, Germany) was built around an 
Olympus IX71 microscope and utilizes an Olympus 60x 1.49NA oil objective mounted on 
a PIFOC nanofocus z-drive controller (Physik Instrumente, Germany).    For illumination, 
two lasers, a 45mW 442nm solid state DPSS (Toptica Photonics, Germany) and a 
225mW Argon-ion laser (National Laser Company, Salt Lake City, UT) were combined 
into an AOTF (accousto-optic tunable filter) to allow for rapid selection of laser lines and 
powers.   The output of the AOTF was coupled via a unimodal fiber optic into a TILL 
Photonics Polytrope unit fixed onto the back port of the microscope.   Within the 
Polytrope, the light first undergoes a beam expansion before being reflected into the 
microscope body by a mirror.   The angle of this mirror is adjustable via a galvanometer 
and sets the position of the laser beam in the back focal plane of the objective, thereby 
allowing fine and rapid control over the incident TIRF angle, as well as the ability to 
rapidly switch between epifluorescence and TIRF illumination modes.  Between the 
mirror and the microscope objective is an additional achromatic tube lens, which focuses 
the laser on the back focal plane of the objective.   The microscope’s filter cube 
assembly contains a dual band laser clean-up filter (z442/514dbx) and a dual band laser 
polychroic mirror (z442/514rdc).    Fluorescence emission from CFP/cerulean and citrine 
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are separated using a Dual-View beam splitter (MAG Biosystems, Pleasanton, CA) 
containing a 505dcxr dichroic, and emission filters appropriate for CFP/cerulean 
(et480/40) and citrine (et555/55).   (All filters were from Chroma Technologies, 
Rockingham, VT).  Images are acquired using a 16-bit, 512x512 pixel Photometrics 
QuantEM 512SC EMCCD camera (Roper Scientific, Tucson, AZ) with a 16x16 µm pixel 
size.  To achieve Nyquist sampling (with a limiting resolution of 200nm, sampled over 3 
pixels), additional magnification from the 1.6x slide magnifier on the IX71 and a 2.5x 
beam expander placed in front of the DualView are employed.    The laser lines, laser 
powers, TIRF angle, z-focus drive, and camera were controlled using Metamorph 
software (Molecular Devices, Sunnyvale, CA). 
 
TIRF FRET Imaging 
The 442nm DPSS and the 514nm line from the Ag-Ion laser were used for TIRF-FRET 
imaging.  Laser powers for each laser line were kept constant for all experiments.   At 
the beginning of each experiment, the Polytrope was aligned such that when the 
galvanometer position was set for epifluorescence imaging, the laser beam was directed 
straight overhead, through the center of the objective.   Variations in this epifluorescence 
position resulting from wobble of the Olympus filter wheel turret were initially corrected 
by torsional stabilization of the filter wheel assembly.   However, throughout the course 
of each experiment, the calibrated epifluorescence position was often checked and small 
readjustments to re-calibrate this position were made when necessary.    Prior to each 
imaging experiment, the accuracy and repeatability of the Polytrope unit in switching 
between various galvanometer positions was confirmed by projecting the laser beam 
onto a wall using a 45-45-90 right angle prism (n=1.515) (Edmund Scientific, 
Tonawanda, NY) and verifying that the laser beam accurately returned to the same 
position on the wall for each different galvanometer setting.   Sensitized-emission TIRF-
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FRET imaging was carried out similarly to methods described in our previous 
publications using FRET imaging under epifluorescence illumination ([23, 24]).  Except 
when stated otherwise, the incident TIRF angles were adjusted independently for the 
442nm and 514nm lines, such that the characteristic TIRF depths (determined using 
fluorescently labeled silica beads; see methods below) of both laser lines were matched.  
For each FRET image, three different excitation/emission images were taken:    1) DD:  
donor excitation (442nm) / donor emission (480nm);   2) DA:  donor excitation (442nm) / 
acceptor emission (555nm); and 3) AA:  acceptor excitation (514nm) / acceptor emission 
(555nm).    The electron multiplication gain and digital gain of the camera were set the 
same for all 3 images (DD, DA, AA), although exposure times of the 3 images were 
individually set to achieve appropriate intensity levels.  Fluorescence intensity was 
determined to be linear to exposure time, allowing for correction.  Images to determine 
FRET stoichiometry calibration constants (taken either of beads conjugated with, or cells 
expressing CFP or cerulean only, citrine only, or a linked CFP-citrine or citrine-cerulean 
protein) were collected for each experiment, using the same incident TIRF angles and 
laser powers used for collection of experimental data.  Shade correction images were 
also collected at the same incident TIRF angles, by imaging glass coverslips conjugated 
with both CFP and citrine proteins and overlaid with PSS (see methods below), in order 
to correct for non-uniformities within the illumination fields for the 442nm and 514nm 
lines.  All imaging was performed at room temperature.   
 
FRET Image Analysis 
TIRF-FRET images were analyzed offline using in-house written MATLAB scripts.   
Following alignment of images using an affine transformation, images were background 
subtracted using the averaged value within a user-defined background region of interest.  
Images were then shade-corrected by dividing each image (on a pixel-by-pixel basis) by 
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the appropriate normalized shade image (each shade image was normalized to its 
median value).    Lastly, images were linearly scaled to account for differences in 
exposure times between images.   These corrected images (CIDD for acquired DD, 
CIDA for DA, and CIAA for AA) were then used for FRET analysis.    
Sensitized emission FRET analysis was carried out using the method of FRET 
stoichiometry [21, 25].  This method requires the determination of 4 calibration 
parameters:  α, β, γ, and ξ.   α and β are proportionality constants that allow for 
correction of the contaminated FRET signal (CIDA) from both crosstalk (ie, direct 
excitation of the acceptor by donor excitation wavelengths) and spectral bleedthrough 
(ie, spillover of donor emission into the acceptor emission channel), respectively.   α was 
determined by taking images of citrine expressing cells or beads conjugated with citrine, 
and calculating the ratio of the CIDA /CIAA images.  β was determined by taking images 
of either cells expressing cerulean, or beads conjugated with CFP, and calculating the 
ratio of the CIDA / CIDD images.  Following determination of α and β, the 
uncontaminated sensitized emission FRET signal can be calculated as:  CIDA – α*CIAA 
– β*CIDD.    The parameter γ represents the ratio of extinction coefficients of acceptor to 
donor, at donor excitation wavelengths, and is required for determination of the fraction 
of acceptor in complex (fA).   The parameter ξ relates the fluorescence intensity of the 
sensitized emission signal to the fluorescence intensity that would have arisen from the 
quenched donor (ie, the donor fluorescence lost due to FRET).  Using ξ, the donor 
fluorescence quenched by FRET can be calculated as:  ξ* (CIDA – α*CIAA – β*CIDD).    
Determination of ξ is necessary for calculation of the fraction of donor in complex (fD), 
and subsequently, for determination of the total donor fluorescence and molar ratio.   
Both γ and ξ are determined by imaging either cells expressing a linked citrine-cerulean 
protein, or beads conjugated with linked CFP-citrine protein, and solving the FRET 
equations (see below) for either  γ or ξ, using the fact that for a linked construct, fA = fD 
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= 1.  Note that determination of γ and ξ requires that the characteristic efficiency (Ec) of 
the linked constructs used for the calibration be pre-determined.   The Ec for the CFP-
citrine construct was previously reported using fluorescence lifetime measurements to 
be 0.40 in solution (pH 7.2) [21].  The Ec for the citrine-cerulean construct was 
determined to be ~0.39 in cells, by calculating the FRET value of this construct using 
calibration parameters determined based on a cerulean-citrine construct whose Ec had 
been determined using lifetime measurements to be 0.31 (A. Hoppe, University of 
Michigan, written communication).      
Determination of the 4 calibration constants α, β, γ, and ξ, and collection of the 3 
required images (CIDD, CIDA, and CIAA) allows for pixel-by-pixel calculations that 
generate 3 new images:  EA (the apparent FRET efficiency of the acceptor), ED (the 
apparent FRET efficiency of the donor), and Ratio (the molar ratio of total acceptor : total 
donor).  EA, ED, and Ratio images were calculated using the following equations: 
 
             Uγ  CIDA – α CIAA – β CIDD
α CIAA
      (1) 
             Uξ  CIDA – α CIAA – β CIDD
CIDD   ξ  α CIAA – β CIDD  CIDA –
     (2) 
      Uξ
γ
    Uα CIAA
CIDD   ξ  CIDA – α CIAA – β CIDD
      (3) 
 
FRET analysis on granules 
FRET analysis of secretory granules labeled by expression of the linked citrine-cerulean-
VAMP2 probe was carried out following alignment of images using an affine 
transformation, and correction of these images for background, shade, and exposure 
time.   Granule detection was performed on CIDA images.  These images were 
converted to binary images using a threshold cut-off of ~6-8x the mean value of the 
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image; this threshold was determined on an image-by-image basis, and was guided by 
visual inspection of how well granules were detected at a specific threshold.  Centroid 
coordinates of each granule were then determined from the binary image, and were 
subsequently used as markers of granule position.  Each individual granule detected 
was visually inspected at its centroid coordinates in all three CIDD, CIDA and CIAA 
images to ensure that:  1) a granule-like fluorescence distribution was present at those 
coordinates for all 3 images; and 2) the granule had not moved noticeably in the x-y 
direction between images.  Only granules that met these criteria and that exceeded a set 
minimum intensity threshold in all three images were used for subsequent analysis.  (For 
cells that co-expressed soluble fluorophore, these criteria did not fully apply, as granules 
were often quite difficult to detect in the CIDD or CIAA images, due to the high 
background of the soluble fluorophore.  However, this did not appear to affect granule 
detection from the CIDA image).  For FRET analyses, mean granule intensities in a 13-
pixel diamond centered on the centroid coordinates of each granule were determined for 
CIDD, CIDA, and CIAA images.  These three mean intensity values for each granule 
were then used in determination of FRET calibration constants or the FRET values for 
EA, ED, and Ratio, using the above equations.   
 
Purification of Bacterially Expressed Proteins  
E. coli (strain BL21 DE3) expressing His-citrine or His-CFP, and E. coli (strain JM109) 
 expressing His-citrine-CFP were a kind gift from Joel Swanson (University of Michigan).   
Cells were grown to an OD of 0.4-0.6, induced with 0.1mM IPTG, grown for an additional 
7 hours at 30C, and pelleted by centrifugation (15 minutes, 5000g, Beckman JA-14 
rotor).   Following centrifugation, cells were resuspended in an equilibration buffer 
(50mM Na2HPO4, 300mM NaCl, 0.5% Triton X-100, pH 7.0, supplemented with protease 
inhibitors (G-Biosciences, St. Louis, MO)), and were mechanically lysed using a French 
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press at 15000psi.  Cell lysates were solubilized by shaking on ice for 1 hour, followed 
by centrifugation to remove insoluble debris (20 minutes, 20,000g, Beckman JA-20 
rotor).  His-tagged proteins were purified from the cell lysates using TALON metal affinity 
resin beads (Clontech, Mountain View, CA) according to the manufacturer’s protocol.   
Following binding of His-tagged proteins to the TALON beads, the beads were rinsed 
several times in wash buffer (50mM Na2HPO4, 300mM NaCl, pH 7.0, supplemented with 
5mM imidazole), and His-tagged proteins were eluted from the beads using wash buffer 
supplemented with 150mM imidazole.  The purity of each protein was determined by 
fractionation by SDS-PAGE and Coomassie staining and was estimated to be ~90%.   
Prior to use in conjugation reactions (see methods below), proteins were dialyzed into a 
coupling buffer. 
 
Conjugation of fluoroproteins to silica beads / coverslips 
Fluoroproteins were conjugated to either 10µm silica beads (Discovery Scientific, 
Vancouver, Canada) or to glass coverslips (1.5 thickness, Warner Instruments, Hamden, 
CT).     For conjugation of fluoroprotein to the silica surfaces, beads or coverslips were 
first amino-silylated for 30 seconds in a 2% solution of 3-aminopropyltriethoxysilane 
(Pierce Biotechnology, Rockford, IL) in acetone, followed by a thorough rinsing with 
acetone.   Fluoroproteins were then crosslinked to this surface using a Sulfo-LC-SPDP 
cross-linker (Pierce) as follows.  Proteins were first passed through a 0.22µm syringe 
filter to remove insoluble debris, and then equilibrated into coupling buffer (50mM 
Na2HPO4, 150mM NaCl, 10mM EDTA, 0.02% NaN3, pH 7.2) by overnight dialysis at 4C 
using 3.5K Slide-a-Lyzer cassettes (Pierce).  Equilibrated protein was then diluted to a 
concentration of ~ 0.6mg/mL in coupling buffer for the crosslinking reaction.   Sulfo-LC-
SPDP crosslinker was added to each protein solution to a final concentration of 1mM, 
and the reaction was allowed to proceed in the dark at room temperature for 30-60 
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minutes.   Following this reaction, free crosslinker was removed from the protein solution 
by dialysis into coupling buffer for 12 hours at 4C using 3.5K Slide-a-Lyzer cassettes.  
The glass surfaces were separately modified with the Sulfo-LC-SPDP crosslinker, by 
covering the surfaces in a solution of 1mM Sulfo-LC-SPDP in coupling buffer for 30-60 
minutes at room temperature.   The modified glass surfaces were then rinsed in coupling 
buffer, and the bound crosslinker was reduced by treatment with 50mM DTT in coupling 
buffer for 30 minutes at room temperature, followed by several rinses in coupling buffer.   
The Sulfo-LC-SPDP modified protein solutions were then added to the modified and 
reduced glass surfaces, and the crosslinking reaction was allowed to proceed in the dark 
for 18 hours at 4C, with shaking.    The protein-modified glass surfaces were rinsed in 
coupling buffer and stored at 4C (in coupling buffer) prior to use.   Visual inspection of 
the surfaces under fluorescence microscopy demonstrated that the fluoroprotein-
modification of the surfaces was largely uniform across the surfaces.   
 
Measurement of evanescent field profile using fluorescently-labeled silica beads 
Measurement of the evanescent profile using large, fluorescently labeled silica beads 
was carried out using methods similar to those previously described [26].   In brief, 10µm 
silica beads coated with bacterially expressed fluoroprotein (either CFP, citrine, or a 
linked CFP-citrine), were imaged in a solution of PBS-EDTA (50mM Na2HPO4, 150mM 
NaCl, 10mM EDTA, 0.02% NaN3, pH 7.2) containing 31% glycerol (w/w), to achieve an 
index of refraction (n ~ 1.372, confirmed by refractometer measurement) similar to that 
of the beads (n= 1.37, as reported by the manufacturer).    The beads were allowed to 
settle on to the glass coverslip, and images of the TIRF footprints of the beads were 
taken using a range of incident TIRF angles.  As bead size and shape varied quite 
substantially, only beads that were ~10µm in diameter (approximated using a reticle 
micrometer) and that appeared to be spherical were chosen for imaging.  All beads were 
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imaged at approximately the same location in the TIRF field.   Multiple consecutive 
images of beads taken at a single incident TIRF angle demonstrated that there occurs a 
rapid and non-uniform photobleaching of the fluorescent signal on the beads, with the 
bottom of the bead (ie, center of the TIRF footprint) exhibiting the fastest photobleach 
rate.   Therefore, to ensure that the evanescent profile measured from each bead was 
accurate, each bead was used for only two TIRF measurements.  Moreover, focusing of 
each bead was performed under dim epifluorescence illumination, with the focus initially 
set to the equatorial plane of the bead.   The z-focus drive was then used to 
automatically move the focal position to the surface of the glass (which was set to one 
bead radius (5µm), below the equatorial plane of the bead) for acquisition of the TIRF 
images.  Bead footprint images that exhibited bright debris or that were distinctly non-
circular were discarded from analysis.   
Determination of the evanescent profile from the TIRF images of the beads was 
automated using MATLAB scripts and the equations described in [26].   Images were 
background subtracted and a binary image of each bead was then generated and used 
to determine the centroid position of the bead.  To better approximate the true center of 
the bead, the centroid coordinates were used to seed a 2D-Gaussian fit of the bead, and 
the determined center of each bead was visually inspected for accuracy.   Pixels were 
then binned according to their radial distance (rounded to the nearest pixel) from the 
center coordinates of the bead (up to a radial distance of 75 pixels, or approximately 
5µm).   The averaged intensities of all pixels within each radial distance bin were then 
determined.   These averaged intensities were then corrected for differences in the 
amount of bead surface area projected onto a pixel at that particular radial distance, 
using the equation: 
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        cos sin      
 
      (4) 
Conversion of radial distance to z-distance was performed on a bead-by-bead basis, 
using bead radius values that were determined from epifluorescence images taken of 
each bead.  Using the geometry of a sphere, the conversion of radial distance to z-
distance was performed by solving the following equation for z:    
              (5) 
Finally, the corrected intensity vs z-distance relationship for each bead image was 
plotted and fit to a double exponential,  which was shown by Mattheyses and Axelrod 
 more tely than a single exponential. (2006) to fit these data far accura
  ⁄   ⁄       (6) 
Here, the decay rate of the fast exponential component corresponds to the characteristic 
TIRF depth at a particular incident angle, whereas the slow exponential component is 
assumed to result from light scatter originating within the objective.   
Relationships of FRET calibration constants and FRET measurements vs. z-
distance were calculated from the bead images, using the FRET stoichiometry equations 
(see FRET methods section) with the corrected intensity vs z-distance relationships for 
the CIDD, CIDA, and CIAA images of each bead.   For experiments in which soluble 
citrine was added to the imaging media, the glass coverslip was pre-blocked with a 
1mg/mL solution of BSA prior to use, to prevent non-specific binding of the soluble 
fluoroprotein to the coverslip. 
 
Determination of evanescent field depth using a prism 
An alternative method for estimating the characteristic TIRF depths involved measuring 
the angle of incidence of the laser as it exits the objective, for each galvanometer 
setting.  This was done by placing a 45-45-90o glass prism (n=1.515) (Edmund 
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Scientific, Tonawanda, NY) on top of the objective (with immersion oil), to couple the 
laser light coming out of the objective and project it onto a nearby wall.   Use of Snell’s 
Law of refraction allowed determination of the angle of incidence of the laser, θi, as it 
exits the objective.   This angle, in conjunction with the wavelength of the laser (λ) and 
the indices of refraction of glass (n1) and the cell or imaging media normally used (n2) 
a the characteristic depth, Dp: could then used to estim te 
  ,  
  /
     (7) 
  
Mathematical Simulation of TIRF-FRET 
To compare our TIRF-FRET results to theoretical expectations based on illumination 
from an exponentially decaying evanescent field, we developed a mathematical model to 
simulate TIRF-FRET.   The model used was similar to that described in [21], with the 
primary exception being that the illumination intensity, rather than being modeled as 
constant (as would be the case for epifluorescence) was modeled as following a double 
exponential decay in the z-axis. (The two exponentials represent the evanescent field 
component and a scatter component; see methods on using beads to determine 
evanescent profile).  The relative contributions of the evanescent field and the scatter 
component were fixed at 85% and 15%, respectively, and the scatter component was 
fixed as decaying with a depth constant of 1500nm. (These values were chosen to 
hose  measured on our system, using fluorescent silica beads): approximate t  typically
 0.85 ⁄  0.15 ⁄        (8) 
Beads and granules were modeled as spheres with diameters of 10µm or 350nm, 
respectively.   To simulate a linked FRET probe that localizes to the surface of the 
bead/granule, we arbitrarily set the surface concentration (# of molecules per unit area) 
for both the acceptor and donor equal to 1000.    The fraction of donor in complex (fD) 
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was set to 1, and the FRET efficiency (E) for the donor and acceptor was set to 0.4 (the 
characteristic efficiency of CFP-citrine in solution).  In some cases, a population of free, 
soluble acceptor molecules was added to this model.  Here, the concentration (# 
molecules per unit volume) was set such that the ratio of the calculated fluorescence 
intensity from the bottom of the bead, to the calculated fluorescence intensity of the 
soluble component outside of the bead, matched the ratio value determined 
experimentally (ie, the ratio of the fluorescence intensity at the center of the bead 
footprint, to the fluorescent intensity of the soluble fluorophore in a region clearly outside 
the bead region, in the CIAA image).   
Fluorescence intensities arising from the bead/granule surfaces and from soluble 
components were determined independently.   For fluorescence arising from the surface 
ule AA, and the sensitized emission FRET signal were modeled as:   of a bead/gran , DD, 
, , ,
 (9)            
, ,   (10) ,         
, , ,   Uα
γ
                (11) 
The coordinate system used here (x, y, z1, z2) depicts the distances of the bottom 
and top surfaces of the bead/granule from the glass interface (z1 and z2, respectively) for 
a given (x,y) position on the bead/granule.   P1 and P2 represent the initial intensities (Io) 
of the donor and acceptor illuminations, respectively, at the glass-water interface (eg, z = 
0).  For completeness, fluorescence from both the bottom and top surfaces of the bead 
at each (x,y) point are taken into account; however, for a 10µm bead, the fluorescent 
arising from the top surface of the bead was negligible due to the large size of the bead.     
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Fluorescence intensity arising from the soluble acceptor was determined for each (x, y, 
z1, z2) point, as separate components arising from below the bottom surface of the 
d/gra n bove the top surface of the bead/granule: bea nule, a d a
, , ,  
=      ∞                 (12)  
In this model, the total DD and FRET fluorescence originated from the surface of the 
bead, whereas the total AA fluorescence signal at each (x,y) point was calculated as the 
sum of AAsurface and AAsoluble at each (x,y) position. 
The fluorescence intensities determined above were then used in conjunction 
with the FRET stoichiometry equations to calculate the expected values of EA, ED, and 
Ratio.  The FRET calibration constants used for these calculations were taken from the 
averaged values of the constants over the first 525nm in z, measured from experiments 
that best approximated the situation being modeled (eg, same characteristic TIRF 
depth).   Note that in order to use the experimentally determined FRET calibration 
parameters in this model, P2 was held constant at the arbitrary value of 100, and ratio of 
P1 to P2 was adjusted for each set of constants used, such that EA, ED, and Ratio 
reported the expected theoretical FRET values (EA = ED = 0.4;  Ratio = 1) when only 
bead/granule surface fluorescence (ie, no soluble fluorophore) was taken into account. 
 
Results 
Determination of evanescent field profiles for 442nm and 514nm laser lines 
 Initial characterization of the TIRF-FRET system involved measurement of the 
evanescent field profiles that resulted from a range of incident TIRF angles (using 
different galvanometer settings) of the 442nm and 514nm laser lines.   Characterization 
of these settings is critically important for TIRF-FRET measurements, as FRET is an 
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intensity based measurement, and as TIRF imaging is unique in that the illumination 
intensity decays exponentially in the z-axis.   
Measurements of the TIRF angles of incidence of the lasers for a range of 
galvanometer settings initially used a glass prism method that coupled the laser light as 
it exited the objective and projected it onto a nearby target.    Simple trigonometry and 
Snell’s law allowed us to determine the angle of incidence, by measuring the height of 
the laser projected onto the target, and the distance from the target to the microscope 
objective.  Following determination of the angle of incidence corresponding to each 
galvanometer setting, the evanescent field profile at each galvanometer setting was then 
measured.  This was done by imaging large (10µm) spherical silica beads that were 
coated with fluoroprotein and resting on the surface of the glass coverslip [26].   Figures 
4.1C and 4.1D (left) show representative bead footprints imaged under TIRF, using the 
442nm or 514nm laser lines, respectively, where each laser line was optimally focused 
at the back focal plane of the objective.    Each point on the bead footprint represents 
fluorescence originating from the surface of the bead, at a specific z-distance from the 
glass coverslip.  This z-distance can be determined for each point on the footprint, given 
the radius of the bead and the radial distance of the point from the center of the footprint 
(Figure 4.1B).   Assuming that the surface of the bead is coated uniformly with 
fluoroprotein, the fluorescence intensity at each point on the bead footprint is directly 
proportional to the intensity of the evanescent field at that point’s corresponding z-
distance.  As shown by representative plots in the middle portions of Figures 4.1C and 
4.1D, an intensity vs. z-distance relationship can be plotted for all points in the bead 
footprint to determine the decay of the evanescent field.  The right portions of Figures 
4.1C and 4.1D show the characteristic TIRF depths measured for a range of incident 
angles for the 442nm and 514nm lines (purple markers or green markers, respectively).  
The solid lines in these plots are the theoretically determined relationships for the 442nm 
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or 514nm lasers respectively, calculated using Equation 7, and assuming two different 
indices of refraction of the imaging media (n= 1.37 or 1.38).  Given that the beads were 
imaged in a solution in which the index of refraction was measured to be ~1.372, the 
experimentally determined values fall largely within the theoretically expected range.   
For the experiments that follow, the focus was optimized for the 442nm line to 
maximize the visualization of our dimmest FRET probe (ie, CFP/cerulean) under TIRF, 
leaving the 514nm line slightly less focused.  The evanescent field profiles for the 514nm 
line were therefore deeper than the theoretical expectations (right portion of Figure 4.1D, 
black markers).    
 
Effects of mismatched evanescent field depths on sensitized emission FRET calibrations 
and measurements 
The rationale driving the development of a sensitized emission TIRF-FRET 
method for use within living cells is that sensitized emission FRET imaging, unlike donor 
dequenching, is non-destructive and rapid, and is thus highly amenable to time-lapse 
imaging.  Sensitized emission FRET imaging, however, requires calibration of the 
imaging system to be able to isolate the sensitized emission signal from contaminants 
such as spectral bleed-through and crosstalk, as well as to be able to calculate apparent 
FRET efficiencies and molar ratios of acceptor to donor, which allow for comparison of 
apparent FRET efficiencies across treatments and cells.   
The sensitized emission FRET approach that we employ here is termed FRET 
stoichiometry ([21, 25]).  This method allows for calculation of the instrument-
independent indices termed EA (apparent FRET efficiency of the acceptor in complex), 
ED (apparent FRET efficiency of the donor in complex) and Ratio (the molar ratio of total 
acceptor to total donor), by determination of four calibration constants, α, β, γ, and ξ (see 
Methods section for a more complete description).   Other sensitized emission methods 
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yielding similar instrument-independent indices of FRET, have also been developed and 
could be similarly applied to TIRF-FRET measurements [27-29].     
With conventional epifluorescence illumination, the FRET stoichiometry 
constants are determined in cells expressing soluble donor, acceptor, or linked donor-
acceptor proteins, under the assumption that the illumination intensity across the 
specimen in the axial (z-) direction is constant.   TIRF imaging, however, differs in that 
the illumination intensity decays exponentially in the z-direction.   This is further 
complicated for sensitized emission TIRF-FRET imaging, where two different 
wavelengths of light are employed, whose evanescent fields decay with different depth 
constants, depending on each laser’s angle of incidence, and the relative difference 
between laser wavelengths (see Figure 4.1A).    To assess how FRET stoichiometry 
calibration constants are affected by evanescent illumination, particularly in regard to 
matching of the characteristic depths of the two illumination wavelengths, we imaged 
10µm silica beads coated with either citrine or linked CFP-citrine protein.  For these 
experiments, 3 different illumination sets were used, in which the characteristic depths 
for the 442nm (D442) and 514nm (D514) laser lines were either 1) matched at 
approximately 270nm, 2) mismatched, with D442 deeper than D514 (D442 = 280nm, D514 = 
140nm) or 3) mismatched, with D442 shallower than D514 (D442 = 160nm, D514 = 270nm).    
Of particular interest was the relationship of the FRET stoichiometry calibration 
constants α, γ, and ξ, to the z-distance from the glass coverslip, under each of the 
imaging conditions.  The calibration constant β was excluded here, as determination of β 
requires only the 442nm laser line.  Indeed, as shown in Figure 4.3B, β remains constant 
with z-distance.  The relationships of the FRET stoichiometry calibration constants vs. z-
distance were calculated using the respective CIDD, CIDA, or CIAA vs. z-distance 
relationships determined from individual beads, and are shown as normalized plots in 
Figures 4.2A-C.    
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The effects of different evanescent field depths on α are shown in Figure 4.2A.  
Greater than two-fold variations in α occur across z-distance when TIRF depths are 
mismatched, with relatively little variation occurring when the TIRF depths are closely 
matched.   α is a proportionality constant that represents the extent to which the donor 
excitation wavelength directly excites the acceptor as compared to the acceptor 
excitation wavelength.  Therefore, the α vs. z-distance relationship largely reflects the 
ratio of the evanescent field profiles of the donor to the acceptor at each z-distance.  
This is borne out by the observation that with D442 deeper than D514, α becomes 
progressively larger with z-distance, whereas with D442 shallower than D514, α becomes 
progressively smaller with z-distance.   Moreover, these variations in α occur within z-
distances < 500nm from the glass-water interface, the distance over which most of the 
evanescent field decays.  The relationships of γ and ξ vs. z-distance also demonstrate 
larger variations for γ and ξ when D442 and D514 are mismatched, compared to when they 
are matched (with γ showing larger changes overall compared to ξ).  Theoretically, γ and 
ξ should remain constant over z-distance, as γ represents the ratio of extinction 
coefficients of the acceptor to donor at donor excitation wavelengths, and ξ represents a 
proportionality constant relating the brightness of the donor to the brightness of the 
acceptor.  The changes in z-distance seen for γ and ξ when D442 and D514 are 
mismatched likely result from the fact that both calculations take into account the CIDD, 
CIDA, and CIAA images taken with the mismatched D442 and D514, in addition to the 
varying α vs. z-distance relationships that result from the mismatched TIRF depths.    
The experiments above indicate that mismatch between the evanescent profiles 
of the two illumination wavelengths used in sensitized emission TIRF-FRET results in 
large variations of the calibration constants over z-distance.   In practical terms, then, to 
accurately determine the apparent FRET efficiency at any particular z-distance requires 
a different set of calibration constants at each z-distance.  This is highly relevant in 
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situations where time-dependent changes in FRET on mobile sub-cellular compartments 
(eg, a secretory granule, mitochondrion, or cortical cytoskeleton) are being examined.  
For example, a change in FRET may be interpreted as being physiologically important, 
when in fact the change results simply from the compartment moving in the z-axis, with 
inappropriate FRET calibration constants applied.   The experiments above used in vitro 
imaging of large beads to determine how FRET calibration constants vary across z-
distance for a given set of evanescent field depths; however, for experiments involving 
live cells, this z-information is typically not available.   
In live cells, calculation of sensitized emission FRET calibration constants under 
TIRF results in values that represent a weighted average of each constant over the z-
distances imaged.   To estimate the magnitude of error one might expect to see in FRET 
measurements where the evanescent field profiles between illumination wavelengths are 
either matched or mismatched, we took the average of each constant vs. z-distance 
relationship over the first 525nm from the glass interface, and applied the averaged 
values of these constants toward calculations of EA, ED, and Ratio vs. z-distance, using 
images of beads coated with the linked CFP-citrine protein.  The results are shown in 
Figure 4.2D-F.  Here, error-free measurements of EA and ED would be apparent as a 
horizontal line at 0.40 (the FRET efficiency of the CFP-citrine linked probe); similarly, 
error-free measurements of Ratio would be seen as a horizontal line at 1.0.  In Figures 
4.2D and 4.2F, large variations of EA and Ratio are clearly seen with mismatched TIRF 
depths.  Figure 4.2D shows that while ED measurements demonstrate some variation 
for mismatched depths, this error is remarkably less pronounced than for EA and Ratio.  
The differences in the magnitude of these effects are likely due to the fact that EA and 
Ratio measurements are largely dependent on the calibration constants α and γ, which 
demonstrated large variations across z-distance for mismatched TIRF depths; ED, 
however, is mostly dependent on ξ, which exhibited relatively small variations across z-
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distance with mismatched TIRF depths.   Again, note that the largest errors in FRET 
measurement occur at depths < 500nm, where the most relevant TIRF-FRET 
measurements would occur.   
Most importantly, errors in calculation of EA, ED, and Ratio are minimized when 
the evanescent profiles of the illumination wavelengths are closely matched.  Matched 
TIRF depths minimize the variation in FRET calibration constants over z-distance, which 
in turn minimizes the error in FRET calculations in the z-dimension, when averaged 
calibration constants are applied.  This is particularly important for TIRF-FRET imaging, 
as variations of the constants and of FRET measurements occur over the exact z-
distances where the TIRF measurements of highest import occur.    Therefore, in live 
cells, FRET calibration constants are best determined using probes that localize to the 
specific sub-cellular compartments of interest.  This would ensure that constants are 
averaged only over the z-distances that are relevant to the FRET measurements at 
hand.   
 
Effects of different but matched TIRF depths on FRET calibration constants 
 We next determined the effects of different, but matched, TIRF depths (ie, D442 
and D514 both shallow, or D442 and D514 both deep) on the values of the FRET calibration 
constants.   The FRET calibration constants were again measured using fluoroprotein-
coated beads, this time, with the following illumination sets:  1)  D442 and D514 matched at 
~270nm;  2)  D442 and D514 matched at ~ 200nm;  or 3) D442 and D514 matched at 
~150nm.  The results are shown in Figure 4.3.  Note that the calibration constants vs. z-
distance relationships stay relatively constant across z-distance, as a result of the 
closely matched TIRF illumination depths.   Interestingly, the magnitude of α is shown to 
increase with increasing TIRF characteristic depths (Figure 4.3A), whereas the value for 
γ decreases with increasing TIRF characteristic depths (Figure 4.3C).  α and γ are 
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determined largely by either the ratio or inverse ratio, respectively, of images acquired 
from excitation with the 442nm line and the 514nm line (CIDA and CIAA).   While the 
characteristic depths of these evanescent fields are matched, this can only be achieved 
by setting the incident angles of the 442nm and 514nm lines to different values.   
Importantly, the initial intensity of an evanescent field at the glass-water interface is 
known to be dependent upon the angle of incidence, with larger angles of incidence 
resulting in weaker initial evanescent field intensities [11].  This property could explain 
the inversely-related changes in the magnitudes of α and γ with changes in the 
characteristic depth, as it appears that the relative difference between the initial 
evanescent field intensities between the 442nm and 514nm lines increases with 
increasing characteristic TIRF depth.   Figure 4.3B and Figure 4.3D demonstrate that the 
magnitude of both β and ξ remains constant, regardless of the TIRF depths used.  This 
result is in line with the fact that determination of both β and ξ depends primarily on the 
ratio of two images acquired using only the 442nm line (CIDA and CIDD).  Thus, unlike α 
and γ, the absolute magnitude of β or ξ should not be expected to change with 
characteristic depth. 
 
Sensitized Emission TIRF-FRET on moving compartments:  Effects of z-distance 
motions on FRET calculations 
 The exponential decay of the evanescent field in the z-dimension allows 
fluorescence intensity under TIRF to be used as a highly sensitive gauge of motions in 
the z-axis.  Indeed, one of the major uses of time lapse TIRF imaging in live cells to date 
involves studying the motions of specific sub-cellular compartments (eg., secretory 
granules) in cells over time, and relating these motions to the functional state of each 
compartment [30-34] .   For TIRF-FRET imaging, however, these z-motions result in 
intensity changes that could potentially confound the interpretation of time lapse TIRF-
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FRET measurements in which the FRET signal localizes to such a moving compartment.  
Therefore, we next characterized the effects of z-motions of sub-cellular compartments 
on TIRF-FRET measurements, initially under conditions where the “true” FRET signal on 
the compartment remained unchanged.  
 Initially, we considered a case where the FRET signal is localized to a sub-
cellular compartment, and where all of the acceptor and donor molecules also localize to 
this compartment.    This situation is in essence modeled in Figures 4.2D-F (with D442 
and D514 matched), where each point on the bead can be thought of as a sub-cellular 
compartment at a specific z-distance from the glass coverslip.  Motions of the 
compartment in the z-axis can be visualized by moving up or down along the bead 
surface.  Note that the actual FRET efficiency on the compartment at any z-distance 
should remain constant at 0.4 (the characteristic FRET efficiency of the CFP-citrine 
probe).    Figures 4.2D-F illustrate that, in this scenario, z-motions have virtually no effect 
on the apparent FRET efficiencies measured.  This occurs, as movement of the 
compartment away from the glass interface in the z-direction decreases the sensitized 
emission FRET signal in equal proportion to the decrease in total donor and total 
acceptor fluorescence signals (as all signals localize only to the compartment).  
Likewise, the molar ratio of acceptor to donor also remains constant, as both acceptor 
and donor signals always change proportionally with movements of the compartment in 
the z-direction. 
 We next examined a more physiological scenario, where the FRET signal 
localizes to a subcellular compartment, but where only a portion of the total acceptor or 
donor localizes to that compartment, with the rest of the acceptor or donor displaying a 
soluble cytosolic distribution.   This scenario is common in cell biology; a specific 
example is a Rab protein that, depending on its activation state, cycles onto or off of a 
secretory granule, and that may only interact with its effector protein when it is cycled 
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onto the granule.  To understand how changes in the z-motion of a compartment might 
result in apparent changes in the measured FRET values, we tested an experimental 
model of this situation.  Similar to above, we imaged 10µm beads coated with the linked 
CFP-citrine protein, but this time, with 3 different concentrations of soluble citrine added 
to the imaging solution, to represent different extents of cytosolic localization of the 
acceptor (the donor remains fully localized to the compartment).   The results of the 
apparent FRET efficiency calculations on these beads are shown in Figures 4.4A,C,E. 
Figure 4.4A shows the measured EA vs. z-distance relationships for the beads, 
and demonstrates that the measured EA values decrease with increasing z-distances of 
the compartment from the glass interface.  This effect is graded, with higher levels of 
soluble citrine resulting in larger overall decreases in EA.  An explanation of these 
results is that as the compartment moves away from the glass interface, the intensity of 
the FRET signal (which is localized to the compartment) decreases exponentially; 
similarly, the intensity of the acceptor signal localized to the compartment also 
decreases exponentially.  However, the growing space between the glass interface and 
the compartment is filled with the soluble population of acceptor, and depending on the 
relative concentrations of the soluble acceptor and the acceptor localized to the 
compartment, the intensity of the total acceptor signal might either decrease (in a less-
than-exponential fashion), or increase.  As EA represents the ratio of the sensitized 
emission FRET signal to the total acceptor signal, the result is that EA will decrease with 
increasing z-distance of the compartment from the glass interface.   In Figure 4.4C, the 
measured ED vs. z-distance relationships are shown, indicating that ED exhibits minimal 
changes over z-distance, compared to EA.   As expected, this results arises from the 
fact that both the FRET signal and the total donor signal localize to the compartment, 
and therefore are subject to the same relative changes in intensity as the compartment 
moves in the z-direction.   As ED is the ratio of the FRET signal to the total donor signal, 
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ED should remain unchanged with movement of the compartment in the z-direction.  
Figure 4.4E demonstrates that the measured Ratio increases as the compartment is 
moved away from the glass interface, with larger increases in ratio occurring with higher 
concentrations of soluble citrine in the imaging media.   An explanation for this result is 
that as the compartment moves away from the glass interface, the total acceptor signal 
will either be decreasing in a less-than-exponential fashion, or increasing (as described 
above), while the total donor signal will be decreasing exponentially.   As the molar ratio 
is the ratio of total acceptor signal to total donor signal, the result is that the molar ratio 
increases as the compartment moves away from the glass. 
The data shown in Figures 4.4A,C,E use a simplified model (i.e., the surface of 
10µm beads) to describe the effects of a moving subcellular compartment on FRET 
measurements.   However, to examine a more physiologically relevant situation, such as 
that which might arise with a secretory granule (a spherical compartment with 350nm 
diameter) moving in the z-dimension, we generated a mathematical model to simulate 
TIRF-FRET under various conditions.  This model is based on that described in [21], 
with the central difference being that in the current model, the illumination intensity 
decays exponentially in the z-dimension.  To validate this model, we first simulated the 
experiments from Figures 4.4A,C,E, by modeling a bead of 10µm diameter coated with a 
linked FRET probe, resting on the surface of a glass coverslip with a set concentration of 
soluble acceptor in the surrounding media.   To model each experimental condition (ie, 
each different concentration of soluble acceptor in the imaging media), the concentration 
of soluble acceptor in the model was adjusted, such that ratio of the maximum on-bead 
fluorescence intensity (ie, at the very bottom of the bead) to the off-bead fluorescence 
intensity (ie, determined in a region clearly outside of the bead) calculated by the model 
matched that determined for each experimental condition.  The results of this model are 
shown in Figures 4.4B,D,F.  Notably, the model accurately matched the shapes and 
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trends of the EA, ED, and Ratio relationships as measured experimentally, with EA 
values decreasing, Ratio values increasing, and ED values remaining unchanged with 
increasing z-distance of the bead surface from the glass coverslip.  Moreover, for EA 
and Ratio, the effects were graded with respect to the concentration of soluble acceptor.  
While the model did not fit the experimental data perfectly, this likely results from the 
underlying assumption used to match the conditions in the model with the experimental 
conditions.  Namely, we assumed that the off-bead fluorescence determined in the 
experiments resulted solely from soluble acceptor, whereas the on-bead maximal 
fluorescence resulted solely from the linked fluorophore conjugated to the bead.  In 
actuality, these fluorescence intensities likely also include contribution from non-specific 
binding of the soluble acceptor to the coverglass, and perhaps to the bead; moreover, 
there may have been a thin film of soluble acceptor between the bead and the 
coverglass.  Each of these situations would result in an error in our estimate of the 
soluble concentration of the acceptor.   These different non-specific localizations of the 
acceptor signal (ie, to the bead or to the coverglass), when incorporated into the model, 
resulted in shifts in the relationships determined for EA and Ratio vs. z-distance (see 
Supplemental Data, Figure 4.S1).    
We next used this TIRF-FRET model to simulate how motions of secretory 
granules might affect TIRF-FRET measurements where FRET was localized to the 
granule.   Granules were modeled as spheres with 350nm diameter (as opposed to the 
10µm beads) coated with a linked FRET probe, and surrounded by a solution containing 
soluble acceptor.  The distance of the bottom of the granule from the glass coverslip was 
varied in the model, and the apparent FRET measurements were calculated through the 
center of the granule (ie, from the bottom-most to top-most points on the granule).   
Characteristic TIRF depths of the donor and excitation wavelengths were matched at 
either 170nm or 270nm.  The results of the simulation for EA and Ratio are shown in 
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Figure 4.4G-H.  As before, ED remained constant at 0.4 regardless of the granule’s z-
position, and the results are therefore not shown here.  The effects of the moving 
granule on EA and Ratio are similar, and at z-distances close to the bead, are slightly 
more pronounced than the results obtained from modeling a 10 µm bead.  This effect is 
likely due to the contribution of the soluble fluorescence above the 350nm granule, 
which while small, is present, unlike the case for the 10µm granule, where there is in 
essence no soluble contribution of fluorescence above the bead.   The 170nm TIRF 
depth resulted in a slightly larger effect on EA and Ratio at short z-distances (<500nm), 
compared to the 270nm depth, although this situation was reversed at larger z-
distances.   
 
Sensitized Emission TIRF-FRET in Living Cells 
 The application of sensitized emission TIRF-FRET in living cells was first tested 
using the simplest situation in which the donor and acceptor were directly linked and 
targeted to the plasma membrane.  Targeting to the plasma membrane was achieved by 
fusing the linked FRET probe to the N-terminus of the pleckstrin homology (PH) domain 
of phospholipase Cδ.  TIRF-FRET images were taken of MIN6 cells expressing the 
linked-PH probe either alone, or in addition to soluble cerulean (donor) or soluble citrine 
(acceptor), using D442 and D514 matched at ~160nm.  Figure 4.5A shows representative 
TIRF images of these cell footprints.  Note that while the fluorescence signal and 
calculated FRET values are largely uniform across the footprint, some streakiness can 
be detected in the images, which results from interference fringes generated by the 
scatter and diffraction of the coherent laser light.  Figures 4.5B-D show the averaged 
values for the fraction of acceptor in complex (fA), fraction of donor in complex (fD), and 
molar ratio, for the three different protein expression conditions.   Note that cells 
expressing the linked-PH probe alone correctly show fA = fD = 1, and ratio = 1.  As 
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expected, cells expressing the linked-PH probe with soluble cerulean demonstrate a 
decrease in fD, no change in fA, and an increase in the molar ratio on average.   
Importantly, there is a linear relationship between fD and ratio, while the fA values 
remain scattered around 1, as shown in Figure 4.5E.  Conversely, cells expressing the 
linked-PH probe with soluble citrine demonstrate no change in fD, a decrease in fA, and 
an increase in the molar ratio on average.    Notably, there is a clear linear relationship 
between fA and the inverse molar ratio for these cells, while fD remains scattered 
around 1 (Figure 4.5F).  Taken together, these data demonstrate the validity of using 
sensitized emission TIRF FRET in cells where the FRET is localized to the plasma 
membrane.   
 We next tested the use of sensitized emission TIRF-FRET in cells in which the 
FRET signal was localized to intracellular compartments.  For these experiments, MIN6 
cells were transfected with a linked citrine-cerulean FRET probe that was fused to the N-
terminus of the protein VAMP2.  In addition to localizing to secretory granules, this probe 
also localized somewhat nonspecifically to a variety of constitutive trafficking organelles 
and other compartments likely involved in vesicle biogenesis.   MIN6 cells were 
transfected with the citrine-cerulean-VAMP2 construct alone, or in addition to soluble 
cerulean or soluble citrine, and TIRF-FRET images were taken with D442 and D514 
matched at ~270nm.   Individual granules were detected in each frame, and the 
averaged CIDD, CIDA, and CIAA intensity values within a 13-pixel diamond centered on 
the granule were used to determine the FRET on the granule.  Representative images of 
these cell footprints and the resulting FRET measurements are shown in Figure 4.6A.  
Note the diffuse fluorescent signal apparent in the CIDD and CIAA images for the cells 
co-expressing soluble cerulean or citrine, respectively.    Importantly, as shown in 
Figures 4.6B and 4.6C, the averaged fractions of donor and acceptor in complex, as well 
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as the averaged molar ratios, change as expected for cells co-expressing the linked-
VAMP2 construct in addition to soluble cerulean or citrine.   
 
Discussion 
 The ability to sequence protein-protein interactions as they occur in living cells in 
real-time, with high spatial resolution, is paramount to furthering our understanding of the 
detailed molecular underpinnings of many important biological functions.  Sensitized 
emission TIRF-FRET has the potential and unique capability of being able to resolve, 
both temporally and spatially, exactly these kinds of details.  However, this method is not 
without its complications, as precise calibrations to the imaging system and the 
fluorescent probes being used are required, such that instrument-independent indices of 
apparent FRET efficiencies and molar ratios of acceptor to donor can be reported 
accurately.  Application of this method is largely straight-forward for simple situations in 
which both donor and acceptor are on the same molecule, which localizes to the plasma 
membrane.  However, our results demonstrate that for more complex situations, for 
instance,  where donor and acceptor tagged molecules localize to multiple intracellular 
compartments  (such as secretory granules and the cytosol), and moreover, where the 
intracellular compartment may be moving in the z-axis over the time course of the 
experiments, additional considerations must be taken into account.   
 
Setting the characteristic TIRF depths for the two excitation lines. 
An important consideration in TIRF-FRET is the effects on sensitized emission 
FRET calibration constants when characteristic TIRF depths for the 442nm and 514nm 
excitation lines are matched versus slightly mismatched.   Large silica beads conjugated 
with the fluoroproteins required for the FRET calibrations (eg, CFP, citrine, and a linked 
CFP-citrine) allowed for a direct measure of how each calibration constant varied with z-
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distance from the glass interface.  The results demonstrate that when the characteristic 
TIRF depths of the illumination lines were mismatched, the calibration constant α 
demonstrated large variations across z-distance (which were most pronounced at 
distances close to the coverslip), with γ and ξ also exhibiting small but pronounced 
variations with z-distance.   More importantly, when these calibration constants were 
averaged over the first 525nm in z-distance from the coverslip (to estimate the constants 
that might be obtained in a live-cell situation), and these averaged constants were 
applied to the FRET calculations, substantial errors arose in the calculated EA and Ratio 
over z-distance, with small but noticeable errors in ED as well.   Again, these errors were 
most prominent close to the glass coverslip (<500nm), at a range where most important 
TIRF measurements are made.  Notably, these errors were largely eliminated when the 
characteristic TIRF depths of the illumination lines were matched.  Therefore, for 
sensitized emission TIRF-FRET measurements that involve compartments moving in the 
z-dimension over the course of the experiment, it is critical that the characteristic TIRF 
depths between excitation lines be closely matched.  Failure to do so could result in 
apparent changes in FRET that are due to movement of the compartment, rather than 
being due to an actual change in protein-protein interaction / probe re-orientation on the 
compartment. 
Of note, we have determined the effects of characteristic TIRF depths on 
sensitized emission FRET calibration constants, specifically with regard to the method of 
FRET stoichiometry [21, 25].  FRET stoichiometry is a 3-cube FRET method that is 
particularly advantageous in that it allows for simultaneous tracking of both acceptor 
occupancy and donor occupancy for a given bimolecular interaction (most other 3-cube 
FRET methods are only capable of tracking either the acceptor or donor only), and 
moreover, for determination of the molar ratio of total acceptor to total donor (this 
capability is unique to FRET stoichiometry).  However, almost all 3-cube FRET imaging 
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methods use calibration constants similar to α and β to correct for cross-talk and bleed-
through, in order to specifically isolate the sensitized emission signal from these spectral 
contaminants.  Conversion of the isolated sensitized emission FRET signal to 
instrument-independent measures of apparent FRET efficiency additionally requires 
another calibration constant, usually termed the G-factor [27, 29, 35] or alpha [28], that 
relates the fluorescence intensity of the acceptor molecule to that of the donor molecule.  
Importantly, the G-factor (or alpha) is equivalent to the quotient of the FRET 
stoichoimetry calibration parameters, γ/ξ.   The G-factor can be calculated in a number 
of different ways, for example, by donor dequenching of a linked FRET probe, or by 
measurements of several different linked FRET constructs with different FRET 
efficiencies.  Regardless, all of these measurements ultimately require imaging of a 
linked FRET probe with the imaging system used for the FRET experiment.  Therefore, 
the effects described here of mismatched characteristic TIRF depths on FRET 
stoichiometry calibration constants are generalizable to other 3-cube sensitized emission 
FRET modalities as well. 
 
 Can sensitized-emission TIRF-FRET be used on cells with multiple probe 
localizations?   
While time-lapse imaging using sensitized-emission TIRF-FRET has been 
reported in live cells for the simple case of a plasma-membrane associated protein 
double-labeled with both donor and acceptor [18], our goal was to expand the range of 
possibilities for FRET calculations using this method.   For instance, do changes in 
FRET that are measured over time accurately reflect changes in the extent of protein-
protein interactions or in re-orientation of probes on an intracellular compartment (eg, a 
secretory granule) over time?  Moreover, does the same hold true if one or both of the 
probes demonstrates multiple subcellular localizations (eg, secretory granule and 
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cytosol)?   Lastly, how are these FRET measurements affected by motions of 
intracellular compartments in the z-dimension?   
The results of our TIRF-FRET modeling offer some general guidelines for 
timelapse TIRF-FRET imaging of subcellular compartments in the presence of a partially 
cytosolic probe.   First, if both donor and acceptor localize completely to an intracellular 
compartment, then changes in apparent FRET efficiency (both EA and ED) and molar 
ratio on the compartment can be accurately tracked, regardless of whether the 
compartment is moving in the z-axis.   Second, if only one of probes exhibits partially 
cytosolic localization (for example, the acceptor), then the apparent FRET efficiency of 
the other probe (in this case, the apparent FRET efficiency of the donor,  or ED) can be 
used as a measure of FRET that is independent of z-axis motions of the compartment.   
However, if the apparent FRET efficiency of the probe exhibiting multiple localizations 
(EA, in this case), as well as the molar ratio, are important to track, these values can be 
followed under limited circumstances.  In the case of a 350nm granule, if the background 
soluble fluorescence signal is less than 5% of the peak fluorescence intensity of the 
acceptor on the granule, then large (up to 500nm) motions of the granule can be 
tolerated before a 10% change in EA or ratio results.  However, with larger fractions of 
cytosolically distributed acceptor, a 10% change in EA or ratio could easily occur with 
less than 100nm movement in the z-direction.   Theoretically, it may be possible to 
correct the EA and Ratio values for the z-motions of granules, using a model similar to 
the one used in this paper, to determine the signal of the soluble fluorescence 
component above and below the granule, and to correct for changes in this signal as the 
granule moves in the z-axis.  This would require that the z-motions of the granule be 
accurately followed over time, either using a 3rd granule-filling, spectrally separated 
fluoresecent probe, or by following the total acceptor signal.  The acceptor signal will be 
a valid measure only if it localizes completely to the granule, and if the distribution of the 
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acceptor signal on the granule does not change over time.   It is important to note that 
these caveats apply mainly for studies on subcellular compartments that may be moving 
in the z-dimension; studies of processes that occur only on the plasma membrane, for 
instance, are relatively free from the caveats discussed above. 
 
Other considerations for sensitized emission TIRF-FRET.   
The major benefit of sensitized emission TIRF-FRET, as opposed to other FRET 
methods performed under TIRF, lies in its potential for being used in time lapse imaging.   
However, under TIRF, we demonstrate that observed changes in apparent FRET 
efficiency over time may result from a variety of different factors, aside from actual 
changes in the bimolecular FRET interaction or re-orientation of the FRET probes.   Our 
investigations have addressed effects on TIRF-FRET of motion of an intracellular 
compartment in the z-axis.  Although not specifically addressed here, the effects of 
photobleaching also need to be considered for proper measurement and calculation of 
FRET; this is especially important for applications requiring high temporal resolution over 
prolonged periods of time.  Prior reports have described specific photobleaching 
correction schemes for sensitized emission FRET under a widefield microscope [29], 
and these corrections may be used to correct for photobleaching in sensitized emission 
TIRF-FRET, provided that variations of the z-profile of the fluorophores over time is 
minimal.   Another factor that should be considered is the interference fringes that arise 
with evanescent illumination, as a result of scattering of the coherent light source.  In a 
worst-case scenario, these fringes could cause local differences in illumination intensity 
that result in incorrectly reported FRET values.  Importantly, several effective solutions to 
this problem have been previously described, including rapid circling of the illumination 
light in the back focal plane of the objective [36, 37].  Lastly, other considerations that 
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should be taken into account are instrumentation noise and noise associated with motion 
of subcellular compartments in between images.    
We have applied these guidelines to perform sensitized emission TIRF-FRET in 
living cells expressing a linked citrine-cerulean FRET probe that localizes either to the 
plasma membrane, or to intracellular compartments (including secretory granules).  
Importantly, the apparent FRET efficiencies, EA and ED, and the molar ratio, shifted 
accordingly when cerulean or soluble citrine were co-expressed with the linked probe.    
Moreover, in cells expressing the linked probe localized to the plasma membrane, the 
calculated fraction of acceptor (fA) or donor (fD) in complex displayed a linear 
relationship with the calculated molar ratios. 
 The development and use of sensitized emission TIRF-FRET in living cells will 
likely have a large impact on our understanding of the dynamics of biological processes 
that occur close to or at the plasma membrane.   At the plasma membrane, dynamic 
TIRF-FRET measurements have the possibilities of elucidating changes in 
conformational structure, post-translational modification, and even protein-protein 
interactions of channels that occur upon ligand binding or depolarization of the 
membrane.  The field of membrane trafficking is also rife with possibilities.   What 
molecular interactions must occur to allow for the regulated insertion or removal of 
specific cell receptors or channels to the plasma membrane?  Are there protein-protein 
interactions that dictate, spatially, where these receptors or channels are inserted?    
Similarly, the fields of regulated exocytosis and endocytosis also have much to benefit 
from this approach.  As exocytosis and endocytosis occur as a cycle, one of the major 
challenges in this field has been to tease apart whether specific protein-protein 
interactions must occur prior to or following membrane fusion events.   However, 
sensitized emission TIRF-FRET has the capability not only to track when protein-protein 





secretory granules that these interactions may be occurring on.  Therefore, being able to 
directly correlate the when and where of a protein-protein interaction to the functional 
state of a granule becomes a real possibility, and one that will be crucial to our 









Figure 4.1.  Measurement of evanescent field profiles for 442nm and 514nm laser lines.   
(A) Theoretical plots of the relationship between characteristic TIRF depth and angle of 
incidence, for 442nm (purple curve) and 514nm (green curve) laser lines, using n1 = 
1.515 and n2 = 1.37 (Eq 7).    (B) Schematic depicting the measurement of characteristic 
TIRF depths using large silica beads, based on methods developed in [26].  A spherical 
bead coated with fluorophore is shown resting on the surface of a glass coverslip (left).   
The image of the bead footprint under TIRF (right) can be used to determine the profile 
of the evanescent field, as the fluorescence intensity of the bead at a given radial 
distance, d, from the center of the bead footprint corresponds to fluorescence arising 
from the bead surface at a specific z-distance, z1, from the glass interface.  Conversion 
of radial distance to z-distance is accomplished using the geometry of a sphere with 
known radius, R.   (C)  Left, Representative images (pseudo-colored below) of 10 µm 
silica beads conjugated with citrine and imaged with the 442nm laser line, under 
epifluorescence (EPI) or TIRF modes.  Numbers above the bead footprints represent the 
characteristic depths determined for the incident TIRF angle used to acquire each 
image.  Center, Average normalized intensity vs z-distance relationships, acquired from 
beads imaged using the 442nm laser line at three different incident TIRF angles.   
Relationships were fitted to a double exponential (Eq 6) to determine the characteristic 
depth at each incident angle; characteristic depths depicted are:  278nm, 221nm, and 
150nm.   Right, Average characteristic TIRF depths were calculated from beads imaged 
using 5 incident angles, and plotted (purple markers) against the incident TIRF angle, 
which was measured using the prism method.   Solid curves indicate theoretical 
relationships between characteristic TIRF depth and angle of incidence (Eq 7) for a 
442nm laser, using n1 = 1.515 and n2 = 1.37 (lower curve) or 1.38 (upper curve).  Beads 
were imaged in a solution where n ~ 1.372.  Markers represent the mean ± SEM.  
Numbers in parenthesis above each bead represent the number of beads used for each 
measurement.  (D) Similar to (C), except that beads were imaged using a focused 
514nm laser line.  Center, Characteristic depths depicted are:  249nm, 194nm, and 
151nm.  Right, Markers in green represent the characteristic depths measured for the 
focused 514nm laser line.  Solid curves indicate the theoretically determined 
relationships for a 514nm laser.  Markers in black indicate the characteristic depths 
measured for the 514nm line when it was slightly defocused.  As expected, the depths 

































Figure 4.2.  Relationship of FRET values measured under TIRF, to differently matched 
characteristic TIRF depths of excitation wavelengths.  For all plots, the open circles 
represent data obtained when the characteristic TIRF depth of the 442nm laser (D442) 
was matched with the characteristic TIRF depth of the 514nm laser (D514), at ~270nm.  
Open squares represent data obtained where D442 > D514, with D442 ~ 280nm and D514 ~ 
140nm.  Open triangles represent data obtained where D442 < D514, with D442 ~ 160nm 
and D514 ~ 270nm.  Markers represent the mean ± SEM.  (A-C)  Relationships of FRET 
calibration constants vs. z-distance were determined by imaging 10µm beads 
conjugated with either citrine (for α) or a linked CFP-citrine protein (for γ and ξ).   The 
intensity vs. z-distance relationships of each bead in the DD, DA, and AA images were 
then used to determine the relationships of (A) α vs z-distance, (B) γ vs z-distance, and 
(C) ξ vs z-distance.   Determination of γ and ξ vs z-distance for each condition utilized 
the α- and β-vs z-distance relationships for that condition.  All plots were normalized to 
the initial value of each constant at z = 0.  β is not shown as  β requires only the 442nm 
laser line (but, see Figure 4.3).   The number of beads used for each average 
measurement in order of (D442 > D514,  D442 < D514, and D442 = D514) was:  α:  (7, 7, 12); β 
(6, 8, 6); ξ and γ:  (7, 4, 10).  (D-F)  Estimation of the error associated with FRET 
measurements as a result of FRET calibration constants varying in the z-dimension.   
FRET calculations were carried out on images of beads conjugated with the linked CFP-
citrine protein.  A single “flat” set of FRET calibration constants was determined for each 
imaging condition, by calculating the average value of each constant for that condition 
over the first 0.525µm in the z-dimension.  These “flat” estimates of the calibration 
constants were then used with the intensity vs. z-distance relationships for DD, DA, and 
AA images to determine the relationships of (D) EA vs z-distance, (E) ED vs z-distance, 
and (F) Ratio vs z-distance, for each imaging condition.  Note that an error-free 
measurement of EA or ED would be evident as a flat horizontal line with EA, ED = 0.4.  
Error-free measurement of Ratio would be evident as a flat horizontal line with Ratio = 1.   
The number of beads used for each averaged measurement of EA, ED, Ratio was, in 












































Figure 4.3.  Effect of characteristic TIRF depth on FRET calibration constants.    In 
these experiments, D442 and D514 were matched at either ~ 270nm (open squares), 
200nm (open triangles), or 150nm (open circles).   FRET calibration constants were 
determined by imaging 10µm beads conjugated with either CFP (for β), citrine (for α) or 
a linked CFP-citrine protein (for γ and ξ).   The intensity vs. z-distance relationships of 
each bead in the DD, DA, and AA images were used to determine the relationships of 
(A) α vs z-distance, (B) β vs z-distance, (C) γ vs z-distance, and (D) ξ vs z-distance.   
Determination of γ and ξ vs z-distance for each condition utilized the α- and β-vs z-
distance relationships for that condition.  Averaged values of the FRET calibration 
constants vs z-distance were obtained from data pooled from 3 independent 


















Figure 4.4.   Effect of a soluble population of fluorophores on TIRF-FRET 
measurements.     Relationships of (A) EA vs. z-distance, (C) ED vs. z-distance, and (E) 
Ratio vs. z-distance, were determined using 10µm silica beads conjugated with a linked 
CFP-citrine protein, with soluble citrine added to the imaging media.  The 3 curves in 
each plot represent different concentrations of soluble citrine that were used, where the 
fluorescence intensity of a region outside the bead region (off-bead) was determined to 
be approximately 4% (red open squares), 12% (green open triangles), or 18% (blue 
open circles) of the peak fluorescence intensity in the center of the bead (on-bead), in 
AA images.   TIRF-FRET imaging was carried out with D442 and D514 matched at ~ 
270nm; calculations of EA, ED, and Ratio vs. z-distance used the FRET calibration 
constants vs. z-distance relationships obtained from beads imaged at this characteristic 
TIRF depth.  Markers represent the mean ± SEM.  The number of beads used for each 
set of averaged FRET measurements was (in order of 4%, 12%, 18% soluble acceptor):  
(8, 10, 11).   (B, D, F) Mathematical TIRF-FRET simulation of a 10µm bead coated with 
a linked donor-acceptor FRET probe, modeled using the same experimental conditions 
as in (A,C,E).   The theoretical relationships of (B) EA, (D) ED, and (F) Molar ratio vs. z-
distance are shown for the 3 different concentrations of soluble acceptor (same color 
scheme as A,C,E).   (G-H) Mathematical simulation of changes in measured (G) EA or 
(H) Ratio, when a linked FRET probe is localized to a 350nm granule moving in the z-
dimension, with 3 different populations of free acceptor in the cytosol (as in A,C,E, the 
ratios of the soluble acceptor fluorescence to the peak acceptor fluorescence on the 
granule at z = 0 are 4% (red squares), 11% (green triangles), or 18% (blue circles).  Two 
different characteristic TIRF depths (matched for D442 and D514) were simulated:  270nm 





























Figure 4.5.  Sensitized-emission TIRF FRET measurements of a plasma-membrane 
targeted linked FRET probe in live MIN6 cells.    Experiments utilized a linked citrine-
cerulean FRET probe, fused to the pleckstrin homology (PH) domain of PLCδ, which 
results in this probe’s targeting to the plasma membrane.  (A)  Representative images of 
MIN6 cells transfected with plasmids expressing citrine-cerulean-PH alone (left column), 
or in addition to soluble cerulean (middle column) or soluble citrine (right column).   The 
image in the right column shows two adjacent cells that exhibit different fluoroprotein 
expression levels.  (B)  Averaged fraction of acceptor in complex, (C) Averaged fraction 
of donor in complex, and (D) Average molar ratio, determined from cells expressing 
citrine-cerulean-PH only (black), or in addition to soluble cerulean (blue) or soluble 
citrine (yellow).  (E) Fraction of donor (fD, filled diamonds) or acceptor (fA, open 
diamonds) in complex vs molar ratio, plotted for individual MIN6 cells expressing citrine-
cerulean-PH and soluble cerulean.  The solid line indicates the linear fit for the fD vs. 
Ratio data.  (F) Same as (E), but for MIN6 cells expressing citrine-cerulean-PH and 
soluble citrine.  Here, the solid line represents the linear fit of the fA vs. ratio data.  FRET 
stoichiometry calibration constants were obtained using cerulean-PH (for β), citrine-PH 
(for α), and citrine-cerulean-PH (for γ and ξ), and used the same TIRF angle of incidence 
as for the experiment.  Bars represent the mean ± SEM.  The number of cells used for 
each condition was:  Linked-PH (12); Linked-PH + cerulean (14); Linked-PH + citrine 
























Figure 4.6.  Sensitized emission TIRF FRET measurements of a linked FRET probe, 
targeted to intracellular compartments in live MIN6 cells.    These experiments utilized a 
linked citrine-cerulean FRET probe, fused to the N-terminus of VAMP2, which results in 
the probe primarily targeting to the surface of secretory granules.  (A)  Representative 
images of MIN6 cells transfected with plasmids expressing citrine-cerulean-VAMP2 
alone (left column), or in addition to soluble cerulean (middle column) or soluble citrine 
(right column).   Note the diffuse fluorescent signal in the CIDD image for the cell co-
expressing soluble cerulean, and the diffuse signal in the CIAA image for the cell co-
expressing soluble citrine.  Apparent FRET efficiencies and molar ratios were 
determined on single granules, using averaged CIDD, CIDA, and CIAA intensities within 
a 13 pixel diamond centered on the granule.  For images of EA, ED, and Ratio, the 
values calculated on each individual granule were pseudo-colored and overlaid on top of 
the CIDA image.  (B)  Averaged fraction of acceptor in complex, (C) Averaged fraction of 
donor in complex, and (D) Average molar ratio, determined from cells expressing citrine-
cerulean-VAMP2 only (black), or in addition to soluble cerulean (blue) or soluble citrine 
(yellow).  Averages were determined by pooling the EA, ED, or ratio values determined 
on individual granules.  FRET stoichiometry calibration constants were obtained using 
cerulean-VAMP2 (for β), citrine-VAMP2 (for α) or citrine-cerulean-VAMP2 (for γ and ξ).  
Bars represent the mean ± SEM.   The number of granules / cells used for each 
condition was:  Linked-VAMP (417 granules/12 cells); Linked-VAMP + cerulean (358 / 



























Figure 4.S1.  Modeling the effects of three alternative/nonspecific localizations of 
soluble acceptor on FRET calculations.  (A) left, schematic of the first situation, where 
the bead floats on a thin layer of soluble acceptor.  In this situation, the measured “on-
bead” fluorescence consists of fluorescence arising from the linked probe conjugated to 
the bead, as well as from the soluble acceptor localized under the bead.  Changing the 
thickness of this layer results in graded effects, mostly on the slope, of the calculated EA 
(middle) and Ratio (right) vs z-distance relationships.  The thicknesses of the layers of 
soluble acceptor under the bead were modeled as:  50nm, 100nm, 200nm, and 300nm 
(shown as lines from red to blue).  (B) left, schematic of the second situation, where a 
portion of the soluble acceptor is non-specifically bound to the glass coverslip.  In this 
situation, the measured “on-bead’ fluorescence arises both from the linked probe 
conjugated to the bead, as well as from the acceptor bound non-specifically to the 
coverglass underneath the bead.  Similarly, the “off-bead” fluorescence arises from the 
soluble acceptor, as well as from the acceptor bound to the coverglass.  Increasing the 
fraction of the soluble acceptor localizing to the coverglass result in graded decreases or 
increases in the magnitude of the measured EA (middle) or Ratio (right) vs. z-distance 
relationships, respectively, with no large changes in the overall shapes of the 
relationships.  The percent of total “off-bead” fluorescence arising from acceptor bound 
non-specifically to the coverglass was modeled as:  10, 30, 50, 70, or 90% (from red to 
purple).  (C) left, schematic of the third situation, where a portion of the acceptor is non-
specifically bound to the surface of the bead.  Here, the “on-bead” fluorescence arises 
from both the linked probe conjugated to the bead, as well as from the acceptor bound 
non-specifically to the bead.  The “off-bead” fluorescence results solely from the soluble 
acceptor.  Increasing the fraction of the “on-bead” fluorescence that arises from non-
specific binding of the acceptor to the bead surface results in graded changes in the 
magnitude and to some extent, the slopes, of the EA (middle) and Ratio (right) vs. z-
distance relationships.  The percent of total “on-bead” fluorescence arising from acceptor 
bound non-specifically to the bead was modeled as:  2, 5, 10, 20, and 30% (from red to 
purple).    In parts A-C, the black markers represent the experimentally measured values 
for the condition where the on-bead:off-bead fluorescence intensity ratio was determined 
to be 12%.  The thick black line represents the original model (as shown in Figure 4.4) 
for this condition.  The population of soluble acceptor in each of these modeled 
conditions was chosen such that the final “on-bead” fluorescence intensity : “off-bead” 
fluorescence intensity ratio was equal to 12%.  In (A), increasing the layer of soluble 
acceptor between the coverglass and the bead required a decrease in the concentration 
of the soluble acceptor (pink to light pink background) to maintain an on-bead : off-bead 
ratio of 12%, whereas in (B) and (C), increasing the extent of soluble acceptor non-
specifically localized to the coverslip or to the bead required increasing the concentration 
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The present dissertation is largely focused on the regulation of SNARE protein 
function with respect to neurotransmitter release and neurosecretion.  As SNARE 
proteins catalyze the final step of membrane fusion, these proteins represent the final 
molecular targets on which the signaling pathways and molecules regulating 
neurotransmitter release must converge.  An understanding of these regulatory 
pathways and the mechanisms by which they modulate SNARE function is thus 
essential to an understanding of how the spatial and temporal properties of 
neurotransmitter release and neurosecretion are controlled.  Accordingly, the first two 
studies of this dissertation focus on the mechanisms by which two different types of 
molecules, namely, bioactive lipids, and the protein tomosyn, exert control over SNARE 
protein function, and consequently, on regulated exocytosis.  The third study of this 
dissertation focuses on the development of an imaging technique that could yield new 
insights into both the spatiotemporal dynamics and the functions of the molecular 
interactions that occur to elegantly orchestrate the process of regulated exocytosis. 
 
Lipid Regulators of SNARE Function:  PA and PI(4,5)P2 
The merging of lipid bilayers and the formation of tight SNARE core complexes 
are two central and tightly coupled processes in membrane fusion.  It is generally 
believed that the requirement of merging lipid bilayers sets a specific energy barrier that  
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must be overcome for membrane fusion to occur, while the formation of SNARE core 
complexes generates the forces necessary to overcome this energy barrier and to 
catalyze membrane fusion.  On the other hand, it has been shown that the presence of 
specific fusogenic lipids in the membrane can greatly reduce the energy barrier for 
fusion, and hence, the work that SNAREs would have to do to catalyze these events.   
The first study of this dissertation addressed the questions of whether direct 
interactions between specific lipids and SNARE proteins exist, and moreover, whether 
these interactions might serve to regulate SNARE protein function.   This study 
demonstrated that the soluble portion of the plasma membrane Q-SNARE Syntaxin1A 
(residues 1-267; lacks the transmembrane domain) formed direct interactions with acidic 
phospholipids, including the fusogenic lipid, phosphatidic acid, as well as PI(4,5)P2, a 
bioactive lipid that has been shown to exert considerable control over the process of 
regulated exocytosis.  The ability of Syntaxin1A to interact with these lipids was mapped 
to Syntaxin1A’s polybasic juxtamembrane domain, as progressive neutralizing mutations 
within this domain progressively reduced the binding affinity of Syntaxin1A for these 
lipids.  To test the function of lipid binding-deficient Syntaxin1A mutant constructs, a 
BoNT-C knockdown and rescue assay was developed so that the secretory function of 
these exogenous Syntaxin1A constructs could be studied in isolation from endogenous 
Syntaxin1A.  Importantly, these assays demonstrated that the progressive loss of 
Syntaxin1A’s ability to bind acidic phospholipids could be correlated to a progressive 
loss in Syntaxin1A’s secretory function.   Amperometric analysis of individual fusion 
events catalyzed by mutant Syntaxin1A molecules subsequently revealed a lengthening 
in fusion pore duration, as well as a decrease in fusion pore diameter, compared to 
fusion events catalyzed by the wild-type Syntaxin1A, suggestive of an energetic defect in 
the mutant Syntaxin1A’s ability to catalyze membrane fusion.  Importantly, the inhibition 
of secretion observed with the lipid binding deficient Syntaxin1A constructs could be 
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rescued by overexpression of phospholipase D1, an enzyme that generates 
phosphatidic acid, whereas knockdown of phospholipase D1 activity greatly inhibited 
control secretion, with little effect on secretion mediated by the lipid-binding deficient 
Syntaxin1A.   Taken together, these experiments suggest that Syntaxin1A-lipid 
interactions are an important determinant of the energetics of membrane fusion.  
Moreover, they suggest that aside from playing a strictly mechanical role to overcome 
the energy barrier for fusion, SNARE proteins may also function to regulate the energy 
barrier itself at sites of fusion, through direct interactions with fusogenic lipids.  Most 
importantly, these studies provide a link to bridge the gap between the protein-centered 
field of SNARE regulation, and the lipid-centered field of membrane fusion.   
While these studies clearly demonstrated that direct interactions between a 
soluble portion of Syntaxin1A and specific acidic phospholipids occur in vitro, the critical 
questions remain as to whether these interactions would still occur for a full-length, 
membrane-reconstituted Syntaxin1A, and moreover, whether these interactions would 
occur in vivo.  Notably, the full-length Syntaxin1A would be anchored to the plasma 
membrane via a transmembrane domain, and the polybasic juxtamembrane region 
would therefore be more structurally restricted in terms of its ability to interact with the 
headgroups of specific lipids.   
One potential approach to detecting Syntaxin1A-lipid interactions in vivo might be 
to first determine whether Syntaxin1A and the lipid co-localize or co-cluster within the 
membrane compartment.  While this approach would certainly not demonstrate a direct 
interaction, it would suggest that such an interaction might be functionally relevant in live 
cells.  A previous study [1] examined the two-dimensional organization of PI(4,5)P2 and 
Syntaxin1A within the plasma membrane, using fixed PC-12 cell membrane sheets (in 
which the top portions of cells adherent to a glass coverslip are removed by a brief 
sonication pulse, leaving an intact layer of plasma membrane adherent to the glass).  
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Antibody labeling with Syntaxin1A resulted in distinct, bright puncta, suggesting that 
endogenous Syntaxin1A forms clusters within the plasma membrane.  Antibody labeling 
of PI(4,5)P2 in these membrane sheets demonstrated that PI(4,5)P2 also distributed as 
bright, punctate clusters within a largely unlabeled plasma membrane.  However, the 
PI(4,5)P2 distribution in fixed cells was quite different from that visualized in live cells by 
overexpression of an eGFP-labeled, PI(4,5)P2-specific PH domain, in which a few 
punctate structures could be discerned on top of a largely uniform bright background.  
These contrasting results leave it unclear as to what the “true” distribution of PI(4,5)P2 is 
in the plasma membrane.  The diffuse labeling in the live, intact cells could have 
potentially arisen as an artifact of overexpression of the eGFP-PH domain and non-
specific binding of this domain to the plasma membrane.  Alternatively, the largely 
punctate structures of Syntaxin1A and PI(4,5)P2 in the plasma membrane sheets could 
have resulted as an artifact of the membrane sheet preparation, fixation, or even 
antibody labeling (as antibodies can, themselves, form clusters).  Regardless, a small 
proportion (~13%) of large dense-core granules was found to colocalize with both 
Syntaxin1A and with PI(4,5)P2, and interestingly, this proportion of granules was greatly 
reduced in cells that had been stimulated to secrete (13% reduced to 3%), suggesting 
that exocytosis preferentially occurs from sites at which both Syntaxin1A and PI(4,5)P2 
are present.  On the other hand, the proportion of granules that colocalized with only 
PI(4,5)P2 clusters was similarly reduced (13% to 3%) following stimulation, suggesting 
several possibilities 1) syntaxin1A clusters do not actually facilitate secretion (fusion 
occurred equally on PI(4,5)P2 sites with or without syntaxin clusters); or 2) a more 
extreme case, fusion is more dependent on PI(4,5)P2 localization than it is on SNARE 
proteins!  One other caveat to these studies is that the authors did not address whether 
the total granule number in cells was reduced following stimulation; in other words, while 
the decrease in the proportion of granules co-localized to PI(4,5)P2 that occurred 
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following stimulation could imply that these granules preferentially fused, an alternative 
explanation would be that this shift in granule localization patterns could simply be due 
to recruitment or priming processes.  Therefore, these studies require some additional 
clarification; however, they do illustrate the functional utility of the approach of 
colocalizing proteins and lipids in the membrane.  Of interest, anti-phosphatidic acid 
antibodies have recently become commercially available (Cosmo Bio, Japan), and could 
be similarly used to determine whether Syntaxin1A and phosphatidic acid co-localize in 
cells, and whether these sites are functionally important to regulated exocytosis.  It is 
important to note, however, that while these studies might support a functional role for 
the Syntaxin1A-lipid interaction, they would not be sufficient to demonstrate a direct 
interaction between Syntaxin1A and phosphatidic acid. 
One potential method to visualize direct Syntaxin1A-lipid interactions in lipid 
bilayers might be to use synthetic fluorescently-labeled lipids (see Molecular Probes, 
Eugene, OR; or Avanti Polar Lipids, Alabaster, AL).  Such lipids can be labeled on their 
acyl chains or on their headgroups (although depending on the specific lipid, the 
fluorescent tag could interfere with the function of the lipid or with its ability to interact 
with its normal molecular partners).  These lipids could potentially be delivered to the 
plasma membranes of live cells, although one would need to be sure that the labeled 
lipid could “flip” or translocate from the outer leaflet of the plasma membrane (where it is 
delivered) to the inner leaflet (where its relevant interactions with Syntaxin1A would take 
place).  One other complicating factor with this approach in live cells is that enzymatic 
activity within the cells could quickly metabolize the fluorescently labeled lipids into other 
by-products, making it unclear as to what the exact lipids / metabolites are that are being 
visualized with the fluorescent label.      
Use of fluorescently labeled lipids in vitro, however, might be the most 
straightforward method for visualization of direct interactions between the full length 
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Syntaxin1A and a specific phospholipid.  Here, the strategy would be to incorporate  
fluorescently tagged lipids into large unilamellar vesicles in which full-length Syntaxin1A 
would then be reconstituted.   Conjugation of the full-length Syntaxin1A with a spectrally 
appropriate, small fluorescent tag near the juxtamembrane region would allow for direct 
interactions between Syntaxin1A and the lipid of interest to be detected using FRET.  
These studies would circumvent any confounding factors of lipid translocation or 
metabolism that might be problematic in live cells.  While nonspecific FRET must always 
be considered as a confounding factor when dealing with high concentrations of donor 
and acceptor fluorophores restricted to a small compartment such as a liposome, this 
could be ruled out by decreasing the concentrations of the fluorescently labeled lipid 
and/or Syntaxin1A, as well as by testing similar concentrations of lipids to which 
Syntaxin1A should not bind.  These experiments should clearly indicate whether the full-
length Syntaxin forms direct interactions with specific lipids in the setting of a lipid 
bilayer.  However, extrapolation of the relevance of these experiments to the live cell 
setting is ultimately limited by issues such as whether or not the concentrations of 
proteins/lipids used adequately reflect the concentrations seen in vivo; and moreover, 
whether there exist specific regulatory mechanisms in live cells that might preclude 
certain of the protein-lipid interactions detected in vitro from actually occurring in vivo.    
Assuming that the Syntaxin1A-lipid interactions that occur in vitro do actually 
occur in vivo, the next questions to address would be to determine the specific function 
of these interactions with respect to regulated exocytosis; in other words, what are the 
specific stages of regulated exocytosis at which these SNARE-lipid interactions are 
important?  The current study demonstrated that lipid binding-deficient Syntaxin1A 
molecules exhibited a reduction in secretory function.  This defect, however, could 
encompass any of the stages of docking, priming, or fusion.  Importantly, this study 
uncovered a defect in fusion pore widening in successful full-fusion events catalyzed by 
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lipid-binding deficient Syntaxin1A molecules.   This suggests that one role of Syntaxin-
lipid interactions is to generate the lateral tension required to expand the fusion pore 
once it has formed.  However, this result does not clearly address the mechanism by 
which the loss of Syntaxin1A-lipid interactions resulted in the decrease in secretion (as 
the effect on fusion pore widening was determined for fusion events that were, in the 
end, successful).  Therefore, important questions remain:  1) Do Syntaxin1A-lipid 
interactions play a role in hemifusion or in the initial formation of the fusion pore?  2) 
Given that Syntaxin1A-lipid interactions regulate fusion pore dynamics, might these 
interactions also control the type of fusion event that occurs, eg, kiss-and-run fusion vs. 
full fusion?, or 3) Given the role of PI(4,5)P2 in priming, might Syntaxin1A-PI(4,5)P2 
interactions play a role in priming?   
The first question, whether Syntaxin1A-lipid interactions might be important for 
hemifusion or initial formation of the fusion pore, could be addressed using in vitro 
SNARE-reconstituted liposome fusion assays [2].  In these assays, two different sets of 
liposomes are created:  one in which the plasma membrane SNAREs Syntaxin1A and 
SNAP25 are incorporated, and another in which the vesicle membrane SNARE 
Synaptobrevin/VAMP2 is incorporated.  Importantly, different types of fluorescent lipids, 
as well as different vesicle content-filling fluorescent dyes, can be uniquely incorporated 
into each set of liposomes, such that as these liposomes undergo SNARE-catalyzed 
fusion, either lipid mixing or content mixing can be closely monitored.  Defects in lipid 
mixing seen for SNARE complexes containing lipid binding-deficient Syntaxin1A 
molecules would illustrate the importance of Syntaxin1A-lipid interactions in mediating 
hemifusion, whereas defects in content mixing would illustrate the importance of 
Syntaxin1A-lipid interactions in mediating the initial formation of the fusion pore.  
Importantly, in vitro assays allow the exact composition of these liposomes to be 
controlled, such that specific roles for specific lipids in these processes could be  
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discerned.   
  The second question, of whether Syntaxin1A-lipid interactions may control the 
type of fusion event that occurs, could be addressed using a combination of 
amperometry and TIRF experiments.  Kiss-and-run events represent fusion events in 
which the fusion pore opens briefly and then closes, without full dilation.  As such, these 
events can be detected in amperometric recordings as a pre-spike foot (ie, opening of 
the fusion pore) in the absence of a spike (ie, without full dilation of the fusion pore).   
These events are somewhat difficult to identify, however, as usually the key 
characteristic distinguishing a pre-spike foot from the background amplifier noise is that 
the pre-spike foot immediately precedes a large spike; regardless, this method has been 
previously used for this type of analysis [3].  If the relative proportion of prespike feet 
without a subsequent spike, compared to the total number of spikes, is altered for cells 
expressing lipid-binding deficient Syntaxin1A compared to wild-type Syntaxin1A, this 
would suggest that Syntaxin1A-lipid interactions are important in determining the mode 
of fusion events.  Similar information could be gleaned using TIRF experiments on cells 
co-expressing the wildtype or mutant Syntaxin1A constructs along with the exocytotic 
marker, synaptopHluorin.  SynaptopHluorin is a fluorescent probe comprised of the 
vesicle SNARE protein synaptobrevin/VAMP2, fused to a lumenal, pH-sensitive 
superecliptic GFP.  Under resting conditions, the acidic environment in the vesicle lumen 
quenches the fluorescence of the pHluorin; however, upon fusion of these vesicles with 
the plasma membrane, the pHluorin becomes exposed to the neutral pH of the 
extracellular solution, and its fluorescence is unquenched.  As such, exocytotic events 
can be detected as bright flashes of fluorescence as each vesicle fuses and its 
associated pHluorin molecules become unquenched.  Importantly, as the pHluorin 
molecules are anchored to the membrane, their diffusion and fluorescence properties 
following fusion can be used to distinguish between full-fusion events and kiss-and-run 
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events.  Namely, full fusion would be characterized by a bright flash, followed by a slowly 
spreading and decreasing fluorescence originating from the initial site of fusion (as the 
vesicle membrane collapses into the plasma membrane and the synaptopHluorin 
diffuses freely throughout the plasma membrane), whereas kiss-and-run fusion would be 
characterized as a bright flash that is confined spatially and that rapidly disappears 
without spreading (as the fusion pore closes and the vesicle is reacidified) [4].      
 The third question, of whether Syntaxin1A-lipid interactions are involved in 
priming could be determined using capacitance measurements under patch clamp 
recordings.  Effects of a lipid binding-deficient mutant Syntaxin1A on the initial size of the 
RRP or on refilling of this vesicle pool following depletion would implicate this region of 
Syntaxin1A as being important in priming.  Moreover, if these effects on capacitance 
measurements were similar to those seen for the cells in which the PI(4,5)P2 generating 
enzyme PIPKI has been genetically deleted [5], this could potentially indicate that the 
priming defect seen with the mutant Syntaxin1A might be related to its inability to bind 
PI(4,5)P2.  A potentially important experiment would then be to determine whether 
overexpression of PIPKI in cells expressing the mutant Syntaxin1A construct would be 
sufficient to rescue the defect in priming.   
 
Protein Regulators of SNARE Function:   Tomosyn 
 Assembly and disassembly of SNARE core complexes is tightly controlled by a 
large number of different proteins.  What regulates these regulators?  In other words, are 
there specific signals that dictate, in general, what the total number of functional SNARE 
core complexes should be at any given time in any given cell?  One possibility is that 
specific signaling pathways that reflect the secretory demand placed on each cell might 
play a key role in regulating the formation/dissolution of SNARE core complexes in a 
manner that would be appropriate for each cell.   
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Tomosyn is a soluble R-SNARE protein that exerts an inhibitory effect on 
regulated exocytosis, supposedly through the formation of non-fusogenic SNARE core 
complexes with Syntaxin1A and SNAP25.  The second study of this dissertation focused 
on whether the inhibitory activity of tomosyn on SNARE core complex formation is 
regulated by secretory demand.  Interestingly, in response to secretagogue stimulation 
with DMPP, tomosyn was found to rapidly translocate from the cytosolic to plasma 
membrane regions of bovine adrenal chromaffin cells.  This translocation was 
associated with an increase in the interaction between tomosyn and syntaxin1A, as 
measured by FRET; importantly, this increased interaction resulted in part from the 
increased cycling of tomosyn into tomosyn-SNARE complexes.  Notably, the 
secretagogue-induced interaction of tomosyn and syntaxin1A occurred downstream of 
the Rho-GTPase/Rho-associated coiled-coil forming kinase (ROCK) signaling pathway, 
as demonstrated by the findings that: 1) secretagogue stimulation resulted in activation 
of RhoA; 2) inhibition of ROCK blocked the secretagogue-induced interaction between 
tomosyn and syntaxin1A; and 3) stimulation with LPA, a non-secretory stimulus that 
activates RhoA, resulted in an increased tomosyn-syntaxin interaction, similar to that 
seen with DMPP treatment.  In PC-12 cells overexpressing tomosyn, secretagogue 
stimulation in the presence of LPA increased the inhibitory effect of tomosyn on 
secretion.  This effect was blocked by inhibition of ROCK and required the ability of 
tomosyn to interact with syntaxin1A.  Taken together, the experiments of this study 
demonstrate that the activity of tomosyn is regulated by secretagogue activation.  These 
studies thus uncovered a mechanism by which the formation of SNARE core complexes 
can be dynamically regulated by secretory demand.  Moreover, these studies highlight 
the value of using fluorescence imaging approaches to follow the spatiotemporal 
dynamics of protein-protein interactions in response to a specific stimulus. 
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While the present study supports the currently accepted model in the field for 
tomosyn’s mode of action, whereby formation of nonfusogenic tomosyn-SNARE core 
complexes results in the inhibition of secretion, it is important to note the shortcomings of 
such a model.  Namely, many tomosyn homologues have been demonstrated to play 
regulatory roles in vesicle trafficking and membrane fusion, yet the R-SNARE motif, 
which is critical for tomosyn’s formation into SNARE core complexes, is not highly 
conserved among tomosyn homologs.  Moreover, the N-terminal region of tomosyn 
comprises the majority of tomosyn’s structure and is the most highly conserved region 
among tomosyn homologs, yet its function remains largely unaccounted for in the 
current model.  Since the publication of the present study, this model has been 
challenged by a collaborative study with the Ashery laboratory, which demonstrated that 
a tomosyn truncation mutant that lacks the R-SNARE domain and that cannot interact 
with Syntaxin1A, is still sufficient to inhibit vesicle priming.  Moreover, tomosyn’s 
inhibitory effect was found to require its intact N-terminal domain, as an N-terminal 
deletion mutant of tomosyn could still bind to Syntaxin1A, yet lacked the ability to inhibit 
secretion [6].  Interestingly, our earlier findings also hinted at the fact that tomosyn does 
not require the R-SNARE motif for inhibition of secretion, as Figure 3.7 demonstrates 
that a C-terminal truncation mutant of tomosyn was capable of inhibiting exocytosis 
similarly to the wild-type tomosyn in response to secretagogue stimulation.  Figure 3.7 
does, however, demonstrate that an intact C-terminal domain of tomosyn is necessary 
for the regulation of tomosyn’s inhibitory activity by the Rho/ROCK pathway.  These 
results suggest that the N-terminal domain of tomosyn may comprise the “business” 
portion of the molecule that functions to inhibit exocytosis, whereas the C-terminal 
domain may be important in regulating the activity of the N-terminal domain or in 
localizing the protein to sites where it may preferentially act to inhibit secretion.   Notably, 
one of the first reports on tomosyn demonstrated that both the N- and C-terminal regions 
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of tomosyn were required for its inhibitory effect on secretion; however, the C-terminal 
truncation mutant of tomosyn used in this study (residues 1-738) deleted not only the R-
SNARE motif, but also a large portion of the hypervariable linker between the R-SNARE 
motif and the N-terminal β-propellers [7].   These results would therefore suggest that 
the hypervariable linker plays a critical role in tomosyn’s inhibitory effect on secretion. 
In general, it appears that a new model for how tomosyn functions to regulate 
secretion may be in order.  This model would need to account for how the N-terminal 
and hypervariable regions of tomosyn could inhibit secretion, which underscores the 
need to identify other proteins with which tomosyn (in particular, regions of tomosyn 
outside of the R-SNARE domain) might interact.   One approach to solving this problem 
would be to purify tomosyn protein that lacks the R-SNARE domain, and to use this 
protein to pull down interacting proteins from a brain lysate; such interacting molecules 
could be subsequently identified using mass spectrometry.  One shortcoming of this 
technique is that functionally significant but low affinity protein-protein interactions may 
not be identified in such an assay; the same would hold true for interacting proteins that 
might require binding to both the N- and C-terminal domains of tomosyn.  Alternatively, 
the full-length tomosyn could also be used to pull down binding partners from a brain 
lysate.  A complicating factor in this case is that the high affinity of tomosyn for syntaxin 
(~15nM), and the high level of syntaxin expression in the brain (~1% of total brain 
protein), would likely out-compete any potential binding partners from being detected.  
To circumvent this problem, the brain lysate could first be immunodepleted of syntaxin 
prior to binding to tomosyn, in order to maximize the chances of detecting novel binding 
partners.  Again, mass spectrometry could then be used to identify these novel 
interaction partners. 
Aside from uncovering new protein-protein interactions for tomosyn, another 
approach to understanding its mechanism of action might be through understanding the 
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functions of its different isoforms.  In mice, there are two paralogous genes for tomosyn 
(tomosyn-1 and tomosyn-2) that result in the expression of 7 different isoforms.  Notably, 
the structural differences between these isoforms all occur within the hypervariable 
region of tomosyn that links the N-terminal β-propellers to the C-terminal R-SNARE 
motif.  Interestingly, the expression of tomosyn isoforms has been shown to be regulated 
developmentally, with levels of tomosyn-1 exceeding levels of tomosyn-2 during 
embryonic stages (E10-E18), and with tomosyn-2 expression levels exceeding tomosyn-
1 expression levels in postnatal stages of development (P12 to adult) [8].  Furthermore, 
expression levels of tomosyn-2 increase substantially over development (31-fold 
increase from E10 to P12), whereas the expression levels of tomosyn-1 remain relatively 
constant over development (only 2.7-fold increase from E10-P12). Moreover, the splice 
variants of tomosyn-2 are also modulated during development, with b-tomosyn-2 
selectively expressed early on (E10-E12), and with all four tomosyn-2 splice variants 
being equally expressed by P12.  This differential regulation of expression of tomosyn’s 
genes and splice variants suggests that tomosyn may play other important roles in 
development, and that the regulation of neurotransmitter release by tomosyn may be 
more intricate than is currently understood.  Importantly, there has been no study of the 
differences in tomosyn genes or isoforms with regard to synaptic function or regulated 
exocytosis (almost all studies have been performed on the m-tomosyn-1 isoform).  
However, the developmental regulation of the expression patterns suggests that 
tomosyn-2 might be more important for regulation of neurotransmitter release in a fully 
developed nervous system compared to tomosyn-1.  Thus, it will be critical to elucidate 
how the different tomosyn isoforms differ functionally.  Moreover, as the isoforms differ 
largely in the hypervariable linker region of tomosyn, these studies will also likely be 
informative as to the specific function of this region.   Notably, this region has been 
demonstrated to contain a PKA phosphorylation site [9], suggesting that post-
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translational modification of this region may provide a key mechanism by which 
tomosyn’s function in neurotransmitter release can be additionally regulated.   
 
Development of an Optical Method to Visualize the Spatiotemporal Dynamics 
of Molecular Interactions that Regulate SNARE Complex Activity 
 
 The first two studies of this dissertation utilized the FRET imaging technique to 
some extent, as a gauge of specific protein-protein interactions that occur in intact, live 
cells.  In the first study, FRET experiments demonstrated that, under resting conditions, 
the lipid binding-deficient Syntaxin1A construct bound to Munc18-1 similarly to the wild-
type Syntaxin1A.  The second study expanded upon this technique to visualize time-
lapse changes in the tomosyn-syntaxin1A interaction that occurred in response to a 
stimulus.  In the final study of this dissertation, the FRET methodology was extended 
even further, through the development of a new optical technique, termed sensitized 
emission TIRF FRET imaging.  This technique could potentially allow for the 
visualization of the spatiotemporal dynamics of molecular interactions occurring at or 
near the plasma membrane, with concomitant tracking of the functional state of the 
individual secretory vesicles at which these interactions may be occurring.  Notably, this 
technique is likely to yield many novel findings in the area of regulated exocytosis, as 
one of the critical remaining problems in the field lies in determining the sequencing of a 
number of different molecular interactions that must take place during the process of 
exocytosis of a secretory vesicle.   
 The third study of this dissertation focused on development of the theoretical and 
experimental considerations required for quantitative application of the sensitized 
emission TIRF FRET imaging in live cells.  The motivating factors driving the utility of 
this technique are that:  1) unlike other methods of FRET imaging, sensitized emission 
FRET imaging is highly amenable to time-lapse imaging of bi-molecular interactions with 
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high sensitivity and high temporal resolution; and 2) TIRF imaging provides extremely 
high axial resolution of the plasma membrane region (exactly where exocytosis occurs) 
to allow individual vesicles to be identified and tracked over time.  While the combination 
of these methodologies would afford the sensitivity and high spatiotemporal resolution to 
sequence the dynamics of molecular interactions occurring near the plasma membrane, 
and to correlate changes in these interactions with changes in the functional state of 
granules, this technique is not without complications.  Namely, sensitized emission 
FRET imaging requires calibration of the imaging system and fluorescent probes used to 
allow for determination of apparent FRET efficiencies and molar ratios.  Moreover, TIRF 
imaging utilizes, for its illumination source, an evanescent field whose intensity decays 
exponentially in the z-direction.  This complicates the interpretation of FRET results, 
which are inherently intensity-based and thus may differ depending on the z-position of 
the molecular interaction that is being tracked.   
Prior to this study, there had been no indications as to how the sensitized 
emission calibration parameters or FRET measurements would be affected by 
evanescent illumination.  Importantly, the current study adapted a technique of imaging 
large (10µm) fluorescent beads, to determine the exact relationships of the sensitized 
emission FRET calibration parameters and apparent FRET measurements with respect 
to z-distance from the glass/water interface.  Of note, matching of the characteristic 
depths of the 442nm and 514nm laser lines was found to be critically important in 
minimizing z-distance dependent changes in FRET calibration parameters (ie, in 
creating flat FRET calibration parameter vs. z-distance relationships).  Moreover, 
matching of the 442nm and 514nm TIRF depths was found to be critical for minimizing 
errors in the calculation of the apparent FRET efficiency at different z-distances from the 
glass-water interface.   
This study also addressed the potential use of sensitized-emission TIRF FRET 
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imaging in experiments in which the donor and acceptor probes exhibit subcellular 
localizations to compartments other than just the plasma membrane (eg, secretory 
granules, mitochondria, cytoskeleton, cytosol).  These considerations are especially 
important in that many of these compartments may exhibit z-axis movements over the 
course of the experiment that could confound “true” changes in apparent FRET, with 
changes in apparent FRET that occur as a result of a change in z-position.  Importantly, 
a combination of in vitro experiments and mathematical modeling led to several useful 
guidelines.  First if both the donor and acceptor molecules localize exclusively to the 
same compartment and these localizations do not change over the course of the 
experiment, then the apparent FRET efficiencies and molar ratios measured will be 
independent of any changes in the compartment’s z-position.  Second, if one of the 
probes (eg, the donor) localizes exclusively to a compartment, whereas the other probe 
(eg, the acceptor) localizes partially to that compartment and partially to the cytosol, then 
measurement of the apparent FRET efficiency of the probe localized exclusively to the 
compartment (eg, ED) will be independent of changes in the compartment’s z-position.  
Moreover, in this case, the extent to which the apparent FRET efficiency EA is 
dependent on changes in z-position of the compartment, will be dictated by a 
combination of the extent of cytosolic localization of the donor, and the extent to which 
the compartment moves in the z-direction.  In these situations, mathematical modeling to 
simulate the specific imaging conditions (eg, subcellular localizations, proportion of 
probes on or off compartments, etc) can provide guidelines as to the amount of error that 
can be expected in EA measurements as a result of change in the compartment’s z-
position.  Lastly, this study implemented sensitized emission TIRF FRET in a controlled 
situation in live cells, and demonstrated that apparent FRET efficiencies and molar ratios 
changed linearly, as expected for linked citrine-cerulean FRET probes localized to either 
the plasma membrane or to secretory granules, in the presence of cytosolic citrine or 
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cytosolic cerulean.  Importantly, this study expands the possibilities for the application of 
sensitized emission TIRF FRET in living cells, and highlights some of the major issues 
which must be considered when applying this methodology to complex situations.  
Full implementation of this technique for simultaneously tracking changes in 
FRET with changes in the functional status of individual granules will require 
incorporation of a spectrally distinct, vesicle-content filling probe, in addition to the FRET 
probes.  Such a probe will allow for tracking of the X, Y, and Z motions of granules 
adjacent to the glass-water interface, as well as determination of when each granule 
undergoes fusion.  Moreover, judicious selection of the FRET probes used in these 
experiments will likely make analysis of the data far more straightforward (ie, consider a 
situation in which both donor and acceptor fully localize to a granule, as opposed to a 
situation in which both FRET probes exhibit multiple subcellular localizations and change 
their localization patterns over time, on a subcellular compartment that moves 
substantially in the z-axis).   
Importantly, full implementation of sensitized emission TIRF FRET concomitant 
with granule tracking capability should provide several key parameters that will be 
immediately helpful in sequencing the function of molecular interactions with respect to 
granule fusion.  For instance, do the molecules interact before or after membrane fusion 
occurs?  If they interact before membrane fusion, what is the latency time distribution of 
when the molecules interact compared to when the granule fuses?  Do molecular 
interactions occur preferentially on granules that fuse vs. those that don’t fuse?  Do the 
molecular interactions occur on granules that are highly mobile vs. those that are 
immobile?  Do the molecular interactions change the mobility status of a granule?  Do 
the molecular interactions appear to be spatially restricted to hotspot clusters of 
granules, or do they occur globally?  While these are seemingly simple questions, the 
answers to such questions remain largely unknown for most proteins involved in 
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regulated exocytosis, including even the SNARE proteins!  This undermines the clear 
need to be able to resolve changes in these molecular interactions on a single vesicle 
level. 
  High temporal resolution visualization of the protein-protein interactions and the 
functional states of granules is ultimately limited by the brightnesses of the fluorescent 
probes used, as well as the sensitivity of the camera, both of which ultimately determine 
the exposure time required to achieve a sufficiently high signal-to-noise ratio.  For 
instance, low fluorescence intensity signals would necessitate higher exposure times, 
which would ultimately dictate the maximum rate of image acquisition.  Moreover, the 
total length of time for which these interactions can be followed at such a high temporal 
resolution will largely be dependent on the rate at which these probes undergo 
photobleaching.  Photobleaching is likely to be the largest problem for sensitized-
emission TIRF-FRET imaging, as this is a process that will likely be difficult to correct 
for, given that the rate of photobleaching will depend on not only the fluorophores used, 
but also the extent to which FRET occurs, as well as the z-positions of the fluorophores 
being imaged.  Technological advances, including development of new genetically 
encoded fluorescent probes with higher extinction coefficients, high quantum yields, and 
higher resistance to photobleaching, as well as development of highly sensitive cameras 
that can largely reduce the required exposure times, are likely to play important roles in 
circumventing the problem of photobleaching.    
Ultimately, the implementation of sensitized emission TIRF FRET is likely to 
transform the current understanding of the molecular processes that underlie regulated 
exocytosis.  This type of transformation has many analogies to how the recordings of 
stochastic single channel currents from ion channels undoubtedly transformed the 
macroscopic view of how ion channels functioned.  Importantly, the ability to visualize 
specific changes in protein-protein interactions in the context of individual secretory 
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granules will be paramount to developing an understanding of the sequencing of 
molecular interactions that must be integrated for regulated exocytosis to occur.   
 
Final Remarks 
 In summary, this dissertation comprises three somewhat distinct research 
projects that contribute to the fields of SNARE protein function and neurotransmitter 
release.  Combined, the first two studies of this dissertation employ a wide variety of 
experimental approaches including molecular biology, biochemistry, electrophysiology, 
and fluorescence imaging, to analyze specific protein-protein and protein-lipid 
interactions that are critical to the process of membrane fusion.  The final study of this 
dissertation lays the groundwork for a novel optical approach by which the 
spatiotemporal dynamics of bi-molecular interactions can be directly correlated to the 
activity of secretory granules or synaptic vesicles during regulated exocytosis.  
Altogether, the studies of this dissertation further our understanding of the molecular 
mechanisms that govern the final stages of neurotransmitter release, and take the 
additional step to develop a new technology that is likely to drive our understanding of 
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